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Abstract 
Thymidine kinase from herpes simplex virus catalyses the 
phosphorylation of a wide range of substrates, including thymidine and 
guanosine analogues. This substrate ambiguity is exploited in 
antiherpes drug therapies. Crystal structures reveal how the enzyme 
accommodates a variety of drugs and suggests approaches both for 
thymidine kinase inhibition and thymidine kinase mutations to enhance 
substrate activation. 
UvrB and UvrC are two components of the nucleotide-excision repair 
mechanism in prokaryotes. Both proteins share a small domain of high 
sequence homology. Interaction between these domains enables the 
first incision made by UvrBC to damaged DNA. A crystal structure of 
this domain from Ecoii UvrB confirms that it adopts a helix-loop-helix 
fold and how it dimerises by a loop-loop contact and not by helix-helix 
contacts. The residues involved in dimerisation are strongly conserved 
in the putative loop region of the homologous UvrC domain and it 
appears likely that the same interaction exists between UvrB and UvrC. 
A Ni-porphyrin with cationic substituents showing a bimodality of 
interactions with a B-type DNA helix is revealed by an atomic resolution 
crystal structure. The porphyrin ring adopts a non-planar conformation 
arising from its nucleic acid contacts, especially its fit into the DNA 
minor groove. Also seen is the end-to-end dimerisation of DNA helices, 
a disordering of the sugar-phosphate backbone and complete hydration 
of the DNA-porphyrin complex. The use of a variety of methods to solve 
the structure is described. The structure possesses a dyad symmetry 
aligned with the crystals' unit cell axes. This creates a situation where 
pseudosymmetry, or merohedral twinning can exist, and posed 
difficulties for the refinement of the structure. 
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Evolving biological complexity 
When one looks at the structures of proteins and nucleic acids it is 
inevitable to wonder how they came to be. Their structure and 
function are one - playfully interwoven. They are the products of 
living things, which in turn are the products of natural selection. In 
their form they carry their past, their present and their future. 
"'It may be claimed that the most important fact about them 
[ living things ] is that they take part in the long term processes 
of evolution" [13. A broad definition, that encompasses viruses as 
well as their hosts. It also includes the environment. All living 
things possess the ability to organise their environment. An 
organism is a kind of go-between; a bit of the environment locally 
modified by its genetic structure E21. The question still lingers as to 
the environment and origins of the first living things [31. Evolution 
theory alone is unable to provide the answer. It is the complexity 
and cooperativity seen at all levels in living things [41, arising from 
the step-by-step adaption of existing structures, that evolution 
best explains [5]. 
Organisms have persisted with proteins since the earliest cells 
arose. But even within the lifespan of a single cell, its proteins do 
not persist as such. They are continually being remade. It is the 
ability to make proteins, and other molecules, which persists. This 
ultimately depends on nucleic acid molecules. But neither do these 
persist forever. Every time a cell divides its nucleic acid molecules 
are remade. What is inherited over the long term are particular 
sequences, the genes, within nucleic acids. A cell's protein 
composition is the expression of its genetic composition. 
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Only genes provide the continuity needed for the evolution of life. 
It is the genetic form that lasts, and it is natural selection which 
shapes the genes 151. Natural selection is mostly a conserver of 
form. It keeps organisms adapted to their environment. If 
environmental pressure changes, natural selection may direct a 
change in the genes, and return their host to a state of optimal 
performance. Yet one of the most interesting questions is how 
natural selection invents. This arises through the discovery of 
alternative functions for preexisting structures [61. Such structures 
are said to be preadapted to the alternative functions to which 
they are put. Preadaptation is a fortuitous and general property of 
all structures. This thesis, for instance, could be used to prop up a 
wobbly table or to press flowers in. 
Preadapted structures especially favoured by living things are 
proteins, amino acid polymers [71. Depending on the unique amino 
acid sequence of a protein it folds into a unique structure. Each 
amino acid is distinguished by the functional groups, the 
chemistry, present in its side-chain. It is the interaction of these 
side-chains within a protein that underlies its folding [8"12]. Some 
proteins bathe in water, others bathe in the oily cell membrane. 
Responding to these contrasting environments, the hydrophobic 
side-chains of a protein tend to be buried in its core or exposed on 
its surface [13,14] 
The folding of a protein brings groups of side-chains together in 
space, to create larger functional groups with novel chemical 
properties [15,16]. Hence each protein is a diverse physicochemical 
framework. This diversity is an integral part of protein function and 
evolution. Enzymes, for instance, almost always show some activity 
over a range of substrates. This "substrate ambiguity" is important 
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for the evolution of enzymes and new metabolic pathways [17-20]. 
Once proteins could be constructed by the sequential 
polymerisation of amino acids by an ancient organism - opportunity 
knocked, and these organisms never looked back. 
Evolution through natural selection requires more than the 
inheritance of structures encoded by genes. It requires the 
potential for the structures to be modified while remaining 
inheritable. These events take place at the genetic level, requiring 
both mutations to the sequences of nucleic acids and the survival 
of these mutations. Mutation is a wholly random process. Yet the 
evolutionary exploration of a structural gene is not wholly 
random [211. It is a succession of random steps checked at each 
step to see if it seems to be in the right direction. A mutation in a 
gene persists only if natural selection does not tend to eliminate 
its presence. 
Since the information required to make proteins is stored in the 
form of nucleic acid sequences, homologies between sequences 
implies a homology in their protein products [221 and their evolution 
from a common ancestral gene. In most cases such sequence 
homologies are only found for recently diverged proteins. Natural 
selection does not tend to conserve the coding sequences for 
proteins. What is conserved is the overall protein fold and residues 
essential to function (231. It is in the folds shared by proteins where 
homologies are most apparent. 
The incidence of homology amongst protein structures is very high, 
with most proteins belonging to a particular structural family [24] 
Homologies are also observed within proteins. Distinct and often 
independently folded units exist within proteins, called domains. In 
many of the multidomain proteins of known structure, two of the 
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domains exhibit similar folds [25,26]. This may be due to a limit on 
the number of stable protein folds. Yet it seems highly improbable 
that separate domains within a protein could have independently 
evolved homologous structures by convergent evolution. It is more 
likely to reflect an evolutionary history founded upon gene 
duplication. 
Gene duplication [271 is an event in which a single chromosome 
acquires both copies of a gene during replication. From the scheme 
outlined so far, gene duplication is a necessary part of structural 
evolution. Without it the idea of preadaptation would have to play 
a secondary role to chance, where every protein began from 
scratch. The inheritance by an organism of two homologous copies 
of a gene facilitates the adaption of one of the duplicated genes - 
while its counterpart continues to direct the synthesis of a 
presumably essential protein. Gene duplication is not the only way 
in which genes, or parts of genes, can be exchanged. between 
chromosomes or genomes but at present the role of these events 
12s in the evolution of ancestral proteins is uncertain 'so1. 
A gap exists between a gene and the protein it specifies - the 
means by which one becomes the other. This gap is bridged by 
other nucleic acid molecules 1311. Not all genes specify the 
synthesis of a protein, but all genes specify the synthesis of a 
nucleic acid molecule whose sequence is the same as the gene. 
Nucleic acids are nucleotide polymers, and like proteins, some of 
them will fold into unique structures possessing functional 
properties [32,33]. So nucleic acids, in addition to carrying genetic 
information, are also preadapted structures. Indeed their 
information content is bound up in their structure. All it takes is 
the modification of nucleic acid structures by amino acids, to 
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provide a framework for making proteins. And this is what is 
observed [34-36]. Both the Information and the apparatus to make 
proteins is based on nucleic acids. This makes the evolution of 
protein synthesis seem almost trivial, since In all likelihood the 
same framework could synthesise other kinds of polymers (37]. 
As a hypothetical point in the evolution of protein synthesis, the 
modification of nucleic acids with amino acids stands out. It has 
parallels seen In the methylation (38,39] and supercoiling of nucleic 
acids [40,41]. It also has parallels seen in the modification of 
proteins (42,43]. The most common kind of protein modification Is 
the binding of metal ions [44,45]. For instance, the metalloprotein 
nitrogenase, found only in certain bacteria (46], makes ammonia 
from dissolved nitrogen gas. Without this amazing catalyst 
providing a source of nitrogen to the food chain, the evolution of 
living things would have been greatly hindered [47]. The covalent 
linking of extra functional groups, or molecules, to a protein can 
also confer novel functional attributes on the protein (48]. Histones, 
for instance, have remarkably stable amino acid sequences, yet 
their genes have abundantly mutated [49,50]. Their functionality 
depends on reversible modifications. The nature of which 
determines whether genes themselves, which are in association 
with histones, are available for expression [51]. 
Evolving the means to specifically attach amino acids to nucleic 
acids, or other preadapted structures, would offer novel 
chemistries. That the means became so elaborated, eventually 
leading to the synthesis of proteins, would not have been its 
objective. Whether the means to do this was first catalysed by 
nucleic acids may never be known. Aside from the nucleic acid 
framework involved in protein synthesis, the catalytic activities we 
observe today in nucleic acids are mostly limited to reactions with 
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other nucleic acids [52]. This may have not always been the case. 
Nucleic acids bind metal ions, indeed their structures depend on 
them. They are also highly reactive, so much so they have to be 
constantly repaired to maintain their genetic Integerity [53,54], 
With the arrival of proteins, the evolutionary pressure to have 
catalytic nucleic acids would be diminished. Nowadays the 
synthesis of nucleic acid molecules is directed solely by proteins, 
called polymerases [55,56]. Yet there is no reason to expect that a 
nucleic acid framework could not do the same. This makes it seem 
that proteins took over. But what it best suggests is the genome 
gradually adapting to the new opportunities on offer. One adaption 
of the genome being the establishment of a genetic code [57-60]; 
whereby particular units of nucleic acid sequence specify particular 
amino acids. Not suprisingly nucleic acids are perfectly preadapted 
for this. 
It is very tempting to place nucleic acids at the heart of it all [60- 
63], Yet it is doubtful whether any of the biochemicals we observe 
today would have been appropriate at the very start of 
evolution [6,64]. It is not amino acids, nucleotides, sugars or lipids 
that are critical (65-68]. It is frameworks such as catalysts [69"72] and 
above all molecules that carry genetic information. There is also 
the remoteness that such biochemicals would have accumulated in 
primordial waters. Even if they had, the first evolving systems 
could not have foreseen which of the molecules in their 
surroundings would have been appropriate for the adaptions that 
. were to emerge in the future 
173,741 
Novel ways of doing things become possible and these may 
displpce older ways [75]. A possibility that is entirely consistent 
with, - moreso a true appreciation of, the idea of preadaptation - 
In 
leads to the question as to whether life has always depended on 
the same kinds of genetic and catalytic molecular species that exist 
now. 
In 1940 Linus Pauling and Max Delbrück proposed that biological 
specificity resulted from a detailed complementariness in the 
structure of two molecules [761. By 1948 he wrote about the gene: 
"If the structure that serves as a template consists of, say, two 
parts, which are themselves complementary in structure, then each 
of these parts can serve as the mold for the production of a replica 
of the other part, and the complex of two complementary parts 
thus can serve as the mold for the production of duplicates of 
itself" [77,78], Five years later, the mold was discovered to be a DNA 
helix made from two self-complementary nucleotide polymers (791. 
All about us, nucleic acids are the informationally active chemical. 
Possibly nucleic acid became established amongst a number of 
candidates [801, possibly coexisting, because it was preadapted for 
the invention of proteins. Leaving us to wonder on how many ways 
existed in the past for the structure of genetic Information and its 
adaption, and what the future holds for genes [8,82]" 
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Binding of nucleoside analogues by herpes 
simplex virus thymidine kinase 
The thymidine kinase from herpes simplex virus (HSV-TK) 
can phosphorylate a wide range of nucleoside substrates. 
This feature is exploited in antiherpes therapies, so that 
only in herpes infected cells are nucleoside analogues 
phosphorylated that can inhibit viral DNA replication. 
Crystals of HSV-TK reveal how its nucleoside binding pocket 
accommodates, without significant distortions, a variety of 
thymidine and guanosine analogues. Approaches for enzyme 
modification and inhibition are also apparent from these 
structural studies. 
Infecting humans, herpes simplex virus type-1 is member of the 
herpesviridae family [83-8'1. Viral entry is established via mucosal 
surfaces or damaged skin and an initial virus replication occurs in 
dermal and epidermal cells. Replicated virions then infect 
cutaneous nerve endings and migrate via axons to the cell bodies 
of ganglia where the virus remains latent for the lifetime of the 
infected individual [88,89]. Upon reactivation from latency the virus 
spreads via the nervous system to the skin and mucosal surfaces to 
cause herpetic lesions, such as facial, oral, and genital cold 
sores [90]. In more extreme outbreaks of the virus, ocular keratitis 
and encephalitis can occur. Epidemological studies estimate that 
60-95% of the human population are infected by a member of the 
[91] herpesviridae family . 
Existing drug therapies for herpes simplex virus target the viral 
thymidine kinase [923. The viral thymidine kinase is not critical for 
viability of the virus, and can be replaced by human thymidine 
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kinase [931. In neurons, where the virus remains latent, the host 
thymidine kinase is suppressed, suggesting that the virally encoded 
thymidine kinase is required for reactivation from latency (94]. 
Thymidine kinase catalyses the phosphorylation of deoxythymidine 
[9s, 96)ß a first step in the synthesis of thymidine triphosphate. The 
phosphate Is transferred to thymidine from ATP. HSV-TK is special 
by virtue of its ability to phosphorylate a number of other 
substrates, including thymidine monophosphate and nucleoside 
analogues [97-101]. Two nucleoside analogues used to treat herpetic 
lesions are aciclovir and ganciclovir (10i-1051. These drugs are most 
successful when they are given in the earliest stages of a herpes 
lesion [90]. Their mode of action ultimately relies on a termination 
of viral DNA replication [1061. After the initial phosphorylations by 
HSV-TK, additional phosphorylations by non-specific host kinases 
generate a nucleoside analogue triphosphate. The incorporation of 
the nucleoside analogue into the replicating DNA strand by the viral 
DNA polymerase results in an arrest of DNA replication. The 
addition of aciclovir to a DNA strand, due to its lack of a 3'OH 
group, terminates chain elongation. While ganciclovir within DNA 
alters its conformation, causing DNA malfunctions and in sufficient 
doses leads, to an arrest of DNA replication. Within the host cell, an 
arrest of DNA replication signals apoptosis of the cell, a process 
[ where the cell digests itself 107,10sß 
Humans are hosts for other herpes viruses , including 
cytomegalovirus, Epstein Barr virus, Varicella-zoster virus (chicken 
pox) and HHV-6 (roseala infantum) [109"1133. A variety of thymidine 
kinases are found amongst the herpesviruses that exhibit a range 
of substrate specificities - and in some cases, they phosphorylate 
[1 the same drugs as herpes simplex virus 
14-1163 
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With the development of gene therapies [1171, humans are now 
becoming hosts to designed HSV-TK containing vectors. By 
transfecting cancer cells with the HSV-TK gene, the dividing cells 
can be killed upon treatment with a nucleoside analogue [h18 120 
Clinical trials of HSV-TK gene therapy have so far been made with 
some success on human brain, prostate and ovarian 
tumours [121-123]. These therapies are limited however due to 
difficulties in specifically transfecting the HSV-TK gene into a 
significant proportion of cancerous cells. One way that is being 
tested to achieve effective delivery of the HSV-TK gene to brain 
[ tumours is to use vectors based on herpes simplex virus 124ý125j 
fig. 1 Dimer of Herpes simplex virus thymidine kinase 
Overall structure HSV-TK ( 374 residues ) possesses an 
aß-topology, at its core is a five-stranded parallel ß-sheet 
surrounded by 14 a-helices ( fig. 1 ). A significant structural 
homology exists between HSV-TK and the nucleotide 
monophosphate kinase ( NMPk ) family of proteins [126,127] However 
their evolutionary connection is unclear, what is known is that HSV- 
TK almost certainly began life as a cellular nucleoside kinase [128- 
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1301 Alignment of HSV-TK with yeast thymidylate kinase [131,1321, a 
member of the NMPk family, shows the overall similarity of their 
folds and the similar locations of their ATP and nucleotide binding 
sites ( figs. 2A, 2B ). 
figs. 2A, 2B Alignment of HSV-TK with yeast thymidylate kinase 
Nucleotide monophosphatase kinses are commonly characterised in 
terms of three domains: The core domain which consists of the 
parallel five-stranded ß-sheet and a motif called aP loop which is 
solvent accessible and involved in ATP binding [133-136). The P loop 
contains a conserved GXGKT sequence motif which binds the 
ß-phosphate of ATP. The NMPbind domain involved in nucleoside 
binding lies within the protein and is made from residues spread 
throughout the protein (127,1371 The lid domain consists of a short 
flexible region of residues, rich in arginine and lysine, which are 
drawn about the active site when ATP and nucleotides are 
133] [133] 
From a number of NMPk crystal structures, a cycle of protein 
movements has been pieced together for the catalytic steps of 
NMPs [138-139]. This cycle of protein movements ( fig. 3 ) are 
essentially distinguished between two forms of the enzyme, an 
23 
open state where substrate binding and release occur, and a closed 




fig. 3 Movements of the lid domain are needed to promote catalysis. 
The binding of ATP by HSV-TK is dominated by the P loop, where all 
the backbone amide groups of the GXGKT motif ( Gly59-Met60- 
Gly61-Lys62-Thr63 in HSV-TK ) point inwards to contact the ATP 
ß-phosphate. The adjacent Thr64 also contacts the ATP 
a-phosphate. The base moiety of ATP makes no distinct protein 
contacts, explaining why other nucleoside triphosphates can replace 
[140-142) ATP as the phosphoryl donor 
The HSV-TK nucleoside binding site involves protein contacts with 
three, almost parallel, a-helices ( fig. 4) [143] The kind of protein- 
nucleoside contacts seen in HSV-TK share common features with 
other NMPb; nd domains. Where a combination of specific and water- 
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mediated hydrogen bonding and steric interactions act to localise 
the nucleoside in the protein ready for phosphorylation. 
fig. 4 Three helices of HSV-TK form its nucleoside binding domain 
In solution and in its crystal structures [141,144], HSV-TK exists as a 
homodimer ( fig. 5 ). The molecules dimerise via a relatively flat 
surface which reduces the solvent accessible surface of a monomer 
by -17%. The interface is formed by three of the longer helices in 
each monomer, with hydrophobic side-chain interactions 
predominating and solvent largely excluded. 
Many of the differences between the sequences of HSV-TK and 
other NMP family differences can be attributed to sequence 
insertions belonging to the dimer interface of HSV-TK [130] A 
possible benefit for the dimerisation of HSV-TK is an improvement 
to overall protein stability [145,146] Since. the active residues for 
deoxythymidine phosphorylation are distributed throughout the 
protein, a general promotion to protein stability through 
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dimerisation may contribute to substrate binding. Energy 
transduction may also occur between monomers (1471. For instance, 
the binding of substrate by one monomer may favour the release of 
phosphorylated substrate from the other. A similar kind of interface 
is seen in the class III ribonucleotide reductases [148,149] In these 
enzymes, nucleotide binding at the dimer interface allosterically 
regulates the ribonucleotide substrate specificity of its active site 
which is -17A away [1501 
fig. 5 Large dimerisation interface of HSV-TK 
Crystal structures Two crystal forms of HSV-TK have been 
solved. The first HSV-TK structure was solved by Wild et al. [151,152] 
then subsequently by Brown et at. [153], belonging to the crystal 
space groups 14 and C2221 respectively. The HSV-TK structures 
from both crystal forms are essentially identical, having a rmsd 
positional difference of 0.52A for their peptide backbones. The 
enzymes in both cases are in the closed conformation with the lid 
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domain enclosing bound substrates, also their N-terminal nuclear 
localisation motif are disordered I'54L 
All the structures of HSV-TK complexed with nucleoside analogues 
described here have the same crystal form as that used by Brown 
et a/., with an outer resolution limit of 1.8-2.5A. In these crystals, 
a HSV-TK dimer is observed in the crystal asymmetric unit. Some 
regions of the protein are disordered, involving residues 11-45, 
70-76,148-153,264-269 and 375-376. A sulphate ion is located in 
the ATP ß-phosphate position of the P loop. Over 250 water 
molecules have been identified. Of these, 150 can be regarded as 
particularly good, having sites mostly in the interior of the protein 
and related by dyad symmetry. 
Crystal packing of HSV-TK Protein crystallography is limited to 
observing a protein in a certain state, that is somewhat Influenced 
by the ordered packing of the protein into the crystal. The 
crystallisation of a protein occurs through its partial and gradual 
dehydration [155-1591ß The presence of water is essential for 
maintaining the protein in a native conformation. When a state 
exists In the solution where the protein is sufficiently dehydrated, 
the association of proteins occurs to compensate for the loss of 
hydration (160j. If the proteins associate in a specific way with each 
other, protein crystals form. The specific way in which proteins 
associate within a crystal, the crystal contacts, gives rise to the 
order and symmetry of the crystal. 
A striking example of the effects of crystal packing is observed in 
all the thymidine kinase crystal structures described here. For 
instance, in the crystal of HSV-TK complexed with aciclovir refined 
without the use of NCS restraints, the rmsd positional difference is 
0.32A for the backbone atoms between the two monomers. This is 
slightly higher than the rmsd coordinate error of 0.26A as 
27 
calculated during refinement, while the rmsd temperature factor 
difference is 8.6A3. The two molecules differ considerably in their 
thermal factors ( fig. 6 ), some regions having twice the thermal 
factor in one molecule as found in the other. To a large extent 
these regions correlate with the differing crystal contacts of each 
molecule. But a spreading of these effects occurs in both 
molecules, even to the ß-sheet core of each molecule. This means 
that the fold of each HSV-TK monomer within the crystallographic 
dimer is largely resistant to crystal contacts. While the distribution 
of thermal energy within a monomer, and possibly between 
[ monomers, is considerably influenced by crystal contacts 
161,162] 
fig. 6 Crystallographic temperature factor differences between monomers shown 
as a Ca trace - red warmer, blue colder 
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Deoxythymidine binding Compared to other NMPk structures, as 
many favourable contacts, if not more, can be identified in the 
binding of deoxythymidine (dT) to HSV-TK [127,144] This is not 
overly suprising in view of the wider range of substrates 
phosphorylated by HSV-TK. 
The base moiety of dT is positioned by a mixture of hydrophobic 
and hydrogen bonding interactions. The plane in which the 
thymidine base lies is sandwiched on one side by Ile100 and 
Met128 and on the other by Tyr172. The thymidine 3NH and 4CO 
groups hydrogen bond with the amide group of Gln125, and its 2CO 
group hydrogen bonds to two water molecules ( fig. 7 ) which in 
turn interact with the protein [163]. One water makes further bonds 
to the side-chain of Arg176 and the carboxyl group of GIn125. The 
other water bonds to the guanidinium group of Arg176 and the 
hydroxyl group of Tyr101. The thymidine 5CH3 group partly 
occupies a hydrophobic pocket made by the side-chains of Arg163, 
Trp88, Tyr132 and Ala167. 
....... .ý. _ 





fig. 7 Protein and water-mediated hydrogen bonds in deoxythymidine binding 
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The localisation of the sugar moiety of dT ( fig. 8 ) involves contacts 
between its 3'OH with the Tyr101 hydroxyl group and the Glu225 
carboxylic group which is part of the lid domain ( residues 219- 
225 ). No specific protein contacts are observed which localises the 
5'OH group of dT. A general distribution of positively charged side 
chains in the vicinity of the 5'OH group, probably contributes most 
to its position. This is also seen in NMPk structures [127], and 




fig. 8 Proximity of P loop and lid domain to the nucleotide binding site. 
Binding of thymidine analogues The crystal structures of four 
5-substituted uracil derivatives complexed with HSV-TK have been 
examined. Three of these compounds, which differ in their 
subsitutions at the C5-position of uracil [164], are 5-iodo-, 
5-bromovinyl- and 5-bromothienyl- deoxyuridine ( IDU [165] 
BVDU [166), BTDU [167] ). The fourth compound is an analogue of IDU 
30 
with its deoxyribose replaced by a 1,5-anhydro-2,3, -dideoxy hexitol 
group ( AHIU [168] ) 
fig. 9 Overlay of the four uracil derivatives 
All the deoxyuridine analgoues ( fig. 9 ) bind in the same way to 
HSV-TK as dT. The location of the uracil base and hydrogen 
bonding interactions of the 3NH and 4C0 groups with Gln125 are 
broadly similar. The bulky C5-substituents of BVDU ( fig. 10A ) and 
BTDU ( fig. 10B ) are accommodated by a hydrophobic pocket 
available in the neighbourhood of the residues Trp88, Tyr132, 
Arg163 and A1a167. This accommodation is at the expense of a 
relocation of the sidechain of Tyr132. The compounds IDU 
( fig-10C ) and AHIU ( fig. 10D ) both show binding modes in which 
the C5-substituted iodines occupy the same region of the active 
site, as do the vinyl and thienyl moieties of BVDU and BTDU, but 
penetrate less deeply and leave Tyr132 in its native conformation. 
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BVDU 
figs. 10A, 1OB, 1OC Showing BVDU, BTDU and IDU binding to HSV-TK 
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The binding to HSV-TK of the deoxyribose moieties of BVDU, BTDU 
and IDU, as expected, are similar to dT. The binding of the 
anhydrous hexitol group of AHIU is also similar, causing no 
significant changes to the protein conformation. Its 3'OH group 
hydrogen bonds to Tyr101 and Glu225, equivalent to the 3'OH of 
deoxyribose. While its terminal hydroxyl is found in the same 
position as the 5'OH of dT. A consequence of the similarity of 
binding of AHIU to binding of the other dT analgoues is that a 1C 
chair conformation is observed. The base and the hydroxymethyl 
group substitute equatorially and axially, respectively. This is in 
contrast to the crystal structure determined for the small molecule 
[ alone 
169] 
fig. 10D The hexitol side-chain of AHIU mimics a deoxyribose group 
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Guanosine analogues Ganciclvoir, penciclovir and aciclovir are 
all guanosine analgoues used clinically for the treatment of herpes 
infections E1051 
. Their efficacies vary in their side chains that replace 
the sugar moiety of guanosine. 9-(4-hydroxybutyl)-N2- 
phenylguanine ( HBPG ) is another guanosine analogue [170-1721 
with a phenyl group added to the N2 position of a guanine base. 
fig. 11 Overlay of HSV-TK interactions with guanosine analogues (light blue and 
orange C atoms) and the HSV-TK deoxythymidine structure (green C atoms) 
The guanine moiety of all four compounds presents a distinct 
binding mode to HSV-TK ( fig. 11 ). However, its binding is not 
accompanied by significant changes to the protein. It shares 
approximately the same plane as the base of thymidine, but is 
somewhat shifted to one side, towards the hydrophobic pocket. To 
accompany this shift, the side-chain amide of Gln125 would rotate 
by 180° to interact via pair-wise hydrogen bonds with the 1NH and 
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6C0 groups of the base. The 6C0 group, in contrast with the 4CO 
group of dT, appears not be in an optimal location to make other 
hydrogen bonds, lying 3.2-3.5A from the guanidinium group of 
Arg176, too long for a direct hydrogen bond, too short for a 
water-mediated bond. The 2NH group interacts with a water 
molecule residing in the hydrophobic pocket, in the vicinity of 
A1a168 and Tyr132, but not mediating further bonds. The guanosine 
base is again sandwiched by Tyr172 and Met231 on one side and 
Met128 and Ile100 on the other. As observed with the 5-substituted 
uracil derivatives, the bulky phenyl group of HBPG fits into the 
same hydrophobic pocket. 
fig-12A Binding of ganciclovir 
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Ganciclovir has a 1,3-dihyroxy-2-propoxymethyl side-chain. This 
acyclic group lies in the same volume as that of the sugar group of 
deoxythymidine, and its two hydroxyl groups occupy similar 
positions to the 3'OH and 5'OH atoms of dT ( fig. 12A ). The 
conformation of the acyclic group is appropriate for the prochiral 
nature of ganciclovir, which is ultimately phosphorylated as the 
[ S-enantiomer of ganciclovir triphosphate 
173 175] 
The two hydroxyl groups of the penciclovir side chain [1761, 
1-hydroxy-3-ethoxy-pentyl, differ from the positions seen for the 
ganciclovir side chain. The ethoxyl group, which may be expected 
to interact at the 3'OH position, is drawn towards the 5'OH position 
and hydrogen bonds with Asp162 ( fig. 12B ). 
fig. 12B Penciclovir side-chain hydroxyls drawn towards the 5'OH site 
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The acyclic groups of aciclovir and HBPG, 1-hydroxy-propoxymethyl 
and 4-hydroxybutyl respectively, are single chained. Difference 
electron-density for the two compounds ( figs. 13A, 14A contoured at 
1.2(; ) clearly shows the terminal hydroxyl group of HBPG to occupy 
the same position as the 5'-OH of dT ( fig. 13B ). While the terminal 
hydroxyl group of aciclovir appears to be distributed between the 
3'-OH and 5'-OH positions of dT ( fig. 14B ). This may reflect a real 
situation, with the side-chain of aciclovir exhibiting two binding 
modes. 
J 











fg. 14B Tyr101 fig. 14B 
Arg176 GIn125 
GIn125 
figs. 13 HBPG binding figs. 14 Aciclovir binding 
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Two magnesium binding sites in HSVTK ? HSV-TK is unusual in 
that it can catalyse phosphoryl transfer to both nucleosides and 
nucleoside monophosphates [953. These reactions have different 
reaction intermediates [17]. Phosphoryl transfer takes place through 
a tube-like region rich in positively charged residues. The binding 
of a magnesium ion is also necessary for phosphoryl transfer. From 
a comparison with other NMP structures [1343, the HSV-TK residues 
Thr63 and G1u83 have been identified as players in magnesium 
binding [1511, although this hasn't been confirmed by experiment. 
Possibly Asp162, which is in the locality of the putative magnesium 
binding site, is important in providing a second magnesium binding 




fig-15 Possible magnesium binding residues of HSV-TK 
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Specificity of HSV-TK nucleoside binding The crystal 
structures of HSV-TK provide a basis for understanding its wide 
substrate specificity. The majority of protein-nucleoside contacts 
act sterically to minimise substrate motion within the active site, 
but contribute little to specificity as, for instance, seen in the 
hydrophobic residues that sandwich the base moiety of the 
nucleosides. It is possible that Tyr172 may make electrostatic base- 
stacking interactions with the base via a deprotonation of its 
hydroxyl group by Arg176 [178] or His58. However in naturally 
occurring HSV-TK variants a phenylalanine side-chain can substitute 
for Tyr172 without affecting viability 
[130,179]. Nucleosides with bulk 
adducts are able to bind because of the large hydrophobic pocket 
adjacent to the active site. The DNA-like hydrogen bonding of the 
bases to Gln125, since it can flip, does not determine any 
nucleoside preference. The presence of water molecules in the 
active site also favours non-specific interactions [163]. In summary, 
many interactions contribute to nucleoside binding, but none make 
any obvious contribution to substrate specificity. 
It may seem suprising, when there is no apparent need, that the 
herpes simplex virus encodes a thymidine kinase which makes it a 
good target for drug therapies. Its lack of substrate specificity 
could reflect weak evolutionary pressures, after all it only has to 
phosphorylate deoxythymidine, and creates a strong likelihood for 
drug resistant viral strains to evolve [180-182]. Of those drug 
resistance strains that are known, many have truncated and 
inactive HSV-TK mutants [183-1851, others have mutated polymerases 
that are no longer drug sensitive [186j. Some mutants have been 
identified where the substrate specificity has been adapted. 
However it is difficult to reconcile these mutations, many of which 
occur in apparently unimportant sites, with their effects [176,181] 
Recently the crystal structures of human deoxycytosine kinase 
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(dCk) and Drosophila multinucleoside kinase (DMDNK) have been 
solved [1303. From these structures homology models have been 
made for human deoxyguanosine kinase and human thymidine 
kinase 2. All these enzymes share with HSV-TK a common ancestor. 
They also display considerable substrate ambiguity [187,188], and 
phosphorylate a variety of nucleoside analogues but not ganciclovir 
or aciclovir - which is fortunate. Most fascinating is DMDNK which 
can utilise all four dexoyribonucleosides as substrates [189). A 
comparison of their structures, especially their active sites, reveals 
a very strong homology with HSV-TK. Yet the factors that 
determine their varying specificities are too subtle to be seen, and 
suggests that a combination of approaches are needed before we 
successfully understand this group of enzymes. 
Guanosine substrates and inhibitors All the guanosine 
analogues described here show the same mode of binding to HSV- 
TK. They differ mostly in the conformation of their various side- 
chains. While there are similarities in the hydrogen bonding 
patterns that occur, it Is probable that the number of hydrogen 
bonds is a factor in determining binding strength. Doubtless, the 
presence of two hydroxymethyl groups in penciclovir and 
ganciclovir contributes to the stronger binding of these drugs 
compared with aciclovir [105,176]" 
Yet the most interesting results to interpret against experimental 
data are the positions of the side-chains of aciclovir and HBPG. 
Aciclovir is the most efficient substrate for inhibiting viral DNA 
replication, but it is a poor substrate for HSV-TK. The possibility of 
mutating HSV-TK to enhance its reactivity towards aciclovir would 
be a great benefit in the use of suicide HSV-TK gene therapies (190]. 
HBPG has been studied as a potential inhibitor of HSV-1 and HSV- 
2 [172]. Direct inhibition of TK has an advantage over the substrate 
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analogue approach in that its affinity to the polymerase active site 
is not critical [191]. The reasons as to why HBPG is an inhibitor that 
is not phosphorylated by HSV-TK are not immediately clear from the 
crystal structures. Both BVDU and BTDU are phosphorylated, so the 
stronger affinity of HBPG binding caused by its phenyl substituent 
does not seem to be important. A potential clue comes from the 
HSV-TK and aciclovir crystal structure. By interpreting the density 
present at the 3'-OH position as belonging to a water, not a 
disordered side-chain, that hydrogen bonds to the epoxy oxygen of 
the side-chain, means that aciclovir may interact via a water- 
mediated bond with the residues Tyr101 and Glu225 ( fig-16 ). The 
same water-mediated hydrogen bond would not be expected for the 
butyl side chain of HBPG. 
fig. 16 Possible water-mediated HSV-TK interaction with aciclovir 
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Such a role for protein-substrate interaction in the vicinity of the 
dT 3'OH site interaction could explain both HBPG Inhibition and the 
poor turnover of phosphorylated aciclovir. Most notably a substrate 
interaction with GIu225 which is part of the lid domain could 
directly influence catalytic efficiency [100,130,182]" 
This being true, the means both to inhibit HSV-TK and to enhance 
its phosphorylation of aciclovir arise. HBPG itself is an excellent 
starting point for designing new inhibitors. Its bulky adduct makes 
use of the hydrophobic pocket to enhance its binding affinity. While 
its alkane side-chain reduces the possibility of making a stable 
interaction with the lid domain. The design of HSV-TK mutants with 
an enhanced reactivity for aciclovir may be possible if a stronger 
interaction between the lid domain and its side-chain can be made. 
This may be achieved by mutations of Tyr101 or GIu225. 
Materials and methods 
Preparation of protein samples Purified samples of HSV type-1 
thymidine kinase (EC2.7.1.21 ATP: thymidine 5'-phosphotransferase) 
were provided by W. Summers [1931 (Yale University, New Haven, 
USA). The protein was sequentially dialysed from its storage 
solution of 200mM Tris-CI pH 7.5; 10% glycerol; 3mM dithiothreitol; 
200pM deoxythymidine; to 40mM Tris-CI pH 7.5; 3mM dithiothreitol; 
200pM deoxythymidine; at 4°C. After dialysis, the concentration 
and possible presence of aggregation of the protein preparation 
was assessed by measuring its absorbance spectrum (240-340nm). 
Crystallisation and drug soaking improvements were made to 
the previously described method for the crystallisation of TK [189]. 
Significantly larger crystals were grown reproducibly by both 
reducing the degree of nucleation and lengthening the period of 
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crystal growth. This was achieved by reducing the initial protein 
and precipitant concentration of the drop, increasing the 
temperature at which the crystals were grown, and lowering the pH 
from 7.5, away from the isoelectric point of the protein. The 
presence of deoxythymidine was essential to both protein 
preparation and crystallisation. 
Crystals were grown by vapour diffusion using the hanging drop 
method. Before crystallisation, the protein solution was centrifuged 
at 12,000rpm for 5 minutes at room temperature to removed 
aggregates. Drops were prepared on siliconised cover slips 
(Hampton Research) of 8pl protein solution with 4pl reservoir 
solution. The 5001iI reservoir solutions contained 200mM Tris-CI pH 
6.75; 3mM dithiothreitol; 200pM deoxythymidine, 24-32% saturated 
ammonium sulphate. The filtering of stock reservoir solutions and 
the use of fresh dithiothreitol proved favourable to crystal size and 
quality. The protein was left to crystallise at 25°C in an incubator. 
Crystals initially appeared after 2-3 days, and were left for over 2 
weeks to reach their full size, being at best 0.6mm In length. 
After the crystals were grown the bound deoxythymidine was 
exchanged for the compound of interest. The compounds were 
dissolved in water, and heated to -40°C for 30min in a water bath. 
Any undissolved compound was removed by centrifugation, and the 
compound concentration in solution was measured by their 
spectrophotometric absorbance. Soaking buffers were made 
containing 32% ammonium sulphate, 200mM Tris-CI pH 6.75,3mM 
dithiothreitol; N1mM compound. Crystals bigger than 0.3mm in 
their longest dimension were transferred to the soaking solution 
and stored at 18°C. The solutions were replaced three times at 
intervals greater than 6 hours. 
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Cryoprotection The exposure of x-rays to crystals, especially 
biomolecular crystals which have significant solvent content and 
weaker packing forces, causes radiation damage and a deterioration 
in diffraction strength due to the generation of free radicals and 
warming. This can largely be overcome by cryogenic cooling [194- 
196] where the crystal is kept in a dry stream of nitrogen vapour at 
-100K during data collection. The use of cryogenic cooling greatly 
facilitated the collection of crystal diffraction data, ensuring the 
completeness of measurements and maintaining the resolution 
throughout its x-ray exposure. Before the transfer of TK crystals to 
the nitrogen stream, they were passed through a cryoprotecting 
solution to prevent ice formation in the crystal and in the liquid 
transferred with the crystal. The crystal was briefly transferred, for 
less than 30 seconds, to a drop of a cryoprotectant solution of 25% 
glycerol, 32% ammonium sulphate, 200mM Tris-CI pH 6.75,3mM 
dithiothreitol and compound, before being directly flash frozen in 
the nitrogen stream. The use of loops smaller than the crystal, 
typically half the size of the crystal, proved to be advantageous. A 
reduction of the mosaicity of the crystal, presumably by reducing 
the amount of mass to be cooled, and also the amount of 
background x-ray scatter was observed. 
Data collection and processing In-house data collection was 
performed on an R-AXIS-IIC mounted on an RU200 rotating anode 
x-ray source ( %=1.54A ) operating at 50kV, 100mA with Yale 
mirror optics (MSC). Synchrotron data collection was performed at 
the Grenoble synchrotron, France, at station BM14 on a MAR345 
detector using a x-ray beam wavelength tuned to X=0.87A. HSV-TK 
crystals soaked with drug were flash frozen and tested for 
diffraction quality in house before being transferred to a 
cryovessel. At the synchrotron, the crystals were transferred from 
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the cryovessel to the goniometer for data collection. A portable 
cryostream ( see appendixI ) was used for the transfer of crystals. 
ROTGEN (CCP4 (197]) was used for reciprocal space simulations and 
all data sets were processed with HKL suite (198,199]. Structure 
factor moduli were calculated from the intensities using 
TRUNCATE E2003(CCP4). 
Refinement The method of structure refinement described here 
differs from that presented in the published work [201-203] 
For the refinement of the TK-dT structure against the higher 
resolution data, the previously solved TK-ganclclovir structure to 
2.2A was used as a starting model. Initially a rigid body refinement 
was performed using REFMAC [2041(CCP4), then subsequently 
individual atomic positional and isotropic temperature factors were 
refined. Then SHELXL (2051 was used to refine the atomic position 
and thermal parameters. Initial refinement of the structure used 
90% of the data and 10%, chosen randomly, for Rfree 
evaluation [206] .A stepwise 
increase in resolution was employed 
from 3A to the resolution limit of the data. The model was checked 
at this point by generating omit maps for 5% regions of the model. 
XFIT (XTALVIEW [2071) was used to visualise the structure and maps 
and for remodelling. Some side-chain positions were found to differ 
with those seen in omit maps and were remodelled to the density. 
The active site compound was also modelled. Any parts of the 
protein or compound that could not be clearly identified were given 
a zero occupancy, excluding them from the refinement but not the 
model. For refinement of the drug, it was initially treated as a rigid 
body, with a variable occupancy factor. Subsequently, its individual 
atoms were refined, using bond distance restraints taken from its 
small molecule crystal structure. Next, the water atoms were 
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identified using cycles of refinement by REFMAC and water picking 
by ARPP [2081. All water positions were confirmed by map analysis. 
With the structure refined this far, an examination of the best 
restraints to apply was made. The weights given to 1,2-distance 
and 1,3-distance restraints was adjusted till the rmsd bond and 
rmsd angle were within acceptable limits. NCS positional restraints, 
which are applied in terms of equivalent 1,4-distances, were 
applied between the monomers. The restraints were weighted 
according to an analysis of Klegwegt plots [2091 to regions within 
both monomers, and no restraints being given to sites of crystal 
contacts. Similarly, isotropic temperature factor restraints were 
defined which produced smoothly varying temperature factors 
between bonded atoms. Note, that the use of NCS restraints for the 
temperature factors between monomers was not used. 
After this stage of refinement, an analysis of the agreement 
between the intensity measurements and the model was made. The 
standard deviation of the individual II F(h)obs I- 
I F(h)caicI I/I F(h)obs I contributions to the R-factor was calculated 
in resolution bins. The most disagreeable reflections, with large 
standard deviations, were nearly all observations of low multiplicity 
and/or the sums of partially recorded reflections. These reflections 
were flagged, and the worst 5% of them were removed. A second 
step of refinement by SHELXL was then made using the pruned 
data. After the final check of the model, all reflections were 
included in the refinement for Rfactor evaluation. 
The exclusion of disagreeable reflections before completing the 
refinement proved to make a positive contribution to a good 
structural model. This can be seen in small improvements to the 
geometry of the structure and map density. These improvements 
were not observed if 5% of the data was randomly removed. 
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Normally in refinement, no special efforts are made to remove bad 
measurements from the refinement. Sometimes low resolution limits 
and F/aF cutoffs are applied. An obvious consequence of 
manipulating the data is to improve the overall crystallographic 
Rfactor. However the use of a specific criteria to flag bad 
observations, seems preferable. To some extent it also permits an 
extra diagnosis of the processing of the diffraction measurements. 
Finally, the use of restrained refinement of anisotropic temperature 
factors of HSV-TK was explored. Without a high ratio of data to 
model parameters, the refinement of anisotropic temperature 
factors is not normally considered. Nevertheless a restrained 
refinement of anisotropic thermal factors was tried with the same 
weights as used for the refinement of isotropic temperature factors. 
This did not bring about a change in the Rfactor or Rfree" In fact, the 
anisotropic temperature factors barely deviated from the prior 
isotropic values. However a three-fold improvement was seen in the 
rmsd bond and rmsd angle values. 
The question arises as to whether trying to model anisotropic 
motions with less than atomic resolution data is a valid one. 
Refinement of various TK structures with data to 2. OA or beyond, 
suggest that it does not harm the refinement at all. Moreover, since 
the restraints make chemical sense, and if they are applied 
correctly, then they should benefit a structure refinement. In NMR 
structure refinements, the data to parameter ratio is low, and it is 
only through the use of many restraints that the structure reveals 
itself. 
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*a Percentage of FI(hkl)l > 2a divided by percentage completeness of observations to highest 
resolution limit 
*b Rfactor for all reflections and includes the 10% of hid randomly chosen for Rfree calculation. 
*b rmsdbod and rmsdangie are the deviations for expected 1,2- and 1,3- Huuber and interatom 
distances 
*d Collected at ESRF synchrotron, station BM14. 
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A domain of UvrB and its interaction with UvrC 
The viability of an organism requires mechanisms for 
repairing DNA lesions. UvrB and UvrC are two components of 
the nucleotide excision repair mechanism found in 
prokaryotes. Both proteins share a small domain of high 
sequence homology. These domains, we named UvrB' and 
UvrC', are found at the C-terminus of UvrB and within the 
body of UvrC. By interacting together, the UvrB' and UvrC' 
domains enable the first incision made by UvrBC to a 
damaged DNA strand. A crystal structure of the UvrB' 
domain from E. co// confirms that it adopts a helix-loop-helix 
fold, stabilised by the packing of hydrophobic side-chains 
between helices. A dimerisation of UvrB' domains is seen in 
the crystal, involving specific contacts between residues in 
and close to their loop regions. Since the same residues are 
strongly conserved in the UvrC' domain, it appears likely 
that a similar mode of dimerisation exists between UvrB and 
UvrC. 
The UvrABC endonuclease system of enzymes repairs damaged DNA 
damage [210-213]. Its enzymatic mechanism ( fig. 17) begins when a 
UvrABB complex recognises a DNA lesion by detecting irregularities 
in local DNA conformation [214-218]. This gives the UvrABC the 
versatility to recognise many kinds of DNA lesions. Then in a 
reaction accompanied by the hydrolysis of ATP and dissociation of 
UvrA2, UvrB binds to the DNA, locally denaturing and unwinding the 
DNA at the site of the lesion 
[219-221], The resulting UvrB-DNA 
assembly, called the preincision complex, then recruits UvrC which 
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makes incisions to the DNA strand containing the lesion [222-225] 
The UvrBC complex hydrolyses the 3rd, 4th or 5th phosphodiester 
bond to the 3' side of the lesion and subsequently the 8th 
phosphodiester bond to the 5' side of the lesion. Finally, the DNA 
strand containing the lesion is unwound from the DNA by UvrD, and 
. 
{ the gap is filled by DNA polymerase 2261 
UvrA2B complex searches 
for DNA lesions 
UvrB is bound to the DNA 
at the site of the lesion 
ATP hydrolysis by UvrB. 
UvrA molecules dissociate. 
Unwinding of the DNA 
UvrC joins UvrB and makes 
its first incision 3' to the 
site of the DNA lesion 
UvrC then makes a second 
incision 5' to the site of 
the DNA lesion 
fig-17 Schematic of DNA repair by UvrABC endonuclease 
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UvrA, UvrB, UvrC and UvrD are all multidomain proteins. The 
central role that UvrB plays in the reaction mechanism is apparent 
from its ability to bind to all of the other proteins as well as to DNA 
lesions. UvrB also forms dimers in solution [227] but It can not 
simultaneously bind both UvrA and UvrC (228]. A crystal structure of 
UvrB from Thermus thermophiius [229-2311 reveals, as 
predicted (232,2331, its homology to DNA helicases [2341. This 
structure is however disordered for both its UvrA and UvrC binding 
domains. The C-terminal UvrB domain has been implicated In 
recruiting UvrC to the preincision complex [235-238] - and may also 
interact with UvrA and UvrD [226,2281. Amongst prokaryotes, the 
UvrB' domain is preceeded by a flexible linker region of variable 
lengths, up to 56 residues long, that is very sensitive to proteases. 
OmpT digestion of E. co/i UvrB ( 673 residues ) results in the 
formation of a truncated form of the protein, called UvrB* 
(235]. In 
the absence of DNA.. UvrB and UvrC form a low-affinity complex in 
solution that is not observed with UvrB* and UvrC 
[236]. UvrB* is 
able to form a preincision complex with a DNA substrate that 
contains a specific lesion. The addition of UvrC to this UvrB*-DNA 
preincision complex does not however lead to significant DNA 
incision, only a 1-2% residual incision is observed. If in the same 
experiment, the DNA substrate is nicked 3' to the DNA lesion, then 
the addition of UvrC results in proficient 5' incision 
[238-239]. 
Together these results indicate the UvrB' binds to UvrC and that 
this Is essential for the 3' incision event to occur 
[235]. 
A high degree of sequence homology ( fig. 18 ) is observed between 
the UvrB' domain and a region of UvrC 
[2401. These homologous 
regions have been shown to be critical for UvrB-UvrC interaction. 
The introduction of a Phe652-*Leu mutation in UvrB, or an identical 
Phe223->Leu mutation in UvrC, resulted in the same loss of 3' 
incision as seen with UvrB*. 
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631 641 651 661 671 
UvrB SPK ALQQKIHELE GL'MQHA, 'Q LHQL' ELFI AAS 
...... ...... ... .. .... ...... .......... ... .... 
UvrC LSG KDDQVLTQLI SRNiETAS, ":. R IQAV RVTE KQF 
202 212 222 232 242 
fig-18 Sequence alignment of homologous regions in E. co/i UvrB and UvrC 
Secondary structure predictions for the UvrB' and UvrC' domains 
score highly for coiled-coil motifs, and a packing of these motifs 
was proposed [235]. A helix-loop-helix fold for E. co/i UvrB' was then 
seen in a NMR secondary structure assignment (241], This structure 
was further characterised by a crystal structure of a UvrB' 
homodimer solved by MAD phasing of seleno-methionine modified 
UvrB' [242] 
UvrB' Crystal structure The crystal possesses P62 symmetry 
with a UvrB' dimer in its asymmetric unit cell ( figs. 19A, 19B ). 
Defined regions of electron-density correspond to residues 628-673 
of the UvrB sequence ( figs. 20A, 20B ). 
figs. 19A, 19B P62 Crystal packing of the UvrB' dimer 
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figs. 20A, 20B Electron-density for UvrB' from the experimental phases 
contoured at la 
The helix-loop-helix fold ( fig. 21A ) of UvrB' confirms an earlier 
NMR secondary structure analysis [2411. The association of the two 
helices forms a hydrophobic core that stretches the full length of 
the monomer ( fig. 21B ). On its surface, salt bridges are formed by 
Arg659 with Asp660 and Glu640 with Arg666. 
fig. 21A Monomer structure of UvrB' fig-22B Hydrophobic core of UvrB' 
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A representation of the UvrB' main chain torsional angles in a 
Ramachandran plot [243]( fig. 23 ) shows that residues which deviate 
from torsional ideality are found in its loop region (N649-L650- 
E651-F652-E653). 
-180 -90 0 90 
fig-23 Ramachandran plot of UvrB' backbone torsional angles 
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Dimer interactions of UvrB' domain In this crystal structure, 
the loop regions of the two UvrB' monomers associate end-to-end 
( figs. 24A, 24B ). Hydrophobic residues lie at the center of the 
dimer interface, reducing the solvent accessible surface area of a 
domain by -11%. The residue contacts, related 
by 
non-crystallographic symmetry, important to dimerisation include 
Met643 to Leu650, (Ala647; AIa655; Ala656) to Phe652, and a salt 
bridge, Glu653 to Arg659. 
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figs. 20,246 Contacts between the loop regions of UvrB' 
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Alternative monomer-monomer interactions arise as a consequence 
of crystal packing ( fig. 25 ). These involve a salt-bridge between 
Arg666 to Glu667 and a van der Waals interaction between Phe669 
and Leu670. 
fig. 25 Other monomer-monomer contacts arising from crystal packing 
However the specificity of residue contacts and slightly lower 
thermal displacements for residues in the loop region, notably 
Arg659 which has the lowest temperature factor of all residues, 
favour the model that it is the loop contacts between monomers 
which are significant. Additional evidence comes from a 
measurement of the UvrB' Stokes radius [2451. These results, plus 
crystallisations of UvrB' without seMet indicate that the presence of 
Se Met residues in the crystal structure is not significant. 
Model for UvrB' and UvrC' interaction A direct alignment of 
the UvrC' sequence with the peptide backbone of UvrB' shows that 
a hydrophobicity of its core and loop region would be preserved. 
The hydrophobic core of UvrC' appears not to extend as far as that 
of UvrB', and the length of its helices may be slightly shorter. 
Taking the UvrB' dimer interactions as seen in the crystal as a basis 
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for UvrB' and UvrC' association ( fig. 30 ), then, in addition to the 
hydrophobic residues in the loop, Glu653 and Arg659 of UvrB would 
make salt bridges with Arg230 and Glu224 of UvrC respectively. 
fig. 30 Proposed model for UvrB' and UvrC' association 
Evidence that favours a model for UvrB'C' interaction via their loop 
regions, as opposed to the formation of a four-helical bundle, is the 
non-specific distribution of charged side-chains in the surfaces of 
UvrB' and the UvrC' model. Also all attempts to pack UvrB' and 
UvrC' together to make a four helical bundle were not revealing. A 
variability in the length of the second helix of the UvrB' domain of 
59 
different prokaryotic UvrBs further undermines the possibility of 
helical associations between UvrB' and UvrC'. 
Also supporting an interloop mode of interaction are the protein 
mutants, Phe652-+Leu in UvrB and Phe223->Leu in UvrC, which 
have both been shown to disturb the interaction between UvrB and 
UvrC [2401. However, an E. coil strain with an Arg659-*Ala mutation 
in UvrB is still UV-resistant [245). Arg659 is one of the six residues 
involved in UvrB' dimerisation and, according to the model 
proposed for UvrB'-UvrC' association, the Arg659--Ala mutation 
would be expected to reduce the dimerisation affinity but 
apparently does not altogether abolish it. A comparison of all 
known UvrB sequences shows that other sequence variations to 
residues in the loop region are also possible. 
The most striking feature of the proposed UvrB'C' interaction is the 
large distance covered, potentially spanning over 50A. Since the 
UvrB' domain is preceeded by a flexible linker region it seems 
improbable that UvrB'C' dimerisation participates in a 
conformational regulation of the UvrBC-DNA incision complex. 
It is more likely that UvrB' acts as a protein hook to recruit UvrC 
from solution to the preincision complex. As shown by UvrB* 
mutants, the 5'-incision step preceeds efficiently when a 3' nick is 
present in the DNA. UvrBC also exhibits a damage-independent 
nuclease activity and this has been attributed to DNA substrates 
containing a nick [240]. This indicates that the 5'-incision step 
depends on a DNA binding activity of UvrC that is distinct from the 
3'-incision step and exists without UvrB'C' interaction. Kinetic 
studies show that catalysis of the 3'-incision by UvrBC is both 
damage-dependent and rate-limiting compared to the rate of 
formation of the preincision complex [237,246]. Footprinting analyses 
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of DNA binding by UvrB indicate that the site of 3'-incision is at 
least partially obscured in the preincision complex (2481. There is 
also variation in the site of 3'-incision, from between 3 to 5 
nucleotides downstream of the lesion [2371. A small residual 3'- 
incision activity, less than 2% of wildtype, is observed for 
truncated UvrB and UvrC proteins lacking their respective UvrB' and 
UvrC domains [2341. These results may suggest that UvrB'C' 
interaction keeps UvrC in the vicinity of the preincision complex 
until some conformational fluctuation of the UvrB-DNA assembly 
permits UvrC to make its DNA contacts for the initial 3'-incision. 
It has been reported that the binding of UvrA involves two domains 
of UvrB [233]. One of these domains is found in the last 98 residues 
of UvrB. Assuming that UvrB' is the only structural motif found in 
this region, then it may be suggested that UvrB' sequentially 
interacts with both UvrA and UvrC - so that UvrA masks the UvrB' 
domain until the preincision complex is formed. 
Materials and methods 
Crystallisation and data collection The cloning, over- 
expression and purification of a MH6L-tagged 55 residue fragment 
of UvrB has been described previously for the preparation of NMR 
samples [241]. Protein incorporating seMet was obtained by 
transforming the auxotrophic strain E. Co/i DL41 (Genetic Stock 
Center) with plasmid and grown on selenomethionine media [248,249]. 
Crystals were grown at 5°C from drops containing 9µI protein 
solution at 2mg/ml in 20mM Tris-HCI pH 7.0,150mM NaCl, 0.1% 
NaN3 mixed with 3µI of reservoir solution containing 35% saturated 
ammonium sulphate, 100mM Tris-HCI pH 8.8,0.1% NaN3. Crystals 
were passed through a solution of 100mM Tris-HCI pH 8.5,20% 
glycerol, 42.5% saturated (NH4)2SO4,0.1% NaN3 and then cryo- 
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cooled directly in liquid propane (250]. Crystal diffraction data was 
collected on a MARCCD detector at station BM14, ESRF synchrotron, 
Grenoble, France. Measurement of the crystal fluorescent spectrum 
identified suitable wavelengths about the Se-edge for the MAD data 
collection. Wavelengths chosen were %1=0.979A, A, 2=0.978A and 
, %3=0.885A. 
MAD phasing The multiwavelength data sets were processed 
using HKL suite E198,1993. Special care had to be taken during scaling 
to remove bad measurements caused by a considerable degree of 
background noise. Using either a high resolution limit of 4. OA or 
3. OA, three selenium sites were located using SOLVEv1.9 [2511. By 
treating the MAD data as MIR data (2521, phases were generated to 
3. OA using MLPHARE [2531(CCP4). Any of the three selenium 
positions identified the other selenium sites in difference density 
maps (FA, 3 - FX1)e'O and a fourth selenium site was found. Once 
phases had been calculated with a <FOM> of 0.51, the resulting 
electron-density map was solvent flattened using DM E254,2551 (CCP4) 
and a solvent content of 70%. The solvent-flattened phases where 
then used within MLPHARE as external phases. This step improves 
the refinement of the anomalous scatterer/heavy-atom parameters, 
and reduces an overestimation of the phase FOM [256]. Then the 
external phases were switched off, and new phases were calculated 
from the MAD data. These phases with a <FOM> of 0.41 were 
solvent flattened a further time, improving the phase <FOM> to 
0.815. 
The use of MLPHARE, which gives initial phases with a <FOM> of 
0.51, was found to be far superior to SOLVE with a phase <FOM> 
of 0.82. Protein connectivity and solvent boundaries were much 
clearer in the MLPHARE generated electron-density maps. MLPHARE 
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is able to refine for each wavelength the real and anomalous 
occupancy of an electron at the selenium sites. These occupancies 
are calculated relative to the data set at the wavelength which is 
taken as native. Despite the poor quality of the data, and inability 
to refine temperature factors, the refined real and anomalous 
occupancies appeared to correctly model the relative real and 
anomalous electron occupancies, ie. the f' and f", of the selenium 
atoms at the different wavelengths. Analysis of the phasing 
statistics shows that the greatest contribution to phasing came 
from the dispersive differences between ?1 and X3. 
Structure refinement The protein structure was modelled to 
the density using XFIT (XTALVIEW [2071). The modelling of the 
protein was checked by use of SFCHECK [257]. Initially, the structure 
was refined using XPLOR (258] and REFMAC [2041, Subsequently 
refinement of the structure using SHELXL97 (205] was tried. All 
residues were modelled to the map generated from the solvent- 
flattened map phases, the refinement of the structure did not 
significantly contribute to better phased electron-density maps. A 
number of surface-exposed side-chains lacked density and were 
given a zero occupancy. No water atoms could be clearly identified 
in difference maps. For the calculation of Rfree factors the same 
15% of the reflections, randomly chosen, were excluded from the 
refinement. The use of a smaller percentage gave rise to worse 
Rfree values. 
Considering the low resolution of the data, SHELXL proved to be 
most useful in refining the structure. By applying tight 1,2- and 
1,3-distance restraints an ideal structural geometry was maintained 
throughout the refinement. The modelling of bulk solvent 
refinement also proved advantageous. To increase the data to 
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parameter ratio, a use of NCS restraints was made. In SHELXL the 
weights of the NCS restraints can be varied according to the 
structure. For the UvrB' structure, the weights of the NCS restraints 
were trivially adjusted to take into account crystal packing. In order 
to get the best modelling of the selenium-methionine side-chains, 
they were allowed to have two alternate conformations. Finally, the 
possibility of refining atomic temperature factors was explored. To 
begin with, a single isotropic temperature factor for all atoms was 
refined as a free variable within SHELXL, the final value 35A2 
closely agreed with an isotropic B value of 31A2 from Wilson plot 
analysis. SHELXL does permit both the use of a temperature factor 
restraint between NCS related atoms and the restrained refinement 
of temperature factors for groups of atoms. However disagreeable 
temperature factor differences will commonly arise between groups 
unless a use is made of temperature factor restraints. SHELXL 
offers this possibility, so that temperature factor restraints, 
weighted according to an expected standard deviation, can be 
applied between bonded atoms. The use of such restraints 
produced smoothly varying temperature factors along the UvrB' 
structure ( fig. 31 ). The restraint was applied with a target 
standard deviation of 1% for the loop region, 2% for the N-terminal 
helix and 3% for the C-terminal helix. When this was tried a drop in 
both the Rfactor and Rfree of N3% was observed. The validity of this 
refinement strategy is reflected in an agreement of lower 
temperature factors for residues making dimer and crystal packing 
contacts. Nevertheless the final crystallographic Rfree of 28.2% is 
relatively high. Since «70% of the unit cell is solvent and one 
quarter of the protein is disordered such a high Rfree does not seem 
unreasonable. 
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Homology modelling The high conservation of residues, in 
UvrC' and in the core and loop of the UvrB' domain, meant that it 
was possible to make a direct homology model by alignment of the 
UvrC' sequence with the backbone of UvrB' using Insightll 
(Molecular Simulation Inc., San Diego, CA, Version 97.2). 
fig. 30 Smoothly varying atomic temperature factors 
Table of crystallographic statistics 
Reciprocal space 
Unit cell dimensions a= 84.81A c= 53.19A 
Wavelength 0.9789 A 0.9788 A 0.8856 A 
Resolution 20.0 - 3.0 A 20.0 - 3.0 A 20.0 - 3.0 A 
Total hk/ Completeness 65307 100.0% 44863 100.0% 65208 100.0% 
Uniquehký 4475 74.3% 4420 65.3% 4450 74.1% 
I Fn, ril >46 
Ra 
merge 9.6% 11.6% 10.2% 
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Table of crystallographic statistics (continued) 





Mean FOM 0.511d, 0.815e 
map correlationf 
Refinement 










0.50 / 0.35 
0.93 / 0.90 
1.17 / 0.77 





48.2A2 (sd 6.3A2) 
0.48A / 2.12A2 
0.006A 0.022° 
0.287 
a Rmerge = Ena E1I <I(hkl)> - I(h0 1/ Eha<I(hkk> where I is intensity of a reflection. Friedel 
pairs are kept separate. 
b Phasing power = <FH>-<E> where FH is the heavy atom structure factor and E is the lack of 
closure. 
c &e,,; s = <E>/<A> where E is the lack of closure error and a 
is the isomorphous difference. 
d Before solvent flattening. 
e After solvent-flattening. 
f Map correlation coefficient calculated with the solvent-flattened map and the map after 
refinement. For grid points in two maps, m and n, it is calculated by 
{ <[ p(r),, x P(r)y ]> - <p(r)m >x <P(r) n> }/{ 4[<P(r)m2> - <P(r) m>2 ]x J[<p(r) n2> - 
<p(r) n>2] } 
9 The free R-factor is a cross-validation residual calculated using 15% of the native data, 
randomly chosen and excluded from the refinement. The crystallographic R-factor is defined 
E( FO I-I Fc I /E I F, I and indicates the accuracy of the model. 
h The refinement ratio is calculated by the number of parameters number of hkl observations 
+ number of restraints) used in the refinement. 
0.89 
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B-DNA minor groove binding and 
end-capping by Ni-porphyrin 
A Ni-porphyrin with cationic substituents shows, as revealed 
by a high resolution crystal structure, a bimodality in its 
interactions with a B-type DNA helix. The porphyrin ring 
adopts a non-planar ruffled conformation that cooperatively 
promotes its nucleic acid contacts, especially its fit into the 
DNA minor groove. Many distortions to the DNA helix arise 
from its binding porphyrin. Also seen is an end-to-end 
dimerisation of DNA helices, a local disordering of the 
sugar-phosphate backbone and a complete hydration of the 
complex. 
Recent years have seen a surge of research on ligands as probes of 
nucleic acid structure and chemistry [250-254]. It is hoped that these 
ligands may form the basis of therapeutic compounds able to 
recognise and target nucleic acids in a sequence specific 
manner [259-2621. One approach is to couple peptide elements able to 
recognise sequence elements with metalloligands that can 
hydrolyse DNA [263-271]. DNA ligands are also being used in the 
study of electron transfer through DNA [272-274]. The unique 
molecular n-stack of DNA is a medium capable of ultrafast 
long-range electron transfer [275,276]. Cyclobutyl-thymidine dimers, 
for instance, can be reversed by charge migration through hundreds 
of base-pairs (27]. 
Porphyrins are one species of metalloligand with a variety of DNA 
binding activities and have found many uses as probes of DNA 
structure [278,279]. They also exhibit catalytic activities. Most notable 
are metalloporphyrins modified with cationic substituents [280,281] 
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that are able to induce strand cleavage in a photo-dependent 
reaction [282,283]" The cationic porphyrin , tetra-(N-methylpyridyl) 
porphyrin (TMPyP, fig. 31 ) has affinities for both duplex [284,285] and 
(286] quadruplex nucleic acids . 
Me Me 
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fig. 31 M"+TMPyP 
TMPyP has anti-tumour activity [287,288] due to its ability to stabilise 
quadruplex DNA and, in doing so, inhibit the telomerase enzyme 
from extending telomere repeats [289]. The interactions between 
duplex DNA and TMPyPs depend on whether or not TMPyP is 
coordinated by a metal cation, and on the type of metal. By itself 
TMPyP favours an entirely intercalative mode of DNA interaction 
between 5'-CpG sites (290"292]. A crystal structure of Cue+TMPyP 
bound to the sequence 5'-d(CGTACG)2 found the ligand 
hem! -intercalated at a 5'-CpG site, with the 5'-C swung out in an 
extra-helical arrangement [293]. TMPyPs coordinated with either Zn2+, 
Nit+, Fe3+, Co3+ and Mn3+ exhibit an "outside" binding mode to 
duplex DNA, favouring AT rich regions [281,294,295]. The outside 
binding mode is thought to involve direct contacts with the minor 
groove of DNA, and distortions to the DNA helix. This minor groove 
interaction of metalloTMPyPs agrees with their ability to attack 
DNA, either in the presence of oxo-species or free-radicals, at the 
[296 C1' position , 
297] 
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Before the crystal structure [2983 described here, no structure for 
the groove binding of TMPyP to DNA was available. Hence it 
confirms a great deal of experimental and theoretical data, and 
allows us to visualise both metalloTMPyP hydrolytic activity and its 
affinity for low melting point regions of DNA. 
Overall structure The crystal uniquely contains a homodimer of 
a duplex DNA-NiTMPy complex ( figs. 32A,, 32B, 32C ). The DNA 
possesses two strands of the self-complementary hexamer 
dBrCCTAGG. The DNA-NiTMPyP dimer occupies «70%, and defined 
solvent occupies «25%, of the asymmetric unit cell. Dimerisation 
involves the end-to-end association of the DNA helices, aligning 
their helical axes to create the appearance of a dodecameric DNA. 
A small relative rotation of «15° between the two helices means 
that a true dodecameric DNA would not superimpose on this 
structure. Many other bridging interactions, most notably the 
complementarity of the NiTMPyP fit into the minor groove of the 
DNA helices, promote crystal order. Two Mgt+. (H2O)6 cations and 
ordered solvent also participate to bring the DNA-NiTMPy 
assemblies together ( f1g. 33 ). 
The exotic ternary nature of the crystals arises from the two 
NiTMPyP binding modes - groove binding and end-capping - to the 
DNA. The dimerisation of DNA helices possibly arises from a lack of 
NiTMPyP, in the crystallisation solution, to end-cap both ends of a 
DNA-helix. However NiTMPyP capping of both ends of each duplex 
would create an excess of positive charge. The balancing of 
electrostatic forces surely contributes to the order and strength of 
the crystals. The charges on NiTMPyP6+ and Mg2+ almost equal the 
charge of each duplex. The likelihood that sodium ions, 
misinterpreted as waters, also exist would give the crystal perfect 
electroneutrality. 
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figs. 32A, 32B, 32C Dimerisation of two DNA duplexes end-capped by NiTMPyP 
fig. 33 Intricate packing of DNA-NiTMPyP dimers helped by Mg. (H20)6 ions 
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Labelling of residues The nucleic acid is described in terms of 
two strands, A and B. Individual nucleotides are numbered 1 to 6, 
and atoms are given their standard names. 
Nucleic acid structure The DNA helix exhibits a B-type 
polymorphism that is subject to significant distortions [299,300]. Most 
notable is a large positive buckling and propeller twisting, both of 
190, for the BrCyt: 1A-Gua: 6g base-pair which underlies the 
end-capping NiTMPyP. This buckling follows the non-planar 
conformation of the porphyrin with which it is in van der Waals 
contact. An opening of the helix occurs in the AT region where 
NiTMPyP makes its minor groove contacts. 
Global base-axis and base-base parametersa 
BrC1A 
- G6B 
C2A - G56 
T3A ' A4B 
A4A - T3B 
G5A - C2B 
G6A - 
BrC1B 
Xdisp Ydisp Inclination Tip Buckle Propeller Opening 
0.65 -1.59 -5.72 1.80 -3.59 -8.20 -3.40 
0.80 -1.68 -3.91 4.61 -15.27 -3.21 3.59 
0.48 -1.50 -1.30 7.65 0.43 -6.73 1.27 
0.74 -1.29 -1.44 6.33 0.62 -1.72 16.61 
-0.23 -1.36 -2.98 14.00 9.89 -7.26 -5.03 
0.22 -1.64 -3.15 4.42 19.07 19.34 -1.43 
a Calculated using the program Curves v5.2. Due to NCS the values given are averaged over the 
two duplexes. 
The minor groove is the DNA surface where the phosphates on 
opposite strands come closest to each other (301,302]. Hence the width 
of the minor groove can be affected by the presence of ions that 
reduce or add to the repulsive forces between phosphates. A plot of 
the minor groove width ( fig. 34 ) for the DNA-NiTMPyP structure 
shows how it deviates from the mean width of 6. OA for canonical B- 
DNA. In the AT region of the duplex the groove reaches its 
maximum width of 6.82A. Either side of the central 5'-TpA pair, the 
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width of the groove narrows, especially towards the center, where 
it reaches a minimum width of 3.2A. It is known that 
metalloTMPyPs favour AT rich regions of DNA, le regions of DNA 
that are more favourably melted [303]. This is probably due to their 
general size, more than any other feature. 
A 
C`w CTAGG 
fig. 34 Variation in minor groove width 
A calculation along the DNA axis of the net Coloumbic potential - 
taking into account the charges on the nickel, magnesium, 
N-methylpyridyl and phosphate groups - shows that the variation in 
charge distribution ( fig. 35 ) does not agree with the variation In 
minor groove width. 
11 Q' /r, 
CBS CTAGG 
fig. 35 Variation in net Coloubic potential along the helical axis 
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The presence of positive charge is strongest away from the center 
of the structure. This may suggest that the shrinking of the minor 
groove width towards the centre arises more from entropic and 
crystal packing forces, than the presence of cationic groups. 
The model of the bases to the electron density ( fig. 36 ) is 
unequivocal. In addition to the expected Watson-Crick hydrogen 
bonding between base-pairs, weak vertical hydrogen bonds occur 
between Cyt1A: 02 and Cyt2B: N1, and between BrCyt1A: 02 and 
Cyt2A: 04'. Where the two helices dimerise, the interaction involves 
base-pair stacking and hydrogen bond contacts between Gua2B: 04' 
and BrC1A: N7. 
fig. 36 Electron-density from a Ea2Fo-Fc map contoured at 1.5ß, 36,4.5a 
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A wide variation in sugar-puckers is observed. The larger deviations 
from the expected C2'-endo pucker for B-DNA are seen on strand A, 
opposite to the face where the porphyrin interacts with the minor 
groove of the DNA. These deviations can partly be attributed to 
additional hydrogen bond interactions which arise as a consequence 
of helical distortion; BrCyt1A: 04' makes hydrogen bonds BrC1A: 05' 
and G6B: N6, Cyt2B: 04' with BrCyt1B: 02, Ade4A: 04' with Thy3A: 03', 
C2B: 04' with a porphyrin -CH- group and G5B04' with B`C1BBR. 
Sugar pucker and backbone torsion angles 
sugar phase alpha beta gamma delta epsilon zeta chi 











180 ... ... 172 151 -179 -92 -100 
114 -60 171 55 114 -166 -85 -119 
145 -70 169 48 143 -100 174 -96 
47 -69 129 47 84 -178 -83 -132 
186 -58 179 58 137 -171 -78 -101 
132 -61 172 55 118 ... ... -107 
C2'endo 178 ... ... 70 152 -170 -170 -125 
-110 180 
c3'endo 138 -65 145 60 70 -150 -67 -154 
58 -130 -172 70 
C2"endo 163 -62 169 58 148 -106 177 -96 
A4B c2"end° 168 -69 149 48 133 -159 -86 -99 
G5B c1'exO 19 -67 158 51 133 -84 147 -89 
G6B c2'endo 174 -77 160 35 150 ... ... -98 
a calculated using the program Curves v5.1. Values averaged due to NCS. 
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A disordering of the phosphate group ( fig. 37 ) linking Cyt1B and 
Cyt2B occurs. Occupancy refinement of its two distinct conformers 
shows the disorder to slightly favour the conformer which is 4.6A 
away from a N-methylpyridyl moiety of NiTMPyP. 
fig. 37 Disordering of the phosphate due to electrostatic forces 
Solvent structure and Mg2+ interactions The crystal structure 
possesses a well ordered hydration network ( fig. 38A, 38B ), with 
198 unique water molecules clearly defined. Nearly half of the 
waters form a first hydration shell of the DNA-NiTMPyP dimer, and 
a subset of these are shared with the first hydration shells of 
symmetry-related molecules. Many waters exhibit tetrahedral 
coordination with other hydrogen bond acceptors and donors. A 
considerable degree of sugar-phosphate hydration is seen, with the 
phosphate oxygens generally participating in bifurcated hydrogen 
bonds with two waters. In some instances this leads to a 
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pentagonal hydrogen bond arrangement for the two phosphate 
oxygens and three waters. Additional solvent interaction with the 
sugar-phosphate backbone involves waters that hydrogen bond with 
-CH- atoms of sugar groups. For each DNA duplex, a Mg 2+ . (H20)6 
cation lies at the center of a considerable water network found in 
its major groove. Each Mgt+. (H20)6 hydrogen bonds with Ade4b: N7, 
Gua5b: 06 and Gua5b: N7 and two phosphate oxygens of a 
symmetry-related DNA helix. This is on the opposite face of the 
DNA helix to where NiTMPyP makes its groove interaction. NiTMPyP 
binding leads to a complete exclusion of water from its sites of 
interaction. Unlike the magnesium cations the N-methylpyridyl 
groups of NiTMPyP show little hydration. 
0 
fig. 38A, 38B Hydration of DNA-TMPyP. Coloured according to atomic thermal 
factors 
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Caution should always be taken when interpreting hydration 
structures seen in DNA and protein crystals [304,30sß, simply because 
their crystal lattice forces only appear as a consequence of 
dehydration (158. The DNA-NiTMPyP crystals were also cooled to 
100K for data collection -a temperature where NiTMPyP would 
never bind to DNA. Nevertheless "static" DNA models from 
crystallographic studies have shown a degree of agreement with 
NMR studies on DNA structure and hydration (3061. From this it 
appears that the hydration of the sugar-phosphate backbone is not 
greatly relevant [307-3091, except in the cases when it contributes to 
hydration patterns seen in the DNA minor groove. Both 
crystallographic and NMR techniques have found spines of water in 
the minor groove [310-312]. Such spines are also seen at the centre of 
this structure, at the point where the two helices dimerise. 
Considering the tightness of the minor groove at this site, the 
presence of a spine of water molecules shows that this hydration 
motif persists even in the presence of considerable helical 
distortion. 
Porphyrin structure and its interactions with DNA The 
porphyrin rings of the TMPyPs are non-planar - exhibiting a so- 
called ruffled conformation ( fig. 39 ). In a ruffled conformation the 
mesocarbons are alternately above and below the porphyrin mean 
plane while the core nitrogens are in the plane. TMPyP by itself 
exhibits a planar conformation in its crystal structure [2951, however 
. the ruffling of the NiTMPyP porphyrin ring is not unexpected 
[313-316] 
Indeed it is especially favoured because of its bulky substituents 
and the coordination of a Ni atom; When the porphyrin is 
substituted with bulky groups on one or more of the mesocarbons 
there are steric interactions between the meso substituents and the 
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adjacent ß-carbons that favour non-planar conformations. Short 
metal-N bond lengths have the effect of drawing in the core of the 
porphyrin. 
fig. 39 Ruffling of the porphyrin as it end-caps the DNA helix 
For the NiTMPyP in this structure, the deviation of the core N 
pyrrole atoms is 0.28A from the lsq mean plane; Each pyrrolic 
subunit is twisted with respect to the next, as seen in the Ca-N-N- 
Ca torsion angles which vary from 16° to 25°; The four 
N-methylpyridyl groups are all orientated in a propeller 
conformation at -600 angles to the porphyrin, values in agreement 
to those seen in the TMPyP crystal structure; The average Ni-N 
bond lengths vary between 1.91-1.95A, also in agreement with 
those seen in other Ni-porphyrin crystal structures. No loss of the 
porphyrin ring electron resonance of TMPyP due to its ruffled 
[317 conformation is expected , 31sß 
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With the expectation that the conformation of the 
self-complementary d(CCTAGG) duplex would exhibit symmetry in 
solution, a striking feature of the ruffled NiTMPyP conformation is 
both its asymmetry and its asymmetric mode of DNA interaction. In 
the CuTMPyP-DNA crystal structure ( fig. 40) [29311, two CuTMPyP 
molecules interact with a single d(CGATCG) duplex. The CuTMPyP 
molecules are planar, sandwiched between two equiplanar bases. 
The internal symmetries, D4M for the CuTMPyPs and C2 for the DNA 
duplex are conserved on their interaction. Only one feature is 
shared in both the metalloTMPyP-DNA crystals structures, this is a 
positioning of the Ni and Cu atoms along the DNA helical axis. 
fig. 40 Hemi-intercalation of CuTMPyP with DNA 
One drawback of the crystallographic technique is that the 
ensemble of possible DNA and TMPyP conformations is not 
observed. Nevertheless these crystal structures suggest that the 
conformation of TMPyPs can change according to their particular 
nucleic acid environment, and that the observed TMPyP and DNA 
conformations are the result of a cooperative exchange of energy 
between the two. 
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Each TMPyP interacts with two DNA helices, end-capping one and 
groove-binding the other. When it end caps the DNA helix, the 
opposing N-methylpyridyl groups are either drawn down around the 
underlying base-pair or pushed away ( fig-39 ). It is unlikely that a 
similar orientation occurs when TMPyPs intercalate with DNA, 
because there would be a clashing of the N-methylpyridyls with the, 
phosphate backbone. The presence of the Ni atoms of NiTMPyP at 
the two ends of a DNA_ helix suggest new metalloligands, based on 
TMPyPs, with which to study long range electron transfer in DNA. 
Suitable modifications to TMPyPs, if desired, should be able to 
eliminate groove binding. The study of electron transfer through 
nucleic acids in the crystalline state is also possible. 
The fit of the porphyrin in the DNA minor groove ( fig. 41 ) is so 
good it seems to wrap around the DNA helix. This is also seen in 
other minor groove binding compounds that maximise their DNA 
contacts by wrapping around it (253,257,2911. A pyrrole group from the 
porphyrin makes van der Waals contacts with Ade4: C2. This pyrolle 
and the two N-methylpyridyl groups adjacent to it may be likened 
to the pivot and blades of a pair of scissors respectively. These two 
N-methylpyridyl blades share their interaction with the bases and 
the backbone on opposite strands. Making contacts with Thy3A: 02 
and Thy3B: 02, respectively. The other two N-methylpyridyl groups 
rest* on the sugar-phosphate backbone of one strand. Maybe 
suprising is the absence of short range electrostatic interactions 
between the N-methylpyridyls and phosphates, all distances being 
greater than 4.5A. The Ni atom lies closest to A4B: C1' and A4B: 03'. 
This proximity may explain the hydrolysis of DNA by TMPyPs at the 
C1' atom (296,297] 
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fig. 41 Minor groove binding of NiTMPyP 
With this structure, the TMPyP molecule has now been shown to 
interact with two surfaces present in a DNA helix, at its ends and in 
its minor groove. It is tempting to propose a sequential mode of 
TMPyP interaction with DNA that firstly involves a minor groove 
association [319]. Whether this depends on AT rich regions could be 
checked by the use of only GC-containing DNA substrates. In the 
presence of free-radicals or oxo-species, subsequent scissions of 
the base-sugar bond could be made, leading to a situation where 
the TMPyP end-caps the DNA molecule. It is also tempting to 
speculate that the mechanism by which TMPyPs achieve DNA 
intercalation - how they poke their N-methylpyridyls through a DNA 
helix - begins with the minor groove binding mode. At this point the 
TMPyP is at its best alignment with the DNA helical axis to take 
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advantage of the extrusion of individual bases from the helix and to-", - 
slip its N-methylpyridyls through. Spontaneous base flipping in DNA 
has been implicated in the action of methyl transferases [320]. This 
mechanism does not however explain the observed 5'-CpG 
dependence of the TMPyP intercalative mode. In the absence of 
experimental data to the contrary - the possibility cannot be 
excluded that TMPyPs, once they find their way into a DNA duplex, 
can then move through it, as well as in and out, until they find 
their most favourable position. 
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Phasing-and refinement of the DNA-porphyrin 
structure 
The DNA-porphyrin crystal structure was determined using 
the MAD method, the quality of the experimental phases 
obtained were as good as those from the refined structure. 
It is shown that the phase ambiguities arising from 
single-wavelength anomalous dispersion could be overcome 
by the use of direct methods. Also shown is a use of 
anomalous differences in a Patterson synthesis to obtain an 
image of the structure. 
initially molecular replacement and isomorphous 
replacement methods were tried to solve the structure 
without success. A reevaluation of these methods shows 
that molecular replacement was not tenable, while 
isomorphous replacement gave clear solutions. With atomic 
resolution data available, an- examination of difference 
Fourier syntheses and partial structure recycling was also 
made. 
The DNA-porphyrin structure is special in that its dyad 
symmetry aligns with the crystals' unit cell axes, giving rise 
to pseudosymmetry. This posed difficulties for the 
refinement of the structure. It also created a situation 
where merohedral twinning of the crystal could occur. 
The aim of an x-ray crystallographic study is to obtain the 
electron-density function that best fits the x-ray scattering function 
of the crystal [321-3241. Usually the electron-density function is 
described in terms of its individual atoms and their thermal 
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motions, and a best fit of the atomic model against its expected 
chemistry is also sought. 
When a crystal is illuminated by a coherent x-ray source, its 
periodicity imposes a periodicity to the scattered x-rays which are 
observable, - a phenomenon known as diffraction ( see appendixA ). 
Once diffracting crystals are obtained, the next goal is to determine 
the individual wave equations, known as structure factors, of the 
scattered x-rays. The set of structure factors form the crystals' 
x-ray scattering function, and from this its electron-density function 
is calculated. A structure factor is characterised by its amplitude 
and phase. The better the values of the amplitudes and phases, the 
better the resulting electron-density function is. The amplitudes are 
measured directly from the intensities of the crystals' diffraction 
pattern. The outer limit to which amplitudes are measured limits 
the resolution of the electron-density function. The phases have 
then to be determined, and a variety of methods exist for this. 
In situations where a crystals' electron-density function, or parts 
of, is similar to a known structure or a model, then a method 
known as molecular replacement may be used to fit structure 
factors amplitudes calculated for the homologous structure to the 
structure factor amplitudes of the crystal ( see appendixB). 
Computational methods, known as direct methods, may also 
determine phases solely from the knowledge of a crystals' 
symmetry and its structure factor amplitudes. These methods 
normally require amplitudes measured to atomic resolution, and use 
statistical distributions for the phase product of a combination of 
structure factors ( see appendixB ). If the resolution limit of the 
amplitudes is too low, then an insufficient number of structure 
factor combinations prevents a unique estimation of phases. It is a 
goal of modern crystallography to remove this resolution factor. A 
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long list of alternative methods, relying solely on computations [325- 
3341, have been proposed in recent years, but none yet have shown 
general success. 
Experimental methods for obtaining phases all 
. 
involve the 
measurement of amplitude differences. Two. broadly similar 
methods, isomorphous replacement and anomalous dispersion, 
involve physically altering the electron-density function of a crystal 
( see appendixC ). In the method of isomorphous replacement, 
heavy atoms are introduced to the crystal. If the heavy atoms 
contribute in a specific way to the electron-density function of the 
crystal,, its structure factors amplitudes will be changed. The 
resulting differences in the amplitudes measured from crystals with 
and without the heavy atom contribution, can then be used to 
provide phase estimates. However, if there is a difference in the 
cell dimensions of the two crystals, known as non-isomorphism, 
then this will also cause amplitude differences. It has been 
proposed that phase information may be obtainable solely from 
non-isomorphism. 
Anomalous dispersion is-- 9a phenomenon which effects the 
. electron-density function of atoms. The extent to which an atom 
exhibits anomalous dispersion depends on the energy of its bound 
electrons and the energy of the incident x-ray source. When atom 
types exhibiting anomalous dispersion exist in, or can be introduced 
to, a crystal, differences are observed in the amplitudes of pairs of 
structure factors, known as Bijovet mates. These differences, as 
when isomorphous replacement is used, can provide phase 
estimates. With the advent of synchrotron radiation, it is possible 
to maximise the amplitude differences produced by anomalous 
dispersion by tuning the x-ray wavelength. 
A choice of two phase estimates can be derived from the amplitude 
differences obtained from isomorphous replacement of anomalous 
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dispersion. This phase ambiguity can be resolved by a combination 
of the two methods, as heavy atoms generally exhibit some 
anomalous dispersion. Additional heavy atom derivatives, or 
anomalous dispersion measured at additional wavelengths can also 
be used. An advantage of the multiwavelength anomalous 
dispersion (MAD) -method over multiple isomorphous replacement 
(MIR) is that the same crystal can be used at all wavelengths 
removing the problem of non-isomorphism. A disadvantage is that 
smaller intensity differences need to be determined. Computational 
methods may also successfully resolve the phase ambiguity. 
In recent years another experimental method to obtain phases, 
called multiple-beam scattering, has been developed [335-338j. These 
experiments take advantage of interference effects between the 
incident wavefronts and wavefronts diffracted within the crystal. 
These interference effects generate amplitude differences. The 
profile of these amplitude differences varies with the alignment of 
the wavefronts and directly 'indicates the phase product of the 
wavefronts. However multiple-beam scattering experiments are 
time-consuming and require high. crystal quality. 
Once phase estimates are obtained, the electron-density function of 
the crystal can be calculated from its structure factors (see 
appendixD ). The electron-density is then interpreted, 'providing an 
atomic model for the structure that fits the electron-density. In 
most instances, the true molecular character of the electron-density 
is ignored. The atomic model is then be refined against the 
amplitude measurements to obtain a better model, and better 
phases with which to see the crystal structure ( see appendixes ). 
Parameters of the atomic model that are usually refined include. the 
atom positions, their occupancy and their thermal motion. 
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Crystallisation of DNA-porphyrin HPLC purified DNA with the 
sequence 5'-CCTAGG was obtained from Oswel DNA Service 
(Medical and Biological Sciences Building, University of 
Southampton, UK). Bromine and iodine modified DNA was also 
obtained from Oswel DNA service. Nickel(II)meso-tetra(4-N- 
methyl(pyridyl))porphyrin was provided by Dr. David Wilson (Dept. 
of Chemistry, Georgia State University, USA). Red crystals ( fig. 42 ) 
up to 1mm in size were grown in the dark by vapour diffusion of a 
12pl drop of 1.25mM (dCCTAGG)2-porphyrin solution, 30mM sodium 
cacodylate pH 7.0,5% MPD, 50mM MgCl2, equilibrated against a 
500pl well solution of 40-60% MPD at 18°C. 
fig. 42 Red crystals of the DNA-porphyrin complex 
The red colour of the crystals clearly shows that no loss of 
electronic resonance in the Ni-porphyrin rings occurred. 
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Data collection The use-of synchrotron radiation was essential 
for collecting multiwavelength data and atomic resolution data. 
Crystals grown using the DNA 5'-BrCCTAGG were prepared in-house 
prior to both synchotron data collections. The crystals were directly 
flashfrozen at 100K ( MSC N2 cryostream ) and tested for diffraction 
quality. They were then transferred to a storage vessel using a 
portable cryostream ( appendixI ). At the synchrotron station, 
crystals were transferred from storage with the portable cryostream 
and mounted in its fixed cry6stream. 
Fluoresence measurements and MAD data were collected at the 
ESRF synchroton, Grenoble, France, on station BM14. The 
flouresence spectrum ( fig. 43 ) for the brominated crystal clearly 
shows an anisotropy in the bromine anomalous signal (339-342]. Two 
distinct fluoresence peaks are observed which indicate that 
bromines occupy two distinct environments within the crystal. It is 
satisfying to see this confirmed in the DNA-porphyrin structure, 
where the bromines are either located close to the end-capping 
Ni-porphyrins or where the DNA helices dimerise. Despite the 
anisotropy in the anomalous signal it was only necessary to collect 
the MAD data at three wavelengths, A'1=0.9189A, a'2=0.9198A and 
x3=0.7747A. For each wavelength, ninety 1.00 oscillation images 
covering a region of reciprocal space located between two major 
zones were recorded on a MAR345 detector. No efforts were made 
to orientate the crystal so that Bijvoet pairs were observed on the 
same oscillation image. 
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fig. 43 Fluoresence spectrums of AgBr (pink) and the crystal (blue). The two 
peaks of the blue line show the anisotropy of bromine anomalous signal in the 
crystal. 
Atomic resolution data was collected at the DESY synchroton, 
Hamburg, Germany, on station X11 (A. =0.9100A). Four large 
crystals were tested for their diffraction strength and the quality of 
the diffraction peaks. Once the best crystal was chosen, three 
passes were made, recording in total a 900 segment of reciprocal 
space on a MAR345 detector. Data was measured in the ranges, 
32.0-2.4A, 2.6-1.4A and 1.6-0.9A, on 30x3°, 70x1.2° and 90x1.0° 
oscillation images, respectively. 
Data from crystals grown with native and iodinated DNA were 
collected on an R-AXIS-IIC with a RU200 rotating anode x-ray 
source (X =1.5418A ) operating at 50kV, 100mA with Yale mirror 
optics (MSC). The crystals were flashfrozen directly at 100K. 
Data processing All the data sets were processed with programs 
from the HKL SUITE [198,199] For the scaling of observations 
between oscillation images, overloaded observations were always 
excluded, and where necessary scale and b factor restraints were 
used. All data sets were of good quality with low Rmerge values. 
Especially good was the atomic resolution data, where the Rmerge in 
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the outer shell 0.89-0.93A, is 18.2%. The crystal used for the 
atomic resolution collection, despite being very large, 
N0.6x0.6x1. Omm3 in size, and flashfrozen, had a low mosaicity of 
-0.15°. As can be seen for the merging statistics of the 
multiwavelength data, the Ranom is significantly larger than the 
Rmerge for all three wavelengths. 
Data processing statistics 
MAD data High resolution data 
Unit cell dimensions a= 32.163A c= 62.179A a= 32.320A c= 62.159A 
Temperature 100 K 100 K 
Mosaicity 0.42° 0.15° 
Wavelength 0.9198A 0.9189A 0.7747A 0.9057A 
Resolution 10 - 1.6A 10 - 1.6A 10 - 1.2A 62 - 0.9A 
Total hki 46411 45830 74431 336951 
Completeness 94.1% 94.2% 94.2% 91.2% 
Unique h1b 8432 8371 14571 43025 
F(hk/) I >4a 92.0% 92.1% 95.2% 82.0% 
a 1.7% 1.7% 1.4% 1.05% 
/ý, b, r, 
b 7.0% 3.2% 4.2% 2.1% 
a merge = Ehia EII <I(hk/)> - I(hk/), I/ Eh <I(hk/)> where I is intensity of a reflection. Bijovet 
mates are kept separate. 
b lýý, o,,, is the Rerge as but with merging of Bijovet mates. 
A crucial step in the solution of the structure was to determine the 
symmetry of the crystal. The Rmerge factors for P4 and P422 space 
groups were almost the same, which would normally indicate that 
the crystal possessed P422 Laue symmetry. Weak zonal reflections, 
considered to be systematic absences, suggested a 41 or 43 screw 
axis along the c axis and a 21 screw axis along the a axis. As 
revealed by MAD phasing, the true symmetry of the crystal 
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structure was found to be P41 and the apparent P422 Laue 
symmetry was a consequence of the non-crystallographic dyad 
symmetry in the structure. 
MAD phasing Programs from the CCP4 SUITEE1971 were used for 
solution of the structure. Analysis of anomalous and dispersive 
difference Patterson maps ( fig. 44 ) clearly revealed four unique 
bromine atoms in the P41 asymmetric unit cell. The dyad symmetry 
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fig. 44 Harker section, z=0.5, for anomalous (coloured orange) and dispersive 
(coloured blue) Pattersons showing mirror symmetry along x=y. 
The direct methods program SHELXS [343] also correctly located the 
four bromine sites with the anomalous differences measured at all 
three wavelengths. P41 is a polar space group, and the location of 
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SHELXS resulted in a uniform distribution of the DNA-porphyrin 
complexes within the unit cell ( figs. 45 ), putting the four positions 
of dyad symmetry along the c axis at 1/8c, 3/8c, 5/8c and 7/8c. 
figs. 45 Distribution of DNA-porphyrin dimers in the unit cell 
SCALEIT [3441 was used to put scale the data sets together. Then 
using MLPHARE [2533 and treating the MAD data at three 
wavelengths as MIR data [2513, the positional, occupancy and 
temperature factors for the bromine atoms were refined and 
experimental phases were calculated to 1.6A. MLPHARE can model 
the dispersive and anomalous differences from the bromines, in 
terms of the relative real and anomalous occupancies of electrons 
between the different wavelengths. The refined occupancies should 
relate to the relative f' and f" contributions at each wavelength. All 
bromine sites showed the same refined occupancies, and the 
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anisotropy of the bromine anomalous signal, as seen in the 
flouresence spectrum, was not detected. 
MAD Phasing statistics 
Wavelength 0.9198 A 0.9189 A 0.7747 A 
treated as native 
Phasing power a 
acentric / centric 4.49/5.45 
D_ _rm 
b 




acentric / centric 
0.87/0.85 
a Phasing power = <FH>-<E> where FH is the heavy atom structure factor and E is the lack of 
dosure. 
b RCu, S = <E>/<A> where E is the lack of dosure error and a is the isomorphous difference. 
The phasing statistics show that the MAD data provided excellent 
phase estimates. From the phase <FOM> of 0.87, a high quality 
electron-density map was expected. It even seemed possible that 
better phases would be obtained from the MAD experiment, than 
from the refined structure. However, the initial map was of a poor 
quality. Both discontinities in electron-density and density from 
ordered water gave the initial map a blobby appearance. To ease 
interpretation of the electron-density a computer program was used 
to fit the bromocytosine bases into the map from the known 
positions of the bromines. The program, using code modified from 
the XTALVIEW [2071 source code, tested all possible orientations of 
the bromocytosine bases against the electron-density. Once the 
positions for these bases were known, the DNA-porphyrin dimer 
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was easily modelled to the map using the program XFIT 
( XTALVIEW ). 
The poor quality of the initial map was subsequently discovered to 
arise from the use of a cutoff in MLPHARE to remove isomorphous 
or anomalous differences greater than 4a. When the cutoffs were 
removed, the resulting electron-density map ( fig. 46 ) was as good, 
if not better, than the electron-density obtained from refining the 
structure against the same 1.6A data. 
fig. 46 MAD experimental electron-density contoured at 1.5a 
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Improving SAD phases Good phase estimates may be derived 
from only single-wavelength anomalous dispersion 
measurements [345,346], If the phases are sufficiently good to define 
an approximate solvent envelope around the electron-density 
function, cycles of removing the density outside the envelope and 
adding density within the envelope can bring significant 
improvement to the phases [347-349] . This method is also an excellent 
way to extend the resolution to which phases are reliable. Solvent 
flattening was not applicable however to overcome the phase 
ambiguities present in SAD data for the DNA-porphyrin structure, 
since only 5% of its unit cell corresponded to bulk solvent. In this 
situation, a direct methods formalism ( see appendixF) was 
employed to discriminate between possible phase choices. This 
formalism takes advantage of the Cochran and the Sim distributions 
to derive a new bimodal phase distribution for the SAD data. 
For the SAD data ( X=0.7747 ) limited to 1.6A resolution, a direct 
methods approach was examined. Note that the anomalous 
differences measured at this wavelength were far from their 
maximum. This method required the preparation of a number of 
values that were obtained either using existing programs or 
individually written computer programs. For acentric reflections 
only, the median structure factor F°h and observed AFh values were 
taken directly from data scaled according to the known atomic 
contents given by TRUNCATE E2003(CCP4). The anomalous electron 
occupancies, positions and thermal factors for the bromine sites 
from MLPHARE were used to calculate F"h. The anomalous lack of 
closure was measured in ten resolution bins, and the expected 
phase variance, a2h, was calculated for each reflection. Normalised 
structure factors were calculated in fifty resolution bins by the 
K-curve method, ie. using the observed <jF°hI2> per resolution bin. 
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The E2, and any E1, relationships were found for the observed 
-indices expanded to P1 symmetry. 
The basic strategy of this method is to find the most probable 
phase from the two choices offered by SAD data. Initially, the 
probability that the sign to be applied to JAýJ, P+, was set to a half. 
This gives values of Aq$h, best =0 and mh = exp(-ah2)IcosAOhI that can 
be used to calculate a new value of P+ for each reflection using the 
mh weighted E2 relationships. These new P+ values that were 
calculated from the anomalous phases, f, significantly differed 
from a half. A further cycle was performed of Agh, best and mh 
calculation, followed by P+ calculation. At this stage, AOh, best which 
gives oh = 0" + A$h, best and mh calculation was used to calculate an 
electron-density map. 
Phase statistics after improvement of SAD phases 
resolution initial Final %P+ mean phase 
<FOM> <FOM> correct error 
10.0-8.12A 0.121 0.399 64.3% 30.10 
8.12-5.26A 0.183 0.542 70.7% 27.1° 
5.26-3.86A 0.223 0.706 76.8% 19.7° 
3.86-2.97A 0.254 0.752 79.2% 16.5° 
2.97-2.77A 0.286 0.812 82.3% 14.8° 
2.77-2.07A 0.293 0.857 85.1% 12.7° 
2.07-1.85A 0.316 0.876 86.3% 10.6° 
1.85-1.60A 0.347 0.912 90.1% 9.6° 
The results indicate that this method was very successful in 
improving the phase estimates from the SAD data, and that it 
resulted in an easily interpretable electron-density map ( fig. 47 ). 
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fig. 47 Electron-density from direct methods improvement of SAD 
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P. function An alternative method exists to solve structures from 
single-wavelength anomalous dispersion measurements and involves 
a use of the Patterson function. The PS function ( see appendixG ) 
describes the changes to the normal Patterson function when 
Freidel's law does not apply. It differs in that the number of 
structural images it contains is determined solely by the number of 
anomalous scatterers in the structure. The P5 function can be used 
analytically to derive phases. Alternatively, by superposition of the 
P5 function a single structural image can be obtained, and this 
method was examined using programs from the CCP4 suite, 
including FFT, MAPROT and SFALL. Fourier transform of structure 
factors with Bijovet intensity differences and phases of -n/2 gave 
the PS maps. The PS map was than translated to all positions 
corresponding to the interatomic vectors between one bromine site 
and all sixteen bromine sites present in the asymmetric unit cell. 
The four P5 maps were added together via a sum function and the 
resulting map was Fourier transformed to provide amplitudes and 
phases for visualisation of the map. 
The resulting map ( fig. 48 ) was of a discontinuous nature, and not 
as good as the map obtained by direct methods improvement of 
SAD phases. Largely this reflects the sixteen-fold degradation of 
the image, and to a small extent the contribution of the nickel and 
phosphorus to the anomalous differences. 
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fig. 47 Electron-density after superpositioning the PS maps 
Molecular replacement The packing of nucleic acids into 
crystals is often intricate. Sometimes it leads to the formation of 
continuous DNA helices within crystals. For this reason, nucleic acid 
crystal structures are commonly resistant to solution by molecular 
[3 replacement methods 
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As was to be expected, the best molecular replacement solutions 
were obtained using the complete DNA-porphyrin structure. Taking 
data from crystals grown with either CCTAGG or CCTAGG, with a 
resolution limit of 3.5A, the program EPMR [3511 was used. EPMR 
employs a search in real space - rotations and translations are 
applied to the model, and from the new model position its structure 
factor amplitudes are calculated and compared with the observed 
values. Out of 100 runs (each run has a different starting point and 
involves 300 step searches for a good solution) only two correct 
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solutions were obtained for the refined structure with its waters 
excluded. The solutions had correlation coefficients of -0.48 over 
incorrect solutions with correlation coefficients less than 0.16. The 
two solutions were not equivalent, with a rotation operation of - 
y, x, z relating the two solutions. If the porphyrin molecules were 
removed from the search model, similar solutions with correlation 
coefficients of -0.36 were obtained. If all temperature factors of 
the refined structure were set to 20, the same solutions were 
identified with correlation coefficients of «0.22, while the value of 
incorrect solutions was -0.19. From this it is clear there is a very 
narrow margin for success. '_`. _ 
When one half of the refined structure was used as a search model 
in 200 runs of EPMR, correct solutions were found but they could 
not be identified by their correlation coefficients. With the same 
search model, the space groups P4122 and P41212 were also tested 
without success, confirming that the crystal structure did not 
satisfy a higher symmetry. 
Phasing by isomophous replacement The facility of easily 
being able to modifiy nucleic acids during their synthesis with 
brominated and iodinated nucleotides means that isomorphous 
replacement techniques are especially favoured in the solution of 
nucleic acid and protein-nucleic acid crystal structures. With the 
true P41 symmetry of the crystal known, a reevaluation of data 
collected for iodinated-DNA derivatives was made. Partly to see if 
these data sets also belonged to the same structure, and for a 
comparison with the MAD phasing method. 
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R, ge = Eha Ed <I(hkQ> - I(h0 
1/ EhW<I(hkk> where I is intensity of a reflection. Bijovet 
mates are kept separate. 
Ro,,, = Rmerge on including Bijovet mates. 
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The native and derivative data were scaled together in SCALEIT. A 
resolution limit of 2.2A was applied. MLPHARE was used for the 
generation of phases. Starting with one iodine site for the crystals 
with DNA 5'-51CCTAGG, three other sites were found. These sites 
were equivalent to the bromine positions. By calculating difference 
Fouriers the iodine sites for crystals with the DNA 5'-C51CTAGG and 
5'-CC51UAGG were found. 
The electron-density generated for each of the individual 
derivatives, using SIRAS phases alone proved to be very 
interpretable. The combination of all three derivatives gave 
excellent phases for the structure with a <FOM> of 0.72 to 2.2A 
( figs. 48A, 48B ). The variation of ±2A in the lengths of the c axis of 
the derivatives did not significantly effect the phase calculation. 
The phases however couldn't be improved by solvent-flattening 
which may be explained in the irregular nature of the solvent 
envelope that would be required. 
fig. 48B Overlay of all the 
iodinated DNA derivatives 
fig. 48A Electron-density from 
MIR phasing 
102 
Direct methods and partial structure expansion Given the 
atomic resolution of the data and the presence of bromines, which 
dominate the phases at high resolution, an exploration was also 
made to see if the structure would solve by direct methods. A 
variety of procedures were attempted for this, the most successful 
simply involved the use of the partial structure defined by the 
bromine atoms. 
First the bromine sites, were refined in SHELXL97 [2051. These sites 
were input to the program DIRDIF [3521, which applies 
weighted-tangent formula refinement to difference structure factors 
( see appendixE ). The resulting phases revealed the majority of 
the structure ( fig. 49 ). Especially well defined was the phosphate 
backbone, and the porphyrin ring group. This is not suprising since 
a conventional Sim-weighted Fourier synthesis revealed the nickel 
and phosphate atom sites as 6a and 4a peaks, respectively. Of 
course, from the bromine sites alone it should have been possible 
to fit a DNA model to them, especially with a knowledge of the 
structures dyad symmetry. 
fig. 49 Electron-density from the bromines in a Sim-weighted Fourier synthesis 
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Dyad symmetry The structure possesses a dyad symmetry where 
the two DNA duplexes dimerise end-to-end. This was first observed 
from the four bromine positions identified by SHELXS. Taking two 
sites, the other two could be generated, 
Bri 0.678 0.568 0.048 -> Br3 0.068 0.178 0.202 
Br2 0.916 0.257 0.059 -> Br4 0.757 0.416 0.191 
where the transformation required is xyz -* y+1/2, x+1/2,1/4-z. The 
rotation component of the dyad symmetry is exactly perpendicular 
to the cell axes. 
The four centres of dyad symmetry within the unit cell are found 
exactly at xyz = (1/4,1/4il/8)i (3/4,1/4,3/8), (3/413/4,5/8) and 
(1/4,3/4,7/8). By applying any of the translations defined by 
t= (±ml/2, ±n1/2rz) where m and n can equal 0 or 1 and z is any 
value, the DNA-NiTMPyP dimer can be moved to an equivalent 
position in the unit cell. This means that the structure has a 
number of possible origins, or pseudosymmetry, which can not be 
distinguished by their structure factor amplitudes. 
This is seen in the two solutions given by molecular replacement. 
The second solution is equivalent to the first by applying the 
transformation ( 1/2-y, l/2+x, z ). The presence of alternative origins 
is also seen in the calculation of phases, where electron-density for 
any of the equivalent structures, or of them all together can be 
generated. For instance, by calculating phases for the bromine 
positions from one structure and bromines from a second structure 
related to the first by the operation y, x, -z. The resulting phases 
with a mean FOM of 0.80 contains electron-density from both 
structures, although of a highly discontinuous nature ( fig. 50 ). In 
this case, the refined real and anomalous occupancies obtained for 
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the bromine sites for each structure were approximately equal, and 
half the values obtained when using only one structure. 
fig. 50 Electron-density generated for the structure located at two different 
origins, related by the operation xyz -> 1/2-y, l/2+x, z 
Structure refinement For the refinement of the structure the 
program SHELXL97 was used. Due to the dyad symmetry of the 
crystals, it was necessary to use restraints to maintain the 
geometry of the structure. There was no possibility of performing 
an unrestrained refinement against the atomic resolution data. 
To understand why the dyad symmetry affected the refinement 
consider two bromine sites related by the dyad symmetry, 
r1 =( x1=0.678, y1=0.568, z1=0.048 ) 
r2 =( x2=0.068, y2=0.178, z2=0.202 ) 
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their contribution F(h) to the structure factor F(h) is 
F'(h) = Eg fgr { exp 2ai h. rl, g ]+ exp I 27i h. r2, g ]l 
= Eg fBr { exp ( 2ai hxl, g + kyl, g + Izl, g )I 
+ exp ( 2n1 hx2, g + 
ky2, g + Iz2, g )l 
making hxi, 9 + kyi, 9 = hX2, g + ky2,9 (modulo 1), and any shifts 
suggested to xi, g and yi, 9 could equally be applied to y2,9 and x2,9, 
respectively. 
All possible 1,2-bond distance and most 1,3-bond distances 
restraints, with allowed standard deviations of 1% and 2% 
respectively, were used. Expected bond lengths and bond angles for 
the DNA and porphyrin were taken, respectively, from the Nucleic 
Acid Database and Cambridge Structural Database [299]. Planarity 
and chiral volume restraints were also applied. Also similarity 1,2- 
and 1,3-distance restraints were used, with allowed standard 
deviations of 1% and 2%, respectively. Only by the combination of 
all these restraints would the structure maintain its geometry, the 
1,2- and 1,3-bond restraints alone were insufficient. 
Checking the geometry of the DNA was simple, but the NiTMPyP 
proved more troublesome. Depending on the restraints used 
different porphyrin conformations were obtained. Its non-planarity, 
and asymmetry in its non-planarity, led to problems in finding the 
best 1,3-distance restraints. This was seen, for instance, in the Ni- 
N bond distances which varied from 1.9A to 2.1A. To check the 
refined porphyrin conformation, the electron-density given by the 
MAD phases was used. 
Each time the restraints were changed it was necessary to refine 
the structure from the beginning. This procedure involved taking 
the structure and idealising its geometry against the restraints and 
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low resolution data (100-3. OA). The resolution was extended by 
0.01A steps to the highest resolution. The success of the restraints 
only being evident at the highest resolution. 
Once the best restraints had been identified and the structure had 
been refined to the highest resolution, the DNA backbone disorder 
was then included in the refinement allowing both conformers a 
sum occupancy of unity. In subsequent steps, anlsotropic 
temperature factors, then solvent atoms and finally riding 
hydrogens atoms were added to the refinement. Lastly, the subset 
of reflections- used for Rfree testing were included for the final 
refinement. 
Refining the anisotropic motion brought a 5% drop in the Rfactor and 
Rfree, which reflects that little anisotropic motion was modelled to 
the refined structure. The modelling of solvent, all 186 waters, 
brought a 10% drop in the Rfactor. The low Rfactor of «10% for the 
1.2A and 0.9A data sets, to an extent reflects that the contribution 
of the bromines at high resolution is almost equal to all the other 
atoms in the structure. 
A strong indicator of the problems caused by the dyad symmetry to 
refinement is seen by analysis of the agreement in the symmetry 
between the two molecules. The structure would be expected to 
exhibit perfect dyad symmetry. However, when the structure was 
refined without the use of NCS restraints, the rmsd positional 
difference between dyad related molecules was 0.52A. This is, 
considering the high resolution of the data, a very high value. NCS 
symmetry restraints could be used at low resolution, but their 
effects were lost as the resolution was extended. 
Within the program a calculation of the Flack x parameter [356] and 
its standard deviation, which together provide an estimate of 
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enantiomorph polarity, gave values of 0.062 and 0.192. This could 
indicate possible merohedral twinning. Using a twinning operation 
of hkl -* kh-l and an initial twinning fraction of 0.1, the final value 
for the twinning fraction refined to 0.50. This brought about a 
reduction both in the Rfactor and the Rfree of N5%. 
Refinement statistics 
resolution 10.0-1.19A 10.0-0.90A 
refined merohedral 0.50000 0.49987 
twinning fraction 
R-factor 10.11% 11.34% 
Mused 28831 84303 
Free R-factor 15.23% 16.39% 
hk/used 1440 4550 
Total atoms 2360 2360 
parameters 21240 21240 
restraints 14386 14386 
rmsd bond 0.03A 0.04A 
rmsd angle 0.18° 0.21° 
Merohedral twinning Increasingly, the analysis of blomolecular 
crystal structures is revealing that merohedral twinning is more of a 
common event than once previously considered [357"363]. Many 
crystal structures that for a long time remained unsolved have been 
found to exhibit twinning. Generally twinning is considered to be a 
problem which greatly hinders the solution of a crystal structure. 
Practical methods used during crystallisation have been developed 
to overcome this problem. Also computational methods exist for the 
detwinning of data. 
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The packing of unit cells within a crystal lattice is subject to a 
degree of disorder, called mosaicity. Crystal mosaicity arises from 
the imperfect packing of domains, collections of unit cells, and 
causes a spreading of a diffraction peak. Both crystallisation and 
the preparation of crystals for experiment can strongly influence 
crystal mosaicity. A situation may exist when the mosaic domains 
within the lattice of a crystal exhibit more than displacements. 
Mosaic domains with different relative orientations may pack 
together, and the crystal is said to exhibit either merohedral or 
non-merohedral twinning. In the case of merohedral twinning the 
reciprocal lattices of the mosaic domains overlap and a single 
diffraction pattern is observed. When non-merohderal twinning of a 
crystal occurs there are multiple diffraction patterns. 
A consequence of merohedral twinning is that the observed 
reflection intensities are the weighted sum of the intensities 
contributed from each of the twinned domains. The interference of 
scattered waves between mosaic domains does not occur. This 
gives 
Iobs(h) = E" a, I(T, h) 
a, is the fractional contribution of twin domain and E a, = 1, T, 
defines the transformation of the twin domains in reciprocal space. 
If we consider two of the structures possibly present in this crystal, 
where for each atom in structureA, the same atom is translated, by 
t 1/2,1/2, f/4 ), to its position in structureB. This transformation 
is equivalent to the operation ( x, y, z ) -ý ( y, x, "/4-z ), which is the 
same transformation that could exist between twin domains. The 
structure factors of structureB are related to those of structureA by 
F13(h) = FA(h)exp( 2aih"t ). The translational shift only effects the 
phases, leaving the structure factor amplitudes unchanged, giving 
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IFB(h)) = IFA(h)j. This is also the case for the anomalous dispersion 
contribution to the structure factor. 
The results obtained for the refinement of the crystal structure 
suggest that the crystals may be perfect merohedral twins. 
However there is no clear proof that the crystals are In fact 
twinned. By the measured amplitudes alone, it Is Impossible to say 
whether the crystals are twinned or not. The temperamentality of 
the structure during refinement stems from the pseudosymmetry. 
The drop in the crystallographic Rfactor and Rfree upon including the 
twinning option during refinement does not Indicate that the 
crystals are perfectly twinned [364]" Either of the two structures 
alone, or the two together with a total occupancy of one give the 
same intensity observations. This means, if the structure was 
twinned, it could have any twinning fraction. 
Two factors suggest the crystal may be twinned. One is the failure 
to see any anisotropy for the bromine anomalous signal - although 
pseudosymmetry may be a factor that can explain this. Another is 
that when all possible interfaces between twin domains were 
examined, one feasible interaction of twin domains was found 
( fig. 51A, 51B ). Considering all the possible ways the DNA- 
porphyrin molecules could have come together to make the crystal, 
it would be suprising if the form that we observe does not reflect 
some higher crystal order. 
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figs. 51A, 51B Possible interaction between twin domains 
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appendix A: The crystallographic scattering function 
Consider coherent radiation of wavelength a, falling on a point 
scatterer P with position vector r relative to some origin 0 
( fig. 52 ). The direction of the incident radiation is defined by the 
unit vector So and the scattered radiation by the unit vector S1. 
fig. 52 Radiation scattered from point P relative to the origin 0 
The scattering from P is ahead of that from a scatterer at 0 by a 
path difference 
OM - NP = r"S, -r"So= r"( S1-So) 
This path difference is equivalent to a phase difference of 





s is known as the scattering vector. By convention the angle 
between Si and So is denoted by 20, making Isl = 2sino / k. 
For a number of point scatterers with position rj and scattering 
amplitude aj the sum of the individual scattered waves, expressed 
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as a complex quantity, is 
A(s) = Yj aj exp ( 2iri rj"s ) 
This can be shown in an Argand diagram ( fig. 53 ), 
eq. A4 
fig-A2 Argand diagram for four point scatterers showing their individual 
contributions to the total scattered wave 
The intensity of scattering in the direction S1 is 
I(s) =I A(s)12 eq. A5 
a real quantity describing the energy of the wave after constructive 
interference of the individual waves. 
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For a continuous distribution of scattering material ( fig. 54 ) 
contained within some finite volume, the variation of scattering 
power from point to point may be expressed as p(r) a function 
which describes the scattered amplitude per unit volume. 
fig. 54 Scattering from a continuous distribution 
The total scattering from the distribution p(r) is given by 
f(s) =f p(r) exp ( 2iri r"s ) d3r eq. A6 
When p(r) describes the electron-density about an atom, f(s) is 
known as the atomic scattering factor. Since the electron cloud 
distribution about an atom is centrosymmetric, atomic scattering 
factors are real and in phase with that from a point scatterer at the 
atomic centre. Distributions for p(r) are obtained by quantum 
mechanical calculations, for crystallographic purposes p(r) is 
usually approximated by a summation of Gaussian distributions. 
Atoms with more diffuse electron clouds exhibit a sharper fall off in 
scattering amplitude due to interference, while heavy atoms are 
more centrally condensed and approximate more closely to point 
atoms ( fig-55 ). 
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fig. 55 The falloff in atomic scattering amplitudes with scattering angle 
isi 
A crystal is a three-dimensional lattice of paralleliped-shaped unit 
cells each of which contains a similar arrangement of atoms. The 
total scattering from a crystal is given by 
F(s) =ký p(r) exp ( 2; ri r"s ) d3r eq. A7 
where p(r) describes the electron-density of a single unit cell and V 
is the unit cell volume. Thus the amplitude of scattering, I F(s) (, is 
proportional to the amplitude of scattering by the contents of one 
unit cell and the number k of unit cells illuminated. 
The quantity F(s) is known as a structure factor, it describes the 
scattering by the electron-density within a crystal unit cell for the 
scattering vector s. In general, a structure factor is a complex 
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number with an amplitude and phase, 
F(s) =I F(s) I exp io(s) eq. A8 
The periodic nature of a crystal imposes a periodicity on the 
radiation which it scatters, a phenomenon known as diffraction. 
Consider a one-dimensional lattice ( fig. 56 ), 
fig. 56 Scattering by a one-dimensional lattice 
the condition for constructive interference from neighbouring cells 
separated in the a direction is given by 
a"( S1 - So )= hA eq. A9 
This condition states that the path difference of waves scattered by 
successive lattice points must be a whole number of wavelengths. 
Taking this to a three-dimensional lattice where each lattice point 
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(uvw) is given by ua + vb + wc, the conditions for a diffracted 
beam to be observed become 
a"s =h, b"s = k,, c"s =/ 
which are known as the Laue equations. 




where the vectors a*, b* and c* are defined by the set of 
equations 
a*a =1 a*b =0 a*c =0 
b*a =0 b*b =1 b*c =0 
c*a=0 c*b=0 c*c=1 egs. A12 
This definition of s satisfies all Laue equations and given a, b, c 
and So the direction of the diffracted beam with indices (hkl) is 
obtained. 
The lattice defined by the vectors a*, b* and c* is known as the 
reciprocal lattice. It provides a useful means with which to define 
crystal diffraction. 
A convenient way of visualising crystal diffraction is to superimpose 
a sphere of radius 1/X, called Ewalds sphere, on the reciprocal 
lattice ( fig-57 ). Every reciprocal lattice point that intersects with 
the surface of the sphere satisfies the conditions for diffraction to 
be observed. During the collection of diffraction measurements the 
crystal is rotated about an axis, thus changing the orientation of 
the reciprocal lattice and bringing other reciprocal lattice points 
. 
[365 into contact with Ewalds sphere , 
366] 
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* rotation axis 
So 
0 
fig. 57 Diffracted beams are observed when reciprocal lattice points intersect 
with Ewalds sphere 
The use of reciprocal lattice vectors permits an alternative 
description of the crystal scattering wave function in terms of 
atomic positions, r;, where 
rj = xj a+ yj b+ zj c eq. A 13 
and xj, yj and zj are given as fractional coordinates, then 
= hxj + kyý + lzj eq. A 14 
The structure factor can now be described in terms of the atomic 
positions and scatter factors, as opposed to a continuous 
electron-density distribution, by 
F(hkf7=Ej fj(s) exp ( 2zi hxj +kyý+/zj ) eq. A15 
where f; (s) is the atomic scattering factor at scattering angle s. 
Commonly a simpler structure factor formalism is used, so that 
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F(h)=Ejfjexp(2; rihxj+kyj+/zj) eq. A16 
It is not normally necessary to collect a complete sphere of 
intensity observations. The structure factor F(-h-k-f) is related to 
the structure factor F(hk/) as follows 
JF(hk/)j exp -iý(hký eq. A17 
Making I(hkl) = I(-h-k-I) which is known as Friedels law. This 
equivalence means it is only necessary to measure the intensities 
for a hemisphere of reciprocal lattice points. 
When, as is commonly the case, the distribution of atoms in the 
unit cell exhibit symmetry relationships, this reduces the unique 
volume of the unit cell. It also leads to additional structure factor 
equivalences in reciprocal space, thereby reducing the number of 
unique intensity observations to be measured. Consider a symmetry 
operation of the form 
S(r) = R(r) +t eg. A18 
where R is a 3x3 rotation matrix and t is a translation vector. 
Then a volume of the unit cell, termed the asymmetric unit, which 
defines the unique contents of the unit cell, under G symmetry 
operations determines the contents of the whole unit cell. The 
structure factor in the presence of crystal symmetry becomes 
F(hko = Ej fj(s) Eg w(g, rj) exp ( 2; ri Sy(rj)"s ) eq. A19 
where S9 are the symmetry operators and the factor w(g, rj) 
normalises the occupancy of a position vector rj in the unit cell. For 
instance, a two-fold rotation axis along the b unit cell axis is 
described by two symmetry operators operations So =xyz and Si 
= -x y -z. Expanding the structure factors, 
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F(hkf7 =Ejwjfj[exp{2; ci(hxj+kyj+/zj)} 
+exp{2; ri(-hxj+kyj-/zj)}] 
F(-hk-0 =Ejwjfj[exp{2ni(-hxj+kyj-/zj)} 
+ exp { 2; ri (hxj + kyj + lzj) }] eqs. A20. 
shows that I F(hkf) I_I F(-hk-1) I and by Friedels law I F(-h-k-1)I _ 
F(h-k/) I, reducing the number of unique reciprocal lattice points 
to be measured by a factor of two. 
When defining the structure factor in terms of discrete atoms , it 
becomes necessary to include the thermal motion of the atoms. 
This need arises because the time-scale of measuring a diffracted 
beam is much greater than the time taken for atoms to vibrate. 
Generally two types of motion are accounted for. For isotropic atom 
motion, the structure factor becomes 
F(hko = Ej fj(s) exp ( -s<ujZ>@ ) exp ( 2; ri rj"s ) eq. A21 
where @ is the transpose of s and <uj2> is the mean square atomic 
displacement along s. Commonly, values called temperature factors 
are used instead of <Uj2> values, they are related by 
Bi = 8n2 <Uj2> eq. A22 
where Bj is the temperature factor for atom j. 
For anisotropic atom motion, the structure factor becomes 
F(hkf) = Ej fj(s) exp ( -2 sUj& ) exp ( 2, ri rj"s ) eq. A23 
where Uj is a variance-covariance matrix expressed in reciprocal 
coordinates that describes the anisotropic atomic displacement. 
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appendixB: Phase constraints and phase invariants 
A crystal is a three-dimensional array of unit cells. The choice of 
the origin for the unit cell is arbitrary ( fig. 58 ), unless symmetry 
elements are present. 






pool 00. ýý 110. 
fig. 58 A two-dimensional periodic pattern and two possible unit cells choices 
An arbitrary unit cell origin means that the structure factors are not 
invariant quantities completely defined by the crystal structure. 
Consider the structure factors F(h) and F(h) where the r; 
correspond to a particular choice of origin 
F(h) = E; fj exp (2fi h"rj ) eq. B1 
F'(h)=exp(2irih"t)Ej fj exp(2, rih"r; ) eq. B2 
where the vector t gives the position of the new origin with respect 
to the original origin. This shows that because 
I F(h) I=I F(h) I and q5'(h) = q5(h) + 2n h"t eq. B3 
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the structure factor amplitudes are invariant while the phases are 
variant with the position of the structure in the unit cell, except for 
h=0 which has a phase of zero for any choice of origin. 
The presence of symmetry elements imposes restrictions on where 
the origin is positioned. The symmetry also lead to restrictions on 
the phases for certain h. Consider the case when there Is a 
two-fold rotation symmetry along the b axis. Then the origin is 
defined to lie along the b axis, ie ror, _(0y0), to agree with the 
symmetry operations S1 =xyz and S2 = -x y -z. The set of all 
structure factors h where h= (hOI) are real with their phase values 
restricted to 0 or it. This can be seen as follows 
F(h0I) = Ej wjfj [ exp { 2; r/ (hxj + lzj) } 
+exp{-2; ri(hxj+lzj)}] 
=2 Ej wjfj cos { 2, r (hxj + /zj) } eqs. B4 
Reflections whose structure factors are restricted to real values, 
are known as centric reflections, and those which have complex 
values are acentric reflections. If the crystal structure possesses an 
inversion symmetry operator, ie Sg = -x -y -z, then all reflections 
are centric and the crystal is described as being centrosymmetric. 
The product of m structure factors is 
Fm(h) = IIm F(hi) =I F(hi) I ... x 
I F(hm) I exp %{ ¢(h1)... +b(hm) } 
eq. B5 
If the origin is shifted to position t, then Fm(h) becomes 
F'm(h) = exp { 2; r% (hi +... hm)"t } Fm(h) eq. B6 
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and the conditions that Fm(h) = F'm(h) is a structure invariant 
quantity occurs when 
Ei hi =0 eq. B7 
For m=2, invariant structure factors exist when h2 = -hi. The 
product for the two factors is F(h)F(-h) = F(h)F(h)* _I F(h)'1 2 
which is a real value and phase independent. Expressing the two 
structure factors 
F(h) = Ej fj exp( 2; ri h"rj ) eq. B8 
F(-h) = Ek fk exp( -2; ri h"rk ) eq. B9 
and combining them 
F(h)F(-h) =I F(h) (Z = Ej Ek fjfk exp { 2; ci h"( rj-rk )} eg. Blo 
shows that IF(h) 12. plays the role of a structure factor with 
scatterers at positions ( rj - rk ) with scattering factors fjfk. The 
Patterson function is defined as 
P(u) = 1/v Eh I F(h) 12 exp { 2'ri h"u } eq. B11 
where u=( rj - rk )- 
When Friedel's law applies, ie I F(h) 12 =I F(-h) 1 2, only the real 
part of the summation remains to give 
P (u) = 1/v Eh>O I F(h) 12 cos { 2, ri h"u } eq. B12 
For a structure containing N atoms, the Patterson function contains 
N images of the structure, each image positioned at each. of the rj 
atom positions and weighted according to fj [367-375]. Depending on 
the size of N, a structural interpretation of the Patterson function is 
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possible. The simplest approach requires finding a single-weight 
interatomic vector t. Superposition of the Patterson function 
translated by +h/2t and -'At gives one image of the structure and 
one image of the inverse structure. The Patterson function 
translated by An is given 
NO = Eh I F(h) 12 exp ( -2; ri h-t, ) cos( 2n h"u ) eq. B13 
A superposition of n Patterson functions can be made by use of the 
minimum function 
P(u) = Min [{ Pi(u) }n ] eq. B14 
For m=3, the reflections hi, h2 and h3 which form a structure 
invariant set are known as structure factor triplets [376-379]. For a 
non-centrosymmetric structure, the phases of structure factor 
triplets, 
(PH _ Ohl + 
Oh2 + Ohs (modulo 2; c ) eq. B15 
are increasingly constrained to PH-+O as the amplitude of the 
structure factor triplet increases. The probability density for OH is 
given by the Cochran distribution, 
P(PH) = Cexp [ KH cos$H ] eq. B16 
where C is a normalisation factor and KH is proportional to the 
product I Fht IXI Fh2 IxI Fh3 I. 
The Cochran distribution for the phases of triplet structure factors 
is derived from statistical considerations of an equal point atom 
crystal structure. This makes it necessary to modify the observed 
124 
structure factor amplitudes I Fh I to best approximate this situation. 
This is achieved by calculating normalised structure factors, 
Eh =k (--u2) /2 Fh eq. B17 
where k is a scale factor, e is the multiplicity of the reflection and 
62 = Ej fj(s)2 is the sum of the atomic scattering factors squared at 
the scattering angle of reflection h. Or alternatively 
IEh IZ=<IFhlzo, -i1 Fhlz eq. B18 
where <I Fh 12> is the average observed structure factor amplitude 
squared for the scattering angle 0 of reflection h. 
Normalised structure factors have the property <I Eh 1 2> = 1. The 
use of normalised structure factors makes 
KH =2 6362 
3/2 1 Ehi II Eh2 II Eh3 I eq. B 19 
where 6,, = E, f; (S)n. The distribution of OH with KH ( fig-59 ) shows 
how the magnitudes of KH distributes OH about 0. 
fig. B2 Cochran distribution shows how OH varies KH 
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The complete set of structure factor triplets for a crystal structure 
are known as the E2 relationships, ie E2 is the set of 
{ hi = h2 + h3 }. When h2 = h3 they are known as E1 relationships. 
When a number of structure factor triplets indicate the phase b(hi) 
the individual Cochran distributions can be summed to give 
P(Onl)=Cexp[EHKHcos(Ohl- On2-On3)] eq. B20 
When OH ; tý 0, a rearrangement of OH = Ohl - On2 - On3 gives 
Ohl $: ýI On2 + On3 (modulo 2; c ) eq. B21 
and if estimates exist for two individual phases for a triplet 
structure factor then the other may be estimated. When a number 
of structure factor triplets indicate the phase Ohl, its best estimate 
is given by 
tan Ohl = T(hi) / B(hi) 
where 
T(hl) = EH KH sin ( Oh2 + Ohs ) 
B(hi) = EH KH COS COh2 +Oh3 ) egs. B22 
This is known as the tangent formula and it - forms the basis of 
computational methods for deriving phases solely from structure 
factor amplitudes. 
The use of structure factor invariants when m >=3 to obtain phase 
estimates from amplitude information is successful only in certain 
situations. This is because the method requires a sufficient number 
of structure factor invariants The statistics used to derive the phase 
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probability distributions for structure factor invariants can be given 
a fuller mathematical treatment by the use of maximum entropy 
methods [378-382] 
appendixC: Experimental methods for obtaining phases 
Two experimental methods, isomorphous replacement (383-3851 and 
anomalous dispersion [386,3871, are commonly used to obtain 
structure factor phases. Both methods rely on perturbing the 
electron-density function of the crystal to give differences in 
structure factor- amplitudes. It is from these amplitude differences 
that the lost phase information can be reconstructed. 
Consider two isomorphous crystals, one native and one derivitised 
with heavy atoms, their structure factors are 
FP(h) = Ej fj exp ( 2; ri h"rj ) eg. cl 
FPH(h) = FP(h) + FH(h) 
= Ej fj exp ( 2; ri h"rj )+ I fk exp ( 2; ri h"rk ) eqs. C2 
By experiment, only the magnitudes I FP"(h) I and I FP(h) I can be 
measured. A number of approaches exist to put the I FP"(h) I on 
approximately the same scale as I FP(h) I. Once this is achieved the 
difference between them, 
AF(h) =I FPH(h) I-I FP(h) I eq. C3 
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can be determined. For centric reflections, the structure factor is 
real and I F"(h) I= I AF(h) I. For acentric reflections, I F"(h) I >= 
I AF(h) I, and the I AF(h) I values approximate to the amplitudes of 
the heavy atom contribution. In most situations, the heavy atom 
structure can be determined using the I AF(h) I terms using either a 
Patterson synthesis or direct methods ( appendixB ). When the 
approximate positions of the heavy-atoms are known, their 
positions, occupancies and temperature factors can be refined to 
give better values of F"(h) ( appendixD ). 
The three known quantities F"(h), I FP"(h) I and I FP(h) I can be 
represented graphically ( fig. 60 ) to show that two solutions for the 
phase of the native structure factor are possible. 
ZI 
FP I 
fig. 60 Phase circle showing how amplitude differences from the isomorphous 
replacement method provide two phase solutions. 
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The two solutions can be expressed as a phase doublet 
b(h) = OH 
(h) ±I Aq(h) I eq. C4 
The absolute value of AO(h) can be calculated as 
Iq(h)I = cos-1{2 
I FPH(h)FP(h) I. 1 (I F"(h) 12_ I FP"(h) 12_ I FP(h) 12)} 
eq. C5 
This phase ambiguity can be resolved by using other heavy atom 
derivatives. Alternatively, density modification or direct methods 
can be used to resolve the phase ambiguity ( appendixF ). Or if the 
heavy atoms exhibit anomalous dispersion, then the phase doublet 
arising from this method can be coupled with that from 
isomorphous replacement to determine the right solution. 
Anomalous dispersion affects both the magnitude and phase of 
scattered radiation. The scattering factor of atoms exhibiting 
anomalous scattering as f(s) = f° + f' + if", where f° is the normal 
scattering, and the anomalous scattering component is divided into 
f' which is real, and if", an imaginary component V2 in advance of 
f° ( fig. 61 ). 
e , --I f" 
Y 
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fig. 61 Theoretical f' and f" scattering factors for bromine atoms about its K- 
shell absorption edge ( A=0.92A ) measured in number of electrons 
Adding these modified atomic structure factors to the structure 
factor equation gives 
F(h) = Ej ( f°j + f'j + if"j) exp ( 2; ci h"rj ) eq. C6 
F(h) = F°(h) + F(h) + F"(h) eq. C7 
The imaginary components F"(h) and F"(-h), each advanced by 11/2 
compared with F(h) and F'(-h) lead to a breakdown of Friedelis 
law, so that 
F(-h) = F°(h) + F'(h) - F"(h) eq. C8 
and 
F(h) - F(-h) = 2F"(h) eq. C9 
This breakdown only aplies to acentric reflections, and two 
reflections F(h) and F(-h) are known as a Bijovet pair. 
Only the magnitudes I F(h) I and I F(-h) I can be observed 
experimentally, and the difference between them 
OF(h) =( F(h) I-I F"(-h) I eq. CiO 
is related to the contribution of the anomalous scattering atoms by 
21 F"(h) I >= I OF(h)I. The I AF(h) I approximate the contribution of 
the anomalous scatterers and Patterson and direct methods may be 
used to find their positions. Refinement of their positions, 
occupancies and thermal factors, allow F"(h) to be calculated, and 
the median structure factor may be derived 
IF(h)12= I F°(h) + F'(h) 12 ='i2 (IF(h)12+IF(-h)I2) _I F(h)1 2 
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eq. Cli 
The known quantities F"(h), F"(-h) and I F(h) I can be represented 
graphically ( fig. 62 ) to show that two possible phases can be 
identified -393], [388 
fig. 62 Two phase choices arsing from Bijovet amplitude differences 
These two possible solutions can be expressed as a phase doublet. 
O(h) = O"(h) oO(h) 
where 
eq. C12 
oO(h)I cos-1 41F(h)I F(h)1 -1(IF(h)1 2+ IF(-h)I2 )I 
eq. C13 
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The phase ambiguity arising from one-wavelength anomalous 
scattering can be resolved by introducing a second wavelength 
[394-396] The two wavelengths must be chosen so that F', ý1 $ F',, 2r 
otherwise F"u coincides with F%21 leaving the ambiguity 
unresolved. From a practical point of view a larger F" gives more 
accurate values for the possible solutions, while a larger difference 
of F' provides better discrimination between possible solutions. 
Considering the case with two wavelengths, this can be shown 
araohically ( fia. 63 ). 
................. 
fig. 63 Bijovet differences from two wavelengths can identify the native phase. 
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appendixD: Determining the best phases 
When determining the best phases values it is necessary to handle 
errors found in both the experimental observations and the heavy 
[397 
atom structure -399] 
Beginning with the case when SIR data is available, a probability 
distribution for the phase can be expressed as 
P(Oh) = Cexp[ -'/z-(On)ZE-Z ] eq. D1 
where C is a normalisation factor, r(Oh) is the lack of closure for 
the phase triangle ( fig. 64 ), and E is the standard deviation of 
E(Oh) values. 
fig. 64 Inaccuracies lead to a lack of closure of the phase circle 
The lack of closure c(qh) is given by 
E(Oh) _I FPH(h)obs I- I FPH(h)calc I eq. D2 
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To obtain the best value of I FPH(h)caic Ia refinement of the heavy 
atom contribution F"(h)caic is needed. The simplest way this can be 
accomplished is by least-squares minimisation of the residual 
R= Eh Wh[ I FPH(h)obs I-I{I FP(h)obs I exp ibh + FH(h)caic }I 12 
eq. D3 
which also leads to a minimisation of the lack-of-closure. 
Parameters of the heavy atom model are 
F"(h)ca, c= Ej gjfj exp ( -8; r Bj ) exp ( '2; ri h"rj ) eq. D4 
where qj is the occupancy, fj is the atomic scattering factor and Bj 
is the temperature factor for heavy atom j. The least-squares 
method however requires an initial estimation of Oh which means 
that the parameters used to calculate FH(h)ca, c are not independent. 
A number of alternatives exist for heavy atom refinement including 
Patterson space refinement and maximum likelihood refinement [400- 
404] 
A similar expression is used for anomalous dispersion phasing and 
the lack-of-closure for the phase circle is given by 
E(Oh) _I A(h)obs ý- ý A(h)calc ( eq. DS 
where A(h) =I F(h) ý-ý F(-h) I 
When multiple phase probability distributions exist from SIRAS, MIR 
or MAD experiments, the best phase is obtained from the joint 
probability distribution 
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P(Oh) =C fId exp[ -1/2Ed(Oh)2Ed-2 ] eq. D6 
where Ed is the average lack of closure. 
The best phase defined by this distribution can be calculated at the 
centroid of the probability distribution 
Fbest(h) =1I F(h) 
I exp ( iOh ) P(qih) dOh 
! P(Oh) dq5h eq. D7 
= mh I F(h) I exp (jobesth ) 
where mh is the phase figure of merit. 
appendixE: Difference Fourier syntheses 
When part of a crystal structure is known it is possible, by means 
of a difference Fourier synthesis, to use its structure factor 
[405 10] information to reveal unknown parts of the structure " 
If we consider a structure factor with amplitude IF(h)I for which 
part of the structure is known and makes a contribution of FK(h) 
FK(h) _ IFK(h)l exp iýk(h) eq. E1 
F(h) = FK(h) + Fu(h) eq. E2 
the phase of for the unknown part of the structure is 
oo(h) = O(h) - OK (h) eq. E3 
the probability distribution of q"(h), known as the Sim 
distribution [411-413], is given by 
P(c5u(h) )= 2nlo(X)'1 exp [X cosq$"(h) ] eq. E4 
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where Io is a modified zeroth-order Bessel function and 
X= 1/2a2' IF(h)FK(h)l, where Qnu = Ej fj" for the unknown part of 
the structure. 
The Sim distribution shows that the most probable value for Ou =0 
and q5(h) = OK (h), the probability increasing with the magnitude of 
X. A Fourier synthesis with structure amplitudes IF(h)I and phases 
0k(h) would be expected to show the positions of the unknown 
parts of the structure. A weighting function depending on X can be 
used to improve the synthesis, giving 
p(r) =E w(h)IF(h)l exp iýK(h) exp ( 2; ri h"r ) eq. Es 
where w(h) = I1(X)/Io(X), where 11 is a modified first-order Bessel 
function. 
Difference Fourier syntheses can also be used to look for additional 
heavy atoms or anomalous scatterers. Given the amplitude 
differences, either 
AF(h)iso =I IFP"(h)i - IFP(h)I I eq. E6 
OF(h)ano =I IF(h)I - IF(-h)I I eq. E7 
A difference Fourier synthesis calculated with the \F(h) amplitudes 
and phases from the known heavy atom contribution, b(h), or the 
anomalous contribution q$ (h), can identify the atoms contributing 
the most to AF(h). 
In some instances, when the known part of the structure is small, it 
is possible to determine phases for the rest of the structure by 
applying direct methods to the difference structure factors. The 
difference structure factor is given by 
136 
F"(h)=IFhIexP(iOh)-IFkhleXp(iokh) eq. E8 
as indicated by the Sim distribution, the most probable value of Oh 
is A. The amplitude of Fu(h) = IF(h) - Fk(h)I, and its phase 
ou(h) = 0, with weight Wh = Ii(X)/Io(X). These values can be used 
with the Cochran distribution 
PCochran(OUhi) =C exp [ Whiy-KH Wh2Wh3 COS (Ouhi ' Ouh2 - OUh3 )] 
eq. E9 
where K = 20-30-2-3/2 I E" h, E" h2E" h3 I, an =E fj" for the unknown part 
of the structure and C is a normalisation factor. At each cycle of 
tangent-fomula refinement new estimates of q"h, are obtained, 
making Ohl no longer equal to ¢kh, and thus the need to recalculate 
the amplitude of E"h, using the relationship I Fhi I =I Fuhi + Fkhi I 
appendixF: Direct methods for resolving phase ambiguity 
A combination of direct methods with SIR or SAD data can be used 
to derive the most probable sign of AOh [414419], Beginning with the 
Cochran distribution 
PCochran(Oht) = Cexp [ EH Ky cos ( Oh1 - Oh2 - Oh3 )I eQ. F1 
where C is a normalising factor, H is the set of structure factor 
triplets for hi = h2 + h3, Ky = 2a3ß2.3/2 1 Eh1Eh2Eh3 I and a,, =E fj" . 
Let 0h = O"h +A Oh where Oh is the native phase, O"h is the phase 
from the heavy-atoms and 1Oh is the phase difference. This gives 
Ohl " ON " Oh3 = AOh1 '( IV3 + Oh2 + Oh3 )= OOhi " 0 
\\ 
eqs. F2 
where e3 = _OH hi + OH hi + OH h3 
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Putting these terms into the Cochran distribution gives 
PCochran(AOhi) = Cexp [E KH cos (nO hi - 0"1) -] eq. F3 
If we define 
a'Sinp' _ 'EH KH sin p" 
a'C05p' = EH KH cos p" egs. F4 
this gives 
a'= [(a'sinp')2+((X'CoSp')2] 
tan p' = a'sinp' / a'COSp' egs. F5 
From the partial structure of the isomorphously replaced atoms, the 
Sim distribution gives an additional phase probability distribution 
PSim (Ahl) =D exp [Ex cos Ohi ] eq. F6 
where u= 21EPH MEHhiI/ß, E"hi is the contribution of the heavy 
atoms to the normalised EP"hi structure factor, 6=off"1E z2 and D 
is a normalisation factor. 
The combination of the Cochran and Sim probability distribution of 
DOh gives 
P(OOh, ) = PCochran"PSim = Eexp [a cos ( oOhl -ß)] 
where 
a=[( cc's inß' )2 +( a'COSß' +x )2 ] 
tan p= a'sinp' /( a'Cosß' +x) 
a'sinß' = EH KH sin ß" 
eq. F7 
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a'COSß' = EH KH Cos ß" - egs. F8 
The combined distributions can be maximised by setting 4Onl = ß, 
which gives 
tan(oq5h, ) =ä sinß'/ (ä cosß'+ x) 
The probability that AO hi is positive is given by 
P+ = 1/2 + 1/2tanh [ sinheghiI ä sinß] 
eqs. F9 
eq. F10 
The probabilities for the sign of eghl can be used to express the 
phase probability of Ohl as the sum of two weighted Gaussian 
distributions. 
Representing the two possible phase solutions as 
and 02 = 0H hi - le0 hil, we obtain 
01 = OH hi + 1O0hili 
P(q5hl)= 2P+ah(2n)h12/ exp [ -2ah-2(Ohl - 01) ] 
+ 2P-ah(2n)h12'4 exp [ -2ah-2(Ohl - 02) ] eq. F11 
Integrating over all possible phase values we obtain, the best 
phase and its figure of merit 
mhl sinOhi, best =I singh, P(q5hl)dOhi 
= exp(-1/2ah12)( P+sinO1+P. sinO2 ) 
mhl COSOhl, best =I COSOh1 P(Ohi)dOhi 
= exp(-1/2(yh12)( P+coSO1+P. C0sq$2 ) 
tanohi, best =( P+sinOj + P. sin02) /( P+COSO1 + P. cos02 ) 




If the Eh, structure factors are weighted by their figures of merit, 
we obtain by the tangent formula 
tan (oOhl) - 
ZH_mh2mh3 KH 
2. beSt +0 h3. best) 
IH mh2mh3-KH COS( ! V3 + DOhz, best + AO h3, best J+ K 
eq. F13 
and 
P+ = 1/2+1/2tanh[sinleOhil x 
F-H mh2mh3 Kt/ sin( W3 + AOh2, best + DOhs, best ý 
Almost the same formalism exists when phase ambiguities from SAD 
situations are handled. In this case the Cochran distribution is 
PCochran(Aýh) = Cexp [E Kh, h' COS (OOh - (OV3 + 0Oh' + OOh-h') )I 
eq. F15 
where e3 = -O"h + O"h' + o"h-h', and the Sim distribution is 
PsIm (AOh) =D exp [Ex sin(o'-¢") cos OOh ] eq. F16 
appendixG: PS function 
An alternative method exists to solve structures from anomalous 
dispersion measurements [420422] and involves a use of the Patterson 
function ( appendixB ). The Patterson function is defined as 
P(u) = 1/v Fail hI F(h) 12exp( -2, ri h"u ) eq. G1 
when Friedels law applies to the data, this can be simplified to 
P(u) = 2/v Eh>o I F(h) 12cos( 2ir h"u ) eq. G2 
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however, when Friedels law breaks down, the function changes to 
P(u) = 1/v Fail hI F(h) 12 cos ( 2; r h"u ) 
+I F(h) 12 sin ( -2; ri h"u ) 
= 
2/V 7-h>o (I F(h) I 2+ I F(-h) I 2) cos ( 2; c h"u ) 
+ (IF(h)I2-IF(-h)I2) sin ( -2; ri h"u ) eqs. G3 
The contribution of the normal Patterson function can be removed, 
leaving only the imaginary component of the Fourier transform 
P(u) = 2/v T-n>o [I F(h) 1 2_ 1 F(-h) 1 2] sin ( -2; ri h-u ) eq. GS 
In the presence of anomalous dispersion the structure factor is 
written 
F(h)=E(f°j+if) )exp(2; cih"r) eq. G6 
where f°j is the real contribution and f"j is the imaginary 








By subtracting and combining terms, we obtain 
F(h) 1 2_ 1 F(-h) 12=2E( f"kf°j + f" jf°k )sin [ 2zi h. ( rj -rk ] 
eq. G7 
This means that when anomalous differences are used as structure 
factors in a Patterson synthesis the resulting peaks for the 
interatomic vector ( rj - rk ) are weighted by the factor 
( f"kf°j + f"jf°k ). When the anomalous scatterers are of the same 
kind then no peaks relating two anomalous scatterers or two non- 
anomalous scatterers exist, ie ( f"kf°j + f"jf°k )=0. The vector ( rj - 
rk ) is from atom j to atom k, vectors from anomalous scatterers to 
non-anomalous scatterers produce positive peaks while vectors in 
the reverse direction yield negative peaks. 
If the crystal contains m anomalous scatterers, then the positive 
region of a PS map consists of a degraded superposition of in 
images of the structure. Each image arising from a different 
anomalous scatterer at the origin. While image degradation is due 
to the cancellation of positive and negative peaks. A single image 
of the structure can be found, by superposition of the P5 maps on 
the interatomic vectors between anomalous scatterers. 
appendix H: Model refinement 
When phases become available, the next step is to model the 
atomic contents to the resulting electron-density maps. Modelling 
involves many cycles of visual inspection of the model and 
refinement of the model against the experimental data. Structure 
factor calculations are made from the model, giving I F(h) I caic, 
which can be compared with IF(h)lobs to determine suitable 
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changes to the model. Least squares methods form the basis for 
minimising the difference between I F(h) I ca, c and 
I F(h) I obs" 
The least squares formalism begins with a set of n experimental 
observations, the structure-factor moduli, 
FH =(I Fhl IiI Fh2I """ I Fhnl ) eq. H1 
and the set of m parameters, X=( xi, x2 ... xm ), that describe the 
structural model. From X the values of FXH for the model can be 
calculated. Least squares refinement of the m parameters involves 
the minimisation of the quantity 
S= EH Wh (IFhI_IFXhI)2 
where each I Fh I is given a weight wh. 




where A=< aij > is the (nx m) design matrix and 
E=( e1, e2, ..., en ), is the set of errors, e, due to imprecisions in 
the measurement process. Assuming the errors e, have joint 
distributions with zero means and finite second moments then 
<FH> = AX eq. H4 
and the variance-covariance matrix M for the experimental errors 
becomes 
M= <(FH - <FH>) (FH - <FH>ý> eq. H5 
For a general variance-covariance matrix M the most satisfactory 
way to estimate X is given by 
S=M M-1 V= minimum, eq. H6 
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where V=F- AX and M is the transpose of V. 
By expanding V the function S to be minimised becomes 
S= CF M'1F -K G^Q M"iF -G WAX +K Z% WAX eq. H7 
The residual S can have several local minim!. In this situtation, 
least square estimation of X does not generally work unless a good 
approximation of the model, X° =( x°1, X02 ... x°m ), is available. 
Each I Fh, I can be expanded in a Taylor series about the point X°: 
F, (X) = F, (X°) +E (8Fj18x f) 8X/ 
+ 1/2 (SZF; /SXjSXk) SXjSXk + .... eq. H8 
When the second and upper derivatives are dropped this gives 
OF, =E (8F, j5xj) Exj+e, eq. H9 
the derivatives are calculated in X° as 
AF, = F, (X) - F, (X°) and ex1= xi - xf eq. H10 
This can be expressed in matrix notation as 
OF=ADX+E eq. H11 
where A={a, 1 }={ SF, /Sxj } is the new design matrix. 
AX is obtained through solution of the set of normal equations 
which given in matrix form is 
BOX=D, eq. H12 
where 
B= G. 1 M A={ bjk }= EH WH (S 1 FXH I /SXj 81 FXH I IsXk) 
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D= GJ M eF ={ df} = EH WH(IAFHI - IFXHI)sIFXHI/Sxf 
eq. H13 
Alternatives to least squares involve the use of maximum likelihood 
or entropy functions. These methods can exploit additional 
information to get better parameter estimates if the distribution of 
errors is available. Such a situation is infrequent, and a Gaussian 
error distribution is often used, this makes the maximum likelihood 
method equivalent to least squares. 
The * parameter values of the model X may be restrained to permit 
only realistic deviations from fixed standard ones. These functions 
are used as supplementary observations. In this situation the 
function to minimise is 
$= EH WH( FH - FXH )2 + EQ wQ ( 9ex - 99 )2 eq. H14 
where gq is the function describing the restraint q and gex is its 
expected value. The normal equations are obtained by expanding S 
in a Taylor series and equalling to zero its derivatives with respect 
to AX): 
(Y-H WH Ek 81 FXH I IsXj 51 FXH I Isxk 
-I- 
Y- Wq 7-k 89q/8Xj SgqlSXk ) AXk 
= EH WH 81 FXH 1 /sx1 eFH +E Wq Sgq/SXj(yex - 9q) BQS. H16 
The effect of restaints is to add contributions to the elements of 
the normal equation matrix. The approximate nature of the 
restraints agrees well with our approximate nature of the chemistry 
involved. A suitable weighting scheme for the restraints is to 
indicate the expected standard deviations of the restraints and 
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scale them to the expected observations. Very small standard 
deviations make restraints equivalent to constraints. 
Two statistics are commonly used to measure the progress of the 
refinement process. Taking H as the set of all I FH I, two subsets of 
H can be defined so that 
H=Hx+H* 
Where H* is randomly chosen and amounts to 5-10% of H. 
The Rfactor is defined as 
Rfactor = £Hx I FH 
I-I FXH ((ý LH I FH 
eq. H 17 
eq. H18 
The Rfree is calculated in the same way as the Rfactor but for the 
subset H*. The Rfactor indicates the minimisation of the residual S. 
By itself this residual says little about the quality of the refinement, 
since simply by lowering the data parameter ratio a lower Rfactor can 
be obtained. As a statistic, the Rfree value depends solely on the 
model X but not its contribution to the model, this makes it an 
excellent indicator of when a refinement is progressing. 
appendixl: Portable N2 cryostream for crystal transfer 
For single crystal diffraction experiments the cryoprotection of 
crystals in nitrogen streams (100-140K) has become routine. 
Cryomethods are especially favoured in the study of biomolecular 
crystals principly because cooling greatly diminishes radiation 
damage which leads to an improvement in data quality. This Is 
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especially advantageous when one is collecting data from a crystal 
derivitised with heavy atoms or for data collected at a synchroton 
beamline, where crystal decay can be very rapid. In some instances 
crystal cryocooling can improve the outer diffraction resolution. 
Also the potential to use loops to pick up crystals for cryoprotection 
provides an easy way of mounting small and fragile crystals for 
data collection. 
The development of crystal cryoprotection has provided 
crystallographers with the opportunity to put cooled crystals into 
storage. This can be useful in many ways, for example, crystals can 
be tested in-house for diffraction quality, put into storage and 
taken to a synchroton, then remounted for data collection. Suitable 
devices for storage are nitrogen vapour shipping containers which 
can be purchased from retailers. 
The transfer of a cryocooled crystal from storage can be a 
complicated manoeuvre. It is necessary to maintain the cooling of 
the crystal at all times and, to avoid the uptake of moisture which 
results in the formation of ice rings; otherwise the crystal is likely 
to lose Its diffraction qualities (mosalcity and resolution). Purpose 
made recovery arcs mounted on goniometer heads and cryo 
tongues have been in use so far. In our laboratory a portable 
cryostream ( fig. 65 ) was designed and built by Tom Rutherford for 
the transfer of flashfrozen crystals between goniometers and 
storage vessels. It provides a manoeuvrable and constant stream of 
vaporous nitrogen at a cooling temperature -140K. 
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fig. 65 Two views of the portable cryostream 
Description of portable cryostream 
" The cryogun consists of a stainless steel delivery arm mounted 
on the lid of a thermoflask. At the longer end of the delivery arm a 
pair of spring loaded jaws is fixed on a 3601 rotable support. 
" The delivery arm is thermoisolated by a vacuum, which can be 
readjusted through a vacuum valve at the top of the short end of 
the delivery arm. At the end a small electric plug is installed, for 
the heating element inside the thermoflask 
" The heating element is mounted on a Plexiglas rod attached 
through the lid. 
" The electric power supply comes from a transformator box and is 
protected by a 1A fuse. 
148 
References 
1 Waddington, CH. 
Towards a Theoretical Biology. I, Prolegomena 
Edinburgh University Press (1968) 
2 Dawkins, R. 
The Extended Phenotype 
Oxford Press (1989) 
3 Schrödinger, E. 
What Is Life ? The Physical Aspect of the Living Cell 
Cambridge University Press (1944) 
4 Lewin R. 
The Thread of Life 
Random House (1982) 
5 Dawkins, R. 
The Blind Watchmaker 
Longman Group (1986) 
6 Cairns-Smith, AG. 
Genetic Takeover 
Cambridge University Press (1987) 
7 Branden C, Tooze J. 
Introduction to Protein Structure 
(Garland Publishing) (1999) 
8 Anfinsen CB. 
Principles that govern the folding of protein chains. 
Science (1973). 181: 223-30 
9 Bier! 0, Kiefhaber T. 
Elementary steps In protein folding. 
Biol Chem (1999). 380(7-8): 923-29 
10 Shea 3E, Brooks CL 3rd. 
From folding theories to folding proteins: a review and assessment of 
simulation studies of protein folding and unfolding. 
Annu Rev Phys Chem (2001) 52: 499-535 
11 Tsai C3, Kumar S, Ma B, Nussinov R. 
Folding funnels, binding funnels, and protein function. 
Protein Sci (1999). 8(6): 1181-90. 
12 Dobson CM, Karplus M. 
The fundamentals of protein folding: bringing together theory and 
experiment. 
Curr Opin Struct Biol (1999). 9(1): 92-101 
13 Booth P3, Curran AR. 
Membrane protein folding. 
Curr Opin Struct Biol (1999). 9(1): 115-21 
14 Rees DC, De Antonia L, Eisenberg D. 
Hydrophobic organisation of membrane proteins. 
Science (1992). 245: 510-12 
149 
15 Lattman EE, Rose GD. 
Protein folding - what is the question ? 
Proc Nat Acad Sci (1993). 90: 439-41 
16 Wright PE, Dyson HJ. 
Intrinsically unstructured proteins: re-assessing the protein structure- 
function paradigm. 
J Mol Biol (1999). 293(2): 321-31 
17 Jensen, RA. 
Enzyme recruitment in evolution of new function. 
Annu Rev MicroBiol (1976). 130: 409-25 
18 Neyfakh AA. 
The ostensible paradox of multidrug recognition. 
J Mol Microbiol Biotechnol (2001). 3(2): 151-54 
19 Thunnissen MM, Nordlund P, Haeggstrom JZ. 
Crystal structure of human leukotriene A(4) hydrolase, a bifunctional 
enzyme In inflammation. 
Nat Struct Biol (2001). 8(2): 131-35 
20 Arnold FH, Wintrode PL, Miyazaki K, Gershenson A. 
How enzymes adapt: lessons from directed evolution. 
Trends Biochem Sci (2001). 26(2): 100-6 
21 Thorne JL. 
Models of protein sequence evolution and their applications. 
Curr Opin Genet Dev (2000). 10(6): 602-5 
22 Koehl P. 
Protein structure similarities. 
Kriventseva EV, Biswas M, Apweiler R. 
Clustering and analysis of protein families. 
Gunasekaran K, Eyles SJ, Hagler AT, Gierasch LM. 
Keeping it In the family: folding studies of related proteins. 
Teichmann SA, Murzin AG, Chothia C. 
Determination of protein function, evolution and interactions by 
structural genomics. 
All appear in Curr Opin Struct Biol (2001, Feb). 
23 Thornton JM. 
From genome to function. 
Science (2001). 292: 2095 
24 Andrade MA, Perez-Iratxeta C, Ponting CP. 
Protein repeats: structures, functions, and evolution. 
J Struct Biol (2001). 134(2-3): 117-31 
25 Paoli M. 
Protein folds propelled by diversity. 
Prog Biophys Mol Biol (2001). 76(1-2): 103-30 
26 Campbell ID. 
The modular architecture of leukocyte cell-surface receptors. 
Immunol Rev (1998). 163: 11-18 
27 Kuzminov A. 
150 
DNA replication meets genetic exchange: chromosomal -damage and its 
repair by homologous recombination. 
Proc Natl Acad Sci USA (2001) 98(15): 8461-8 
28 Südhof TC, Goldstein JL, Brown MS, Russel DW. 
The LDL receptor gene: a mosaic of exons shared with different proteins. 
Science (1985). 228: 815-28 
29 Patthy L. 
Genome evolution and the evolution of exon-shuffling -a review. 
Gene (1999). 238(1): 103-14 
30 Heringa J, Taylor WR. 
Three-dimensional domain duplication, swapping and stealing. 
Curr Opin Struct Biol (1997). (3): 416-21 
31 Voet D, Voet JG. 
Biochemistry 
John Wiley & Sons (1995) 
32 Sen D, Geyer CR. 
DNA enzymes. 
Curr Opin Chem Biol (1998). 2(6): 680-7 
33 Doherty EA, Doudna 3A. 
Ribozyme structures and mechanisms. 
Annu Rev Blophys Biomol Struct (2001). 30: 457-75 
34 Maguire BA, Zimmermann RA. 
The ribosome in focus. 
Cell (2001). 104(6): 813-16 
35 Rodnina MV, Wintermeyer W. 
Ribosome fidelity: tRNA discrimination, proofreading and induced fit. 
Trends Blochem Sci (2001). 26(2): 124-30 
36 Hardesty B, Kramer G. 
Folding of a nascent peptide on the ribosome. 
Prog Nucleic Acid Res Mol Biol (2001). 66: 41-66 
37 Nyborg J. 
Possible evolution of factors involved In protein biosynthesis. 
Acta Biochim (1998). 45(4): 883-94 
38 Szyf M, Detich N. 
Regulation of the DNA methylation machinery and its role in cellular 
transformation. 
Prog Nucleic Acid Res Mol Biol (2001) 69: 47-79 
39 Goldberg B, Urnovitz HB, Stricker RB. 
Beyond danger: unmethylated CpG dinucleotides and the 
Immunopathogenesis of disease. 
Immunol Lett (2000). 73(1): 13-18 
40 Lilley DM, Chen D, Bowater RP. 
DNA supercolling and transcription: topological coupling of promoters. 
Q Rev Biophys (1996). 29(3): 203-25 
41 Woldringh CL, Jensen PR, Westerhoff HV. 
Structure and partitioning of bacterial DNA: determined by a balance of 
compaction and expansion forces? 
151 
FEMS Microbiol Lett (1995). 131(3): 235-42 
42 Harding JJ, Crabbe MSC (Eds. ) 
Post-Translational Modifications of Proteins. 
CRC Press (1992) 
43 Schiene C, Fischer G. 
Enzymes that catalyse the restructuring of proteins. 
Curr Opin Struct Biol (2000). 10(1): 40-45 
44 Degtyarenko K. 
Bioinorganic motifs: towards functional classification of metalloproteins. 
Bloinformatics (2000). 16(10): 851-64 
45 Beinert H, Holm RH, Munck E. 
Iron-sulfur clusters: nature's modular, multipurpose structures. 
Science (1997). 277: 653-9 
46 Chan MK, Kim J, Rees DC. 
The nitrogenase FeMO-cofactor and P-cluster pair: 2.2A resolution 
structure. 
Science (1993). 260: 792-94 
47 Rees DC, Howard JB. 
Nitrogenase: standing at the crossroads. 
Curr Opin Chem Biol (2000). 4(5): 559-66 
48 Jenuwein T, Allis CD. 
Translating the histone code. 
Science (2001). 293: 1074-80 
49 Kasinsky HE, Lewis JD, Dacks 3B, Ausio 3. 
Origin of H1 linker histones. 
FASEB 3 (2001). 15(1): 34-42 
50 Ramakrishnan V. 
The histone fold: evolutionary questions. 
Proc Natl Acad Sci USA (1995). 92(25): 11328-30 
51 Aalfs 3D, Kingston RE. 
What does 'chromatin remodeling' mean? 
Trends Biochem Sci (2000). 25(11): 548-55 
52 Jaschke A, Seelig B. 
Evolution of DNA and RNA as catalysts for chemical reactions. 
Curr Opin Chem Biol (2000) 4(3): 257-62 
53 Lindahl T. 
Instability and decay of the primary structure of DNA. 
Nature (1993) 363: 709-15 
54 Lindahl T, Wood RD. 
Quality control by DNA repair. 
Science (1999). 286: 1897-905 
55 Patel PH, Suzuki M, Adman E, Shinkai A, Loeb LA. 
Prokaryotic DNA polymerase I: evolution, structure, and "base flipping" 
mechanism for nucleotide selection. 
J Mol Biol (2001). 308(5): 823-37 
56 Landick R. 
RNA polymerase clamps down. 
152 
Cell (2001). 105(5): 567-70 
57 Crick FHC, Burnett L, Brenner S, Watts-Tobin RJ. 
General nature of the genetic code for proteins. 
Nature (1961). 192: 1227-32 
58 Davis BK. 
Evolution of the genetic code. 
Prog Biophys Mol Biol (1999). 72(2): 157-243 
59 Knight RD, Freeland SJ, Landweber LF. 
Rewiring the keyboard: evolvability of the genetic code. 
Nat Rev Genet (2001). 2(1): 49-58 
60 Knight RD, Landweber LF. 
The early evolution of the genetic code. 
Cell (2000). 101(6): 569-72 
61 Oparin, Al. 
The Origin of Life 
Macmillan (New York) (1938) 
62 Dickerson RE. 
Chemical evolution and the origin of life. 
Sci Amer (1978). 239: 70-86 
62 Dyson, FJ. 
A model for the origin of life. 
3 Mol Evol (1982). 18: 344-50 
63 Orgel LE. 
The origin of life -a review of facts and speculations. 
Trends Biochem Sci (1998). 23(12): 491-5 
64 Lahav N, Nir S, Elitzur AC. 
The emergence of life on Earth. 
Prog Biophys Mol Blol (2001). 75(1-2): 75-120 
65 Huber C, Wächtershäuser G. 
Peptides by activation of amino acids with CO on (Ni, Fe)S surfaces: 
Implications for the origin of life. 
Science (1998). 281: 670-2 
66 Huber C, Wachtershauser G. 
Activated acetic acid by carbon fixation on (Fe, Ni)S under primordial 
conditions. 
Science (1998). 276: 245-47 
67 Wachtershauser G. 
Before enzymes and templates: theory of surface metabolism. 
Microbiol Rev (1988). 52: 452-84 
68 Crabtree RH. 
Prebiotic chemistry. Where smokers rule. 
Science (1997). 276: 222 
69 Russell M7, Hall A7. 
The emergence of life from iron monosulphide bubbles at a submarine 
hydrothermal redox and pH front. 
J Geol Soc London (1997). 154(3): 377-402 
70 MacLeod G, McKeown C, Hall A), Russell Mi. 
153 
Hydrothermal and oceanic pH conditions of possible relevance to the 
origin of life. 
Orig Life Evol Biosph. (1994) 24(1): 19-41 
71 Rode BM. 
Peptides and the origin of life. 
Peptides (1999). 20(6): 773-86 
72 Blankenship RE. 
Origin and early evolution of photosynthesis. 
Photosynth Res (1992). 33: 91-111 
73 Forsdyke DR, Mortimer JR. 
Chargaff's legacy. 
Gene (2000). 261(1): 127-37 
74 Wachtershauser G. 
Life as we don't know It. 
Science (2000) 289: 1307-8 
75 Shapiro R. 
Origins. A skeptics Guide to the Creation of Life on Earth. 
Summit Books (1986) 
76 Pauling L. 
A Theory of the Structure and Process of Formation of Antibodies'. 
3 Am Chem Soc (1940). 62: 2643-8 
77 Pauling L. 
Molecular Architecture and the-Process of Life. 
21st Sir Jesse Boot Foundation Lecture, Nottingham, 1948. 
78 Pauling, L, Hayward R. 
The Architecture of Molecules. 
Freeman (1964) 
79 Watson 3D, Crick FHC. 
Molecular structure of nucleic acids. 
Nature (1953). 171: 737-8 
80 Margulis L, Crick FHC. 
Plastic DNA takes over critical cell activities. 
J. Artificial Biol (1988). 3: 26-34 
81 Zuckerkandl E, Pauling L. 
Molecules as documents of evolutionary history. 
J Theor Biol (1965). 8(2): 357-66 
82 Rose S, Lewontin RC, Kamin U. 
Not In Our Genes. 
Penguin Books (1988) 
83 Boehmer PE, Lehman IR. 
Herpes simplex virus DNA replication. 
Ann. Rev. Blochern (1997). 66: 347-84 
84 Becker Y, Asher Y, Bujanover S, Darai G. 
The dynamic herpesvirus DNA genome: the case of MDV-1 and HSV-1. 
Acta Virol (1999). 43(2): 81-9 
84 Umene K, Sakaoka H. 
Evolution of herpes simplex virus type 1 under herpesviral evolutionary 
154 
processes. 
Arch Virol (1999). 144(4): 637-56 
85 Subak-Sharpe JH, Dargan D3. 
HSV molecular biology: general aspects of herpes simplex virus 
molecular 
biology. 
Virus Genes (1998). 16(3): 239-51 
86 Raftery M, Muller A, Schonrich G. 
Herpesvirus homologues of cellular genes. 
Virus Genes (2000). 21(1-2): 65-75 
87 Becker Y, Asher Y, Bujanover S, Darai G. 
The dynamic herpesvirus DNA genome: the case of MDV-1 and HSV-1. 
Acta Virol (1999). 43(2-3): 81-89 
88 Cohrs R3, Gilden DH. 
Human herpesvirus latency. 
Brain Pathol (2001). 11(4): 465-74 
89 Klelnschmidt-DeMasters BK, Gilden DH. 
The expanding spectrum of herpesvirus infections of the nervous system. 
Brain Pathol (2001). 11(4): 440-51 
90 Whitley R3, Roizman B. 
Herpes simplex virus infections. 
Lancet (2001). 357: 1513-18 
91 O'Farrell N. 
Increasing prevalence of genital herpes in developing countries: 
implications for heterosexual HIV transmission and STI control 
programmes. 
Sex Transm Infect (1999). 75(6): 377-84 
92 Darby, GK. 
A history of antiherpes research. 
Antiviral Chem Chemother (1994). 5: 3-9 
93 Meyding-Lamade U, Lamade W. 
HSV and the CNS. 
Neuroscientist (1996). 2: 44-54 
94 Chen SH, Cook WJ, Grove KL, Coen DM. 
Human thymidine kinase can functionally replace herpes simplex virus 
type 1 thymidine kinase for viral replication in mouse sensory ganglia 
and reactivation from latency upon explant. 
J Virol (1998). 72: 6710-15 
95 Chen MS, Prussof WH. 
Association of thymidylate kinase activity with pyrimidine 
deoxyribonucleotide kinase Induced by herpes simplex virus. 
3 Biol Chem (1978). 253: 1325-27 
96 Chen MS, Summers WP, Walker 3, Summers WC, Prusof WH. 
Characterisation of pyrimidine deoxyribonucleotide kinase (thymidine 
kinase) and thymidylate kinase as a multifunctional enzyme in cells 
transformed by herpes simplex virus type-1 and in cells infected with 
mutant strains of herpes simplex virus. 
J Virol (1979). 30: 942-45 
97 Vogt 3, Perozzo R, Pautsch A, Prota A, Schelling P, Pilger B, 
155 
Folkers G, Scapozza L, Schulz GE. 
Nucleoside binding site of herpes simplex type 1 thymidine kinase 
analyzed by X-ray crystallography. 
Proteins (2000). 41(4): 545-53 
98 Pilger BD, Perozzo R, Alber F, Wurth C, Folkers G, Scapozza L. 
Substrate diversity of herpes simplex virus thymidine kinase. Impact of 
the kinematics of the enzyme. 
3 Biol Chem (1999). 274(45): 31967-73 
99 Sulpizi M, Schelling P, Folkers G, Carloni P, Scapozza L. 
The rational of catalytic activity of herpes simplex virus thymidine 
kinase. a combined biochemical and quantum chemical study. 
3 Biol Chem (2001). 276(24): 21692-97 
100 Perozzo R, )elesarov I, Bosshard HR, Folkers G, Scapozza L. 
Compulsory order of substrate binding to herpes simplex virus type 1 
thymidine kinase. A calorimetric study. 
3 Biol Chem (2000). 275(21): 16139-45 
101 Kussmann-Gerber S, Wurth C, Scapozza L, Pilger BD, Pliska V, 
Folkers G. 
Interaction of the recombinant herpes simplex virus type 1 thymidine 
kinase with thymidine and aciclovir: a kinetic study. 
Nucleosides Nucleotides (1999). 18(3): 311-30 
102 Elion GB, Furman PA, Fyfe )A, De Miranda P, Beauchamp C, 
Schaeffer H). 
Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) 
guanine. 
Proc Nat Acad Sci USA (1977) 74: 5716-20 
103 Schaeffer H), Beauchamp C, De Miranda P, Elion GB, Bauer DI, 
Collins P. 
9-(2-hydroxyethoxymethyl)guanine activity against viruses of the herpes 
group. 
Nature (1978). 272: 583-85 
104 Smith KO, Galloway KS, Kennell WL, Ogilvie KK, Radatus BK. 
A new nucleoside analog 9-[[2-hydroxy-l-(hydroxymethyl)ethoxy]methyl] 
guanine, highly active in vitro against herpes simplex virus typel. 
Antimicrob. Agents & Chemother (1982). 22: 55-61 
105 Keller PM, Fyfe )A, Beauchamp L, Lubbers CM, Furman PA, 
Schaeffer H), Elion GB. 
Enzymatic phosphorylation of acyclic nucleoside analogs and correlations 
with antiherpetic activities. 
Blochem Pharm (1981). 30: 3071-77 
106 Ilsley DD, Lee SH, Miller WH, Kuchia RD. 
Acyclic gunaosine analogues inhibit DNA polymerase a, 8 and c with very 
different potencies and have unique mechanisms of action. 
Biochemistry (1995). 34: 2504-10 
107 Weber CH, Vincenz C. 
The death domain superfamily: a tale of two interfaces? 
Trends Biochem Sci (2001). 26(8): 475-81 
108 Li GM. 
The role of mismatch repair in DNA damage-induced apoptosis. 
Oncol Res (1999). 11(9): 393-400 
156 
109 Borchers K, Field H]. 
Neuronal latency in human and animal herpesvirus Infections. 
Curr Top Microbiol Immunol (2001). 253: 61-94 
110 Soderberg-Naucler C, Nelson ]Y. 
Human cytomegalovirus latency and reactivation -a delicate balance 
between thevirus and its host's immune system. 
Intervirology (1999). 42(5-6): 314-21 
111 Sinkovics ]G, Horvath ]C. 
Kaposi's sarcoma: breeding ground of herpesvirldae -A tour de force 
over viral evolution. 
Int J Oncol (1999). 14(4): 615-46 
112 Raftery M, Muller A, Schonrich G. 
Herpesvirus homologues of cellular genes. 
Virus Genes (2000). 21(1-2): 65-75 
113 Darby, GK. 
In search of the perfect antiviral. 
Antiviral Chem Chemother (1995). 6: 54-63 
114 Gustafson EA, Chillerni AC, Sage DR, Fingeroth 3D. 
The Epstein-Barr virus thymidine kinase does not phosphorylate 
ganciclovir or aciclovir and demonstrates a narrow substrate specificity 
compared to herpes simplex virus type thymidine kinase. 
Antimicrob. Agents & Chemother. (1998) 42: 2923-31 
115 Tenney D3, Yamanaka G, Voss SM, Cianci CW, Tuomari AV, 
Sheaffer AK, Alarn M, Colonno R]. 
Lobucavir is phosphorylated in human cytomegalovirus-Infected and - 
uninfected cells and Inhbitis the viral DNA polymerase. 
Antimicrobial Agents & Chemother (1997). 41: 2680-85 
116 Zimmermann A, Michel D, Pavic I, Hampl W, Luske A, Neyte 3, 
DeClercq E, Mertens T. 
Phosphorylation of aciclovir, ganciclovir, penciclovir and S2242 by the 
cytomegalovirus UL97 protein: a quantitative analysis using recombinant 
vaccinia viruses. 
Antivir Res (1997). 36: 35-42 
117 Borelli E, Heyman R, Hsi M, Evans RM. 
Targetting of an Inducible toxic phenotype In animal cells. 
Proc Nat Acad Sci USA (1988). 85: 7572-76 
118 Culver KW. Ram Z, Wallbridge 5, Ishii H, Oldfield EH, Blaese RM. 
In vivo transfer with retroviral vector producer cells for treatments of 
experimental brain tumours. 
Science (1992). 256: 1550-52 
119 Aghi M, Hochberg F, Breakefield XO. 
Prodrug activation enzymes in cancer gene therapy. 
3 Gene Med (2000). 2(3): 148-64 
120 Freeman SM. 
Suicide gene therapy. 
Adv Exp Med Biol (2000). 465: 411-22 
121 Dachs GU, Dougherty G], Stratford 13, Chaplin D3. 
Targeting gene therapy to cancer: a review. 
Oncol Res (1997). 9(6-7): 313-25 
157 
122 Costantini LC, Bakowska 3C, Breakefield XO, Isacson O. 
Gene therapy in the CNS. 
Gene Ther (2000). 7(2): 93-109 
123 Mesnil M, Yamasaki H. 
Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir 
cancer gene therapy: role of gap-junctional intercellular communication. 
Cancer Res (2000). 60(15): 3989-99 
124 Lachmann RH, Efstathiou S. 
Gene transfer with herpes simplex vectors. 
Curr Opin Mol Ther (1999). 1(5): 622-32 
125 Hammerschmidt W. 
Herpesvirus vectors come of age. 
Curr Opin Mol Ther (2000). 2(5): 532-9 
126 The chapters by Anderson EP and Noda L. 
The Enzymes 3rd Ed. 
Academic Press (1973) 
127 Schulz, GE. 
Binding of nucleotides to proteins. 
Curr Opin Struct Biol (1992). 2: 61-67 
128 Koonin EV, Senkevich TG. 
Evolution of thymidine and thymidylate kinases: the possibility of 
independent capture of TK genes by different groups of viruses. 
Virus Genes (1992). 6(2): 187-96 
129 Harrison PT, Thompson R, Davison A3. 
Evolution of herpesvirus thymidine kinases from cellular deoxycytidine 
kinase. 
3 Gen Virol (1991). 72: 2504-10 
130 3ohansson K, Ramaswamy S, Ljungcrantz C, Knecht W, Piskur 3, 
Munch-Petersen B, Eriksson S, Eklund H. 
Structural basis for substrate specificities of cellular deoxyribonucleoside 
kinases. 
Nat Struct Biol (2001). 8(7): 616-20 
131 Lavie A, Schlichting I, Vetter IR, Konrad M, Reinstein 3, Goody 
RS. 
The bottleneck In AZT activation. 
Nat Med (1997). 3(8): 922-4 
132 Lavie A, Vetter IR, Konrad M, Goody RS, Reinstein 3, Schlichting 
I. 
Structure of thymidylate kinase reveals the cause behind the rate 
limiting step In AZT activation. 
Nat Struct Biol (1997). 4: 601-4 
133 Schlauderer G3, Proba K, Schulz GE. 
Structure of a mutant adenylate kinase ligated with an ATP-analogue 
showing domain closure over ATP. 
3 Mol Biol (1996). 256(2): 223-7 
134 Abele U, Schulz GE. 
High resolution structure of adenylate kinase from yeast liganded with 
AP5A showing the pathway of phosphoryl transfer. 
Protein Sci (1995). 4: 1262-71 
158 
135 Yan, H Tsai, M. D. 
Mechanism of adenylate kinase. 
Biochemistry (1991) 30: 5539-46 
136 Krell T, Maclean J, Boam DJ, Cooper A, Resmini M, Brocklehurst K, 
Kelly SM, Price NC, Lapthorn A], Coggins JR. 
Biochemical and X-ray crystallographic studies on shikimate kinase: the 
important structural role of the P-loop lysine. 
Protein Sci (2001). 10(6): 1137-49 
137 Schulz, G. E., Muller, C. W & Diederichs, K. 
Induced-fit movements In adenylate kinase. 
3 Mol Biol (1990). 213: 627-30 
138 Vonrhein C, Schlauderer G3, Schulz GE. 
Movie of the structural changes during a catalytic cycle of nucleoside 
monophosphate kinases. 
Structure (1995). 3(5): 483-90 
139 Muller CW, Schlauderer G3, Reinstein J, Schulz GE. 
Adenylate kinase motions during catalysis: an energetic counterweight 
balancing substrate binding. 
Structure (1996). 4(2): 147-56 
140 Jamieson AT, Gentry GA, Subak-Sharpe JH. 
Induction of both thymidine and deoxycytidine kinase activity by herpes 
viruses. 
J Gen Virol (1974). 24(3): 465-80 
141 Cheng YC, Ostrander M. 
Deoxythymidine kinase induced in HeLa TK- cells by herpes simplex virus 
type I and type II. II. Purification and characterization. 
3 Biol Chem (1976). 251(9): 323-6 
142 Shugar D. 
The NTP phosphate donor in kinase reactions: is ATP a monopolist? 
Acta Biochim (1996). 43(1): 9-23 
143 Darby G, Larder BA, Inglis MM. 
Evidence that the "active centre" of herpes simplex virus thymidine 
kinase Involves an interaction between three distinct regions of the 
polypeptide. 
I Gen Virol (1986). 67: 753-8 
144 Vogt J, Perozzo R, Pautsch A, Prota A, Schelling P, Pilger B, 
Folkers G, Scapozza L, Schulz GE. 
Nucleoside binding site of herpes simplex type 1 thymidine kinase 
analyzed by X-ray crystallography. 
Proteins (2000). 41(4): 545-53 
145 Blundell TL, Srinivasan N. 
Symmetry, stability, and dynamics of multidomain and multicomponent 
protein systems. 
Proc Natl Acad Sci USA (1996). 93(25): 14243-8 
146 ]ones S, Thornton JM. 
Protein-protein interactions: A review of protein dimer structures. 
Prog Biophys Mol Biol (1995). 63: 31-65 
147 Wurth C, Kessler U, Vogt ], Schulz GE, Folkers G, Scapozza L. 
159 
The effect of substrate binding on the conformation and structural 
stability of Herpes simplex virus type 1 thymidine kinase. 
Protein Sci (2001). 10(1): 63-73 
148 Jordan A, Reichard P. 
Ribonucleotide reductases. 
Annu Rev Biochem (1998). 67: 71-98 
149 Scott CP, Kashlan OB, Lear 3D, Cooperman BS. 
A quantitative model for allosteric control of purine reduction by 
murine ribonucleotide reductase. 
Biochemistry (2001) 40(6): 1651-61 
150 Logan DT, Andersson 3, Sjoberg BM, Nordlund P. 
A glycyl radical site in the crystal structure of a class III ribonucleotide 
reductase. 
Science (1999). 283: 1499-504 
151 Wild K, Bohner T, Aubry A, Folkers G, Schultz GE. 
The three-dimensional structure of thymidine kinase from herpes simplex 
virus type-1. 
FEBS Lett (1995). 368: 289-92 
152 Wild K, Bohner T, Folkers G, Schultz GE. 
The structures of thymidine kinase from herpes simplex virus type-1 in 
complex with substrates and a substrate analogue. 
Protein Sci (1997). 6: 2097-106 
153 Brown DG, Visse R, Sandhu G, Davies A, Rizkallah P3, Melitz C, 
Summers WC, Sanderson MR. 
Crystal structures of the thymidine kinase from Herpes simplex virus 
type-1 In complex with deoxythymidine and ganciclovir. 
Nat Struct Biol (1995). 2: 876-881 
154 Degreve B, Esnouf R, De Clercq E, Balzarini J. 
Characterization of multiple nuclear localization signals in herpes simplex 
virus type 1 thymidine kinase. 
Biochem Biophys Res Commun (1999). 264(2): 338-42 
155 McPherson A, Malkin A3, Kuznetsov YG. 
The science of macromolecular crystallization. 
Structure (1995). 3(8): 759-68 
156 Sutton B3, Sohl MK. 
Crystallization of membrane proteins for X-ray analysis. 
Methods Mol Biol (1994). 27: 1-18 
157 McPherson A, Malkin A3, Kuznetsov YuG. 
Atomic force microscopy in the study of macromolecular crystal growth. 
Annu Rev Blophys Blomol Struct (2000). 29: 361-410 
158 Luft 3R, DeTitta GT. 
Kinetic aspects of macromolecular crystallization. 
Methods Enzymol (1997). 276: 110-31 
159 Kierzek AM, Zielenkiewicz P. 
Models of protein crystal growth. 
Biophys Chem (2001). 91(1): 1-20 
160 Schoenborn BP, Garcia A, Knott R. 
Hydration in protein crystallography. 
Prog Blophys Mol Biol (1995). 64(2-3): 105-19 
160 
161 Juers DH, Matthews BW. 
Reversible lattice repacking illustrates the temperature dependence of 
macromolecular Interactions. 
J Mol Biol (2001). 311(4): 851-62 
162 Huang DB, Chang CH, Ainsworth C, Brunger AT, Eulitz M, Solomon 
A, Stevens FJ, Schiffer M. 
Comparison of crystal structures of two homologous proteins: structural 
origin of altered domain interactions in immunoglobulin light-chain 
dimers. 
Biochemistry (1994). 33(49): 14848-57 
163 Scheffzek K, Kliche W, Wiesmüller L, Reinstein J. 
Crystal structure of the complex of UMP/CMP kinase from Dictyostellum 
discoideum and the bisubstrate inhibitor P1-(5'-adenosyl)-P5-(5'-uridyl) 
pentaphosphate and Mg24 at 2.2A: implications for water mediated 
specificity. 
Biochemistry (1996). 35: 9716-27 
164 De Winter H, Herdewijn P. 
Understanding the binding of 5-substituted 2'-deoxyuridine substrates to 
thymidine kinase of herpes simplex virus type-1. 
3 Med Chem (1996). 39: 4727-37 
165 Spadari S, Maga G, Focher F, Ciarocchi G, Manservigi R, Arcarnone 
F, Capobianco M, Caruro A, Colonna F, lotti S, Garbesi A. 
5-iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L- 
uridine: effective phosphorylation by herpes simplex virus type-1 
thymidine kinase, antiherpetic activity and cytotoxicity studies. 
Mol Pharmacol (1992) 47: 1231-38 
166 Ciucci A, Iafrate EM, Manzini 5, Giachetti A. 
Mechanism of antiviral action of (E)-5-(2-bromovinyl)-2'-deoxyuridine 
(BVDU) 
Antivir Chem & Chemother (1997). 8: 565-71 
167 Luyten L, Dewinter H, Busson R, Lescrinier T, Creuven I, Durant F, 
Balzarini 3, De Clerq E, Herdewijn P. 
Synthesis of 2'-deoxy-5-(isothiazol-5yl)uridine and Its Interaction with 
the HSV-1 thymidine kinase. 
Helvet Chim Acta (1996). 79: 1462-74 
168 Verheggen I, van Aerschot A, Toppet 5, Snoeck R, Janssen G, 
Balzarini J, De Clerq E, Herdewijn P. 
Synthesis and antiherpes activity of 1,5-anhydrohexitol nucleosides. 
3 Med Chem (1995). 36: 2033-40 
169 Verheggen I, Van Aerschot A, Van Meervelt L, Rozenski 3, Wiebe 
L, Snoeck R, Andrei G, Balzarini J, Claes P, De Clercq E. 
Synthesis, biological evaluation, and structure analysis of a series of new 
1,5-anhydrohexitol nucleosides. 
J Med Chem (1995). 38(5): 826-35 
170 Xu H, Maga M, Focher F, Smith ER, Spadari S, Gambino J, Wright 
GE. 
Synthesis, properties and pharmokinetic studies of N2-phenylguanine 
derivatives as inhibitors of herpes simplex virus thymidine kinases. 
J Med Chem (1995). 38: 49-57 
171 Gaudio AC, Takahata Y, Richards WG. 
161 
Prediction of the binding mode of N-2-phenylguanine derivative inhibitors 
to herpes simplex virus type 1 thymdine kinase. 
J Comput Mol Design (1998). 12: 15-25 
172 Gebhardt BM, Wright GE, Xu HY, Focher F, Spadari S, Kaufman HE. 
9-(4-hydroxybutyl)-N2-phenylguanine (HBPG), a thymidine kinase 
inhibitor, suppresses herpes virus reactivation in mice. 
Antivir Res (1996). 30: 87-94 
173 Kaufman HE, Varnell ED, Wright GE, XU HY, Gebhardt BM, 
Thompson HW. 
Effect of 9-(4-hydroxybutyl)-N2-phenylguanine (HBPG), a thymidine 
kinase inhibitor, on clinical recurrences of ocular herpetic keratitis in 
squirrel monkeys. 
Antivir Res (1996). 33: 65-72 
174 Elion GB, Furman PA, Fyfe )A, De Miranda P, Beauchamp C, 
Schaeffer H). 
Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) 
guanine. 
Proc Nat Acad Sci USA (1977) 74: 5716-20 
175 Karkas )D, Germershausen 3, Tolman RL, MacCoss M, Wagner AF, 
Liou R, Bostedor R. 
Stereochemical considerations in the enzymatic phosphorylation and 
antiviral activity of acyclonucleosides. I. Phosphorylation of 2'-nor-2'- 
deoxyguanosine. 
Biochim Biophys Acta (1987). 911(2): 127-35 
176 Vere Hodge RA, Darlison 53, Earnshaw DL, Readshaw SA. 
Use of isotopically chiral [4'-13C]penciclovir and 13C NMR to determine 
the specificity and absolute configuration of penciclovir phosphate esters 
formed in HSV-1 and HSV-2 infected cells and by HSV-1-encoded 
thymidine kinase. 
Chirality (1993). 5(8): 583-8 
177 Arnold )RP, Chen MS, Cullis PM, Lowe G. 
The stereochemical course of phosphoryl transfer catalyzed by herpes 
simplexvirus type-1 thymidine kinase. 
J Biol Chem (1986). 261: 1985-7 
178 Alber F, Kuonen 0, Scapozza L, Folkers G, Carloni P. 
Density functional studies on herpes simplex virus type-1 thymidine 
kinase substrate interactions: The role of Tyr172 and Met128. 
Prot Struct. Funct and Genet (1998). 31: 453-9 
179 Field H). 
Herpes simplex virus antiviral drug resistance--current trends and future 
prospects. 
J Clin Virol (2001). 21(3): 261-9 
180 KussmannGerber S, Kuonen O, Folkers G, Pilger BD, Scapozza L. 
Drug resistance of herpes simplex virus type 1- Structural 
considerations at the molecular level of the thymidine kinase. 
Eur. 3 Biochem (1998). 255: 472-81 
181 Galmarini CM, Mackey )R, Dumontet C. 
Nucleoside analogues: mechanisms of drug resistance and reversal 
strategies. 
Leukemia (2001). 15(6): 875-90 
162 
182 Pelosi E, Mulumba GB, Coen DM. 
Penciclovir and pathogenesis phenotypes of drug-resistant herpes 
simplex virus mutants. 
Antivir Res (1998). 37: 17-28 
183 Bodaghi B, Mougin C, Michelson S, Agut H, Dighiero P, Offret H, 
Frau E. 
Acyclovir-resistant bilateral keratitis associated with mutations In the 
HSV-1 thymidine kinase gene. 
Exp Eye Res (2000). 71(4): 353-9 
184 Wilber BA, Docherty 33. 
Analysis of the thymidine kinase of a herpes simplex virus type 1 Isolate 
that exhibits resistance to (E)-5-(2-b romovinyl)-2'-deoxyuridine. 
3 Gen Virol (1994). 75(7): 1743-7 
185 Palu G, Gerna G, Bevilacqua F, Marcello A. 
A point mutation in the thymidine kinase gene is responsible for 
acyclovir-resistance in herpes simplex virus type 2 sequential Isolates. 
Virus Res (1992). 25(1-2): 133-44 
186 Hwang CB, Ruffner KL, Coen DM. 
A point mutation within a distinct conserved region of the herpes simplex 
virus DNA polymerase gene confers drug resistance. 
3 Virol (1992). 66(3): 1774-6 
187 Van Rompay AR, Johansson M, Karlsson A. 
Phosphorylation of nucleosides and nucleoside analogs by mammalian 
nucleoside monophosphate kinases. 
Pharmacol Ther (2000). 87(2-3): 189-98 
188 Knecht W, Munch-Petersen B, Piskur J. 
Identification of residues Involved in the specificity and regulation of the 
highly efficient multisubstrate deoxyribonucleoside kinase from 
Drosophila melanogaster. 
3 Mol Biol (2000). 301(4): 827-37 
189 Munch-Petersen B, Piskur 3, Sondergaard L. 
Four deoxynucleoside kinase activities from Drosophila melanogaster are 
contained within a single monomeric enzyme, a new multifunctional 
deoxynucleoside kinase. 
3 Biol Chem (1998). 273(7): 3926-31 
190 Black ME, Newcomb TG, Wilson HMP, Loeb LA. 
Creation of drug specific herpes simplex virus type 1 thymidine kinase 
mutants for gene therapy. 
Proc Nat Acad Sci USA (1996). 93: 3525-9 
191 Gane P3, Dean PM. 
Recent advances in structure-based rational drug design. 
Curr Opin Struct Biol (2000). 10(4): 401-4 
192 Klerdaszuk B, Krawiec K, Kazimierczuk Z, 3acobsson U, 
Johansson NG, Munch-Petersen B, Eriksson S, Shugar D. 
Substrate/inhibitor properties of human deoxycytidine kinase (dCK) and 
thymidine kinases (TK1 and TK2) towards the sugar moiety of 
nucleosides, including 0'-alkyl analogues. 
Nucleosides Nucleotides (1999). 18(8): 1883-903 
193 Sanderson MR, Freemont PS, Murthy HMK, Krane JF, Summers WC, 
Steitz TA. 
163 
Purification and crystallisation of thymidine kinase of herpes simplex 
virus type-i. 
J Mol Biol (1988). 202: 917-9 
194 Chance B, Fischetti R, Powers L. 
Structure and kinetics of the photoproduct of carboxymyoglobin at low 
temperatures: an X-ray absorption study. 
Biochemistry (1983). 22(16): 3820-9 
195 Hope H. 
Cryocrystallography of biological macromolecules: a generally applicable 
method. 
Acta Cryst B (1988). 44 (1): 22-6 
196 Rodgers DW. 
Cryocrystallography. 
Structure (1994). 2(12): 1135-40 
197 Collaborative Computational Project Number 4 
Acta Cryst D (1994). 50: 760-3 
198 Otwinowski Z. 
Oscillation data reduction program. 
in 
Sawyer L, Isaacs N, Bailey S. 
Data Collection and Processing. CCP4 Daresbury Study Weekend (1993). 
199 Otwinowski Z, Minor W. 
Processing of X-ray diffraction data collected in oscillation mode. 
Meth Enzymol (1994). 276: 307-26 
200 French S, Wilson K. 
On the treatment of negative intensity observations. 
Acta Cryst A (1978). 34: 517-25 
201 Champness JN, Bennett MS, Wien F, Visse R, Summers WC, 
Herdewijn P, De Clerq E, Ostrowski T, 3arvest RL, Sanderson MR. 
Exploring the active site of herpes simplex virus type-1 thymidine kinase 
by x-ray crystallography of complexes with aciclovir and other ligands 
Prot Struct Func Genet (1998). 32: 350-61 
202 Bennett MS, Wien F, Champness JN, Batuwangala T, Rutherford T, 
Summers WC, Hongmao S, Wright GE, Sanderson MR. 
Structure to 1.9A of a complex with herpes simplex virus type-1 
thymidine kinase of a novel, non-substrate inhibitor: X-ray 
crystallographic comparison 
with binding of aciclovir. 
FEBS Lett (1999). 443: 121-5 
203 Ostrowski T, Wroblowski B, Busson R, DeClerq E, Bennett MS, 
Champness JN, Summers WC, Sanderson MR, Herdewijn P. 
5-substituted pyrimidines with a 1,5-anhydro-2,3, dideoxy-D-arabino- 
hexitol moiety at Ni: Synthesis, antiviral activity, conformational 
analysis, and interaction with viral thymidine kinase. 
J Med Chem (1998). 41: 4343-53 
204 Murshudov GN, Vagin AA, Lebedev A, Wilson KS, Dodson E3. 
Efficient anisotropic refinement of macromolecular structures using FFT. 
Acta Cryst D (1999). 55 (1): 247-55 
205 Sheldrick GM, Schneider TR. 
164 
SHELXL: High-resolution refinement. 
Meth Enzymol (1997). 277: 319-43 
206 Brünger AT. 
The Free R value: a Novel Statistical Quantity for Assessing the Accuracy 
of Crystal Structures. 
Nature (1992). 355: 472-4 
207 McCree DE. 
XtalView Xfit -A versatile program for manipulating atomic 
coordinates and electron density. 
3 Struct Biol (1999). 125: 156-65 
208 Perrakis A, Harkiolaki M, Wilson KS, Lamzin VS. 
ARP/wARP and molecular replacement. 
Acta Cryst D (2001). 57(Pt 10): 1445-50 
209 Klegwegt A. 
The analysis of non-crystallographic symmetry. 
Acta Cryst A (1982). A38: 62-7 
210 Sancar A. 
DNA excision repair. 
Ann Rev Biochem (1996). 65: 43-83 
211 van Houten B. 
Nucleotide excision repairs in E. coli. 
Microbiol Rev (1990). 54: 18-51 
212 Batty DP, Wood RD. 
Damage recognition in nucleotide excision repair of DNA. 
Gene. 2000 Jan 11; 241(2): 193-204. 
213 Goosen N, Moolenaar GF, Visse R, van de Putte P. 
Nucleic Acids and Molecular Biology 
(Eckstein, F. and Lilley, D. eds) (1998) 
214 Zou Y, Luo C, Geacintov NE. 
Hierarchy of DNA damage recognition In Escherichla Coll nucleotide 
excision repair. 
Biochemistry (2001). 40(9): 2923-31 
215 Yamagata A, Masui R, Kato R, Nakagawa N, Ozaki H, Sawai H, 
Kuramitsu S, Fukuyama K. 
Interaction of UvrA and UvrB proteins with a fluorescent single- 
stranded DNA. Implication for slow conformational change upon 
Interaction of UvrB with DNA. 
J Biol Chem (2000). 275(18): 13235-42 
216 Moolenaar GF, Monaco V, van der Marel GA, van Boom )H, Visse R, 
Goosen N. 
The effect of the DNA flanking the lesion on formation of the UvrB-DNA 
preincision complex. Mechanism for the UvrA-mediated loading of UvrB 
onto a DNA damaged site. 
J Biol Chem (2000). 275(11): 8038-43 
217 Zou Y, Van Houten B. 
Strand opening by the UvrA(2)B complex allows dynamic recognition of 
DNA damage. 
EMBO J (1999). 18(17): 4889-901 
218 Zou Y, Bassett H, Walker R, Bishop A, Amin S, Geacintov NE, 
165 
van Houten B. 
Hydrophobic forces dominate the thermodynamic characteristics of 
UvrA-DNA damage Interactions. 
I Mol Bio) (1998). 281(1): 107-19 
219 Goosen N, Moolenaar GF. 
Role of ATP hydrolysis by UvrA and UvrB during nucleotide excision 
repair. 
Res Microbiol (2001). 152(3-4): 401-9 
220 Theis K, Skorvaga M, Machius M, Nakagawa N, Van Houten B, 
Kisker C. 
The nucleotide excision repair protein UvrB, a helicase-like enzyme with 
a catch. 
Mutat Res (2000). 460(4): 277-300 
221 Moolenaar GF, Monaco V, van der Marel GA, van Boom JH, Visse R, 
Goosen N. 
The effect of the DNA flanking the lesion on formation of the UvrB-DNA 
preincision complex. Mechanism for the UvrA-mediated loading of UvrB 
onto a DNA damaged site. . 
3 Biol Chem (2000). 275(11): 8038-43 
222 Visse R, King A, Moolenaar GF, Goosen N, van de Putte P. 
Protein-DNA interactions and alterations in the DNA structure upon 
UvrB-DNA preincision complex formation during nucleotide excision 
repair in Escherichia coli. 
Biochemistry (1994). 33(33): 9881-8 
223 Verhoeven EE, Wyman C, Moolenaar GF, Hoeijmakers JH, 
Goosen N. 
Architecture of nucleotide excision repair complexes: DNA is wrapped 
by UvrB before and after damage recognition. 
EMBO 3 (2001). 20(3): 601-11 
224 Nazimiec M, Lee CS, Tang YL, Ye X, Case R, Tang Ms M. 
Sequence-Dependent Interactions of Two Forms of UvrC with DNA 
Helix-Stabilizing CC-1065-N3-Adenine Adducts. 
Biochemistry (2001). 40(37): 11073-81 
225 Tang Ms, Nazimiec M, Ye X, Iyer GH, Eveleigh J, Zheng Y, Zhou W, 
Tang YY. 
Two forms of UvrC protein with different double-stranded DNA binding 
affinities. 
J Biol Chem (2001). 276(6): 3904-10 
226 Ahn B. 
A physical Interaction of UvrD with nucleotide excision repair protein 
UvrB. 
Mol Cell (2000). 10(5): 592-7 
227 Hildebrand EL, Grossman L. 
Oligomerization of the UvrB nucleotide excision repair protein of 
Escherichla coll. 
3 Biol Chem (1999). 274(39): 27885-90 
228 Hsu DS, Kim ST, Sun Q, Sancar A. 
Structure and function of the UvrB protein. 
3 Biol Chem (1995). 270(14): 8319-27 
229 Shlbata A, Nakagawa N, Sugahara M, Masui R, Kato R, 
166 
Kuramitsu S, Fukuyama K. 
Crystallization and preliminary X-ray diffraction studies of a DNA 
excision repair enzyme, UvrB, from Thermus thermophilus HB8. 
Acta Cryst D (1999). 55 (3TE704-5 
230 Machius M, Henry L, Palnitkar M, Deisenhofer 1. 
Crystal structure of the DNA nucleotide excision repair enzyme UvrB 
from Thermus thermophilus. 
Proc Nat Acad Sci USA (1999). 96: 11717-22 
231 Nakagawa N, Sugahara M, Masui R, Kato R, 
Fukuyama K, Kuramitsu S. 
Crystal structure of Thermus thermophilus HB8 UvrB protein, 
a key enzyme of nucleotide excision repair. 
J Blochem (1999). 126(6): 986-90 
232 Moolenaar GF, Visse R, Ortizbuysse M, Goosen N, van 
de Putte P. 
Helicase motiv-V and motif-VI of the Escheria coil UvrB 
protein of the UVRABC endonuclease are essential for 
the formation of the preincision complex. 
3 Mol Biol (1994). 240: 294-307 
233 Nakagawa N, Masul R, Kato R, Kuramitsu S. 
Domain structure of Thermus thermophilus UvrB protein. Similarity In 
domain structure to a helicase. 
3 Biol Chem (1997). 272(36): 22703-13 
234 Theis K, Skorvaga M, Machius M, Nakagawa N, Van Houten B, 
Kisker C. 
The nucleotide excision repair protein UvrB, a helicase-like enzyme with 
a catch. 
Mutat Res (2000). 460(3-4): 277-300 
235 Moolenaar GF, Franken KLMC, Dijkstra DM, Thomas-Oates 3E, 
Visse R, van de Putte P, Goosen N. 
The C-terminal region of the UvrB protein of Escherichia coll contains 
an Important determinant for UvrC binding to the preincision complex 
but not the catalytic site for 3'-incision. 
J Biol Chem (1995). 270: 30508-315 
236 Visse R, van Gool A3, Moolenaar GF, de Ruijter M, van de Putte P. 
The actual incision determines the efficiency of repair of cisplatin- 
damaged DNA by the Escherichia coil UvrABC endonuclease. 
Biochemistry (1994). 33(7): 1804-11 
237 Visse It, de Ruijter M, Moolenaar GF, van de Putte P. 
Analysis of UvrABC endonuclease reaction intermediates on cisplatin- 
damaged DNA using mobility shift gel electrophoresis. 
3 Biol Chem (1992). 267(10): 6736-42 
238 Verhoeven EE, van Kesteren M, Moolenaar GF, Visse R, Goosen N. 
Catalytic sites for 3' and 5' incision of Escherichia coil nucleotide 
excision repair are both located in UvrC. 
J Biol Chem (2000). 275(7): 5120-3 
239 Moolenaar GF, Bazuine M, van Knippenberg IC, Visse R, Goosen 
N]. 
Characterization of the Escherichia coil damage-independent UvrBC 
endonuclease activity. 
167 
J Biol Chem (1998). 273: 34896-903 
240 Moolenaar GF, Franken KLMC, van de Putte P, Goosen N. 
Function of the homologous regions of the Escherichia cola DNA excision 
repair proteins UvrB and UvrC In stabilization of the UvrBC-DNA 
complex and in 3'-incision 
Mut Res (1998). 385: 195-203 
241 Alexandrovich A., Sanderson MR, Goosen N, Moolenaar GF, 
Lane AN. 
NMR assignments and secondary structure of the UvrC binding domain 
of UvrB. 
FEBS Lett (1999). 451: 181-5 
242 Sohl M, Alexandrovich A, Moolenaar G, Visse R, Goosen N, 
Vernede X, Fontecilla"Camps 3C, Champness 3, Sanderson MR. 
Crystal structure of Escherichia coil UvrB C-terminal domain, and a 
model for UvrB-uvrC Interaction. 
FEBS Lett (2000). 465(2-3): 161-4 
243 Ramachandran GN, Ramachandran C, Sasisekharan V. 
J Mol Biol. (1963). 7: 95-7 
244 Alexandrovich A, Czisch M, Frenkiel TA, Kelly GP, Goosen N, 
Moolenaar GF, Chowdry BZ, Sanderson MR, Lane AN. 
Solution Structure, Hydrodynamics and Thermodynamics of the UvrB 
C-terminal Domain. 
J Blol Struct Design (in press) 
245 Lin 33, Phillips AM, Hearst 3E, Sancar A. 
Active-site of A(BC) excinuclease. Binding, bending and catalysis 
mutants of UvrB reveal a direct role in 3' and an indirect role In 5' 
Incision. 
J Blol Chem (1992). 267: 17693-700 
246 Lin 33, Sancar A. 
Active-site of A(BC) excinuclease . 1. Evidence for 5' incision by UvrC through a catalytic site Involving Asp399, Asp438, Asp466 and His538 
residues. 
J Blol Chem (1992). 25: 17688-176 
247 Visse R, King A, Moolenaar GF, Goosen N, van de Putte P. 
Protein-DNA Interactions and alterations in the DNA structure upon 
UvrB-DNA preincislon complex formation during nucleotide excision 
repair in Escherichia coll. 
Blochem (1994). 33: 9881-8 
248 Hendrickson WA, Horton )R, LeMaster DM. 
Selenomethionyl proteins produced for analysis by multiwavelength 
anomalous diffraction (MAD) -a vehicle for direct determination of 
3"dimenslonal structure. 
EMBO J (1990). 9: 1665-72 
249 Doublle S. 
Preparation of selenomethionyl proteins for phase determination. 
Meth Enzymol (1997). 276: 523-30 
250 Vernede x, Fontecilla-Camps 3C. 
A method to stabilize reduced and or gas-treated protein crystals by 
flash-cooling under a controlled atmosphere. 
3 Appl Cryst (1999). 32: 505-9 
168 
251 Terwilliger TC, Berendzen J. 
Automated MAD and MIR structure solution. 
Acta Cryst D (1999). 55: 849-61 
252 Ramakrishnan V, Biou V. 
Treatment of multiwavelength anomalous diffraction data as a special 
case of multiple isomorphous replacement. 
Meth Enzymol (1997). 276: 538-57 
253 Otwinowski Z. 
Maximum likelihood refinement of heavy atom parameters 
in Wolf W, Evans PR, Leslie AGW. (eds). 
Isomorphous Replacement and Anomalous Scattering. 
CCP4 Daresbury Study Weekend (1991). 
254 Cowtan K. 
'dm': An automated procedure for phase Improvement by density 
modification. 
Joint CCP4 and ESF-EACBM Newsletter on Prot. Crystal. (1994). 31: 34-8 
255 Cowtan K, Zhang KY3. 
Density modification for macromolecular phase improvement. 
Prog Blophys and Mol Biol (1999). 72: 245-270 
256 Kohlstaedt LA, Wang 3, Friedman 3M, Rice PA, Steitz TA. 
Crystal structure at 3.5 A resolution of HIV-1 reverse 
transcriptase complexed with an inhibitor. 
Science (1992). 26; 256(5065): 1783-90 
257 Vaguine AA, Richelle. J, Wodak S3. 
SFCHECK: a unified set of procedures for evaluating the 
quality of macromolecular structure-factor data and their 
agreement with the atomic model. 
Acta Cryst D (1999). 55: 191-205 
258 Brünger AT, Kurcyan 3, Karplus M. 
Crystallographic R-factor refinement by molecular-dynamics. 
Science (1987). 235: 458.60 
259 Various articles In Methods Enzymol (2001). 340: 412-30. 
260 Umek RM, Lin SW, Vielmetter 3, Terbrueggen RH, Irvine B, Yu C3, 
Kayyem 3F, Yowanto H. Blackburn GF, Farkas DH, Chen YP. 
Electronic detection of nucleic acids: a versatile platform for molecular 
diagnostics. 
J Mol Diagn (2001). 3(2): 74-84 
261 Gaasterland T, Oprea M. 
Whole-genome analysis: annotations and updates. 
Curr Opln Struct 81ol (2001). 11(3): 377-81 
262 Murphy C3, Barton 3K. 
Ruthenium complexes as luminescent reporters of DNA. 
Methods Enzymol (1993). 226: 576-94 
263 Reddy BS, Sondhl SM, Lown 3W. 
Synthetic DNA minor groove-binding drugs. 
Pharmacol Ther (1999). 84(1): 1-111 
264 Han X, Gao X. 
Sequence specific recognition of ligand-DNA complexes studied by NMR. 
Curr Med Chem (2001). 8(5): 551-81 
169 
265 Turner PR, Denny WA. 
The genome as a drug target: sequence specific minor groove binding 
ligands. 
Curr Drug Targets (2000). 1(1): 1-14 
266 Winters TA. 
Gene targeted agents: new opportunities for rational drug development. 
Curr Opin Mol Ther (2000). 2(6): 670-81 
267 Dervan PB, Burli RW. 
Sequence-specific DNA recognition by polyamides. 
Curr Opin Chem Biol (1999). 3(6): 688-93 
268 Nielsen PE. 
Antisense peptide nucleic acids. 
Curr Opin Mol Ther (2000). 2(3): 282-7 
269 Ray A. Norden B. 
Peptide nucleic acid (PNA): its medical and biotechnical applications and 
promise for the future. 
FASEB J (2000). 14(9): 1041-60 
270 Sreedhara A, Cowan 3A. 
Catalytic hydrolysis of DNA by metal ions and complexes. 
J Biol Inorg Chem (2001). 6(4): 337-47 
271 Kielkopf CL, Erkkila KE, Hudson BP, Barton 3K, Rees DC. 
Structure of a photoactive rhodium complex intercalated Into DNA. 
Nat Struct Biol (2000). 7(2): 117-21 
272 Nunez ME, Barton 3K. 
Probing DNA charge transport with meta Ilointercalators. 
Curr Opin Chem 131o1 (2000). 4(2): 199-206 
273 Fink HW. 
DNA and conducting electrons. 
Cell Mol Life Sc! (2001). 58(1): 1-3 
274 Odom DT, Barton 3K. 
Long-range oxidative damage in dna/rna duplexes. 
Biochemistry (2001). 40(30): 8727.37 
27S Wan C, Flebig T, Schlemann 0, Barton 3K, Zewail AH. 
Fcmtosecond direct observation of charge transfer between bases In 
DNA. 
Proc Natl Acad Sci USA (2000). 97(26): 14052-5 
276 Reid GD, Whittaker D3, Day MA, Creely CM, Tuite EM, Kelly 3M, 
Beddard GS. 
Ultralast electron-transfer reactions between thionine and guanosine 
bases. 
3 Am Chem Soc (2001). 123(28): 6953.4 
277 Medvedev D, Stuchebrukhov AA. 
DNA repair mechanism by photolyase: electron transfer path from the 
photolyase catalytic cofactor FADH(-) to DNA thymine dimer. 
J Theor ß1o1 (2001). 210(2): 237-48 
278 Flel R3. 
Porphyrln-nucleic acid Interactions: a review. 
J Biomol Struct Dyn (1989). 6(6): 1259-74 
170 
279 Ford KG, Neidle S. 
Perturbations in DNA structure upon interaction with porphyrins revealed 
by chemical probes, DNA footprinting and molecular modelling. 
Bloorg Med Chem (1995). 3(6): 671-7 
280 Carvlin M3, Mark E, Fiel R, Howard 3C. 
Intercalative and nonintercalative binding of large cationic porphyrin 
ligands to polynucleotides. 
Nucleic Acids Res (1983). 11(17): 6141-54 
281 Sehlstedt U, Kim SK, Carter P, Goodisman 3, Vollano 3F, Norden B, 
Dabrowiak 3C. 
Interaction of cationic porphyrins with DNA. 
Biochemistry (1994). 33(2): 417-26 
282 Mestre S. 3akobs A, Pratviel G, Meunier B. 
Structure/nuclease activity relationships of DNA cleavers based on 
cationic metalloporphyrin-oligonucleotide conjugates. 
Biochemistry (1996). 35(28): 9140-9 
283 Dougherty T3, Gomer C3, Henderson BW, 3ori G, Kessel D, 
Korbellk M, Moan 3, Peng Q. 
Photodynamic therapy. 
3 Natl Cancer Inst (1998). 90(12): 889-905 
284 Carviln M3, Datta-Gupta N, Fiel R3. 
Circular dichrolsm spectroscopy of a cationic porphyrin bound to DNA. 
Biochem Biophys Res Commun (1982). 108(1): 66-73 
285 Banville DL, Marzllli LG, Wilson WD. 
31P NMR and viscometric studies of the interaction of meso-tetra(4-N- 
methylpyridyl) porphine and its NI(II) and Zn(II) derivatives with DNA. 
Biochem Blophys Res Commun (1983). 113(1): 148-54 
286 Han H, Langley DR, Rangan A, Hurley LH. 
Selective Interactions of Cationic Porphyrins with G-Quadruplex 
Structures. 
3 Am Chem Soc (2001). 123(37): 8902-13 
287 Villanueva A, Cagglarl L, 3ori G, Milanesi C. 
Morphological aspects of an experimental tumour photosensitized with a 
meso-substituted cationic porphyrin. 
3 Photochem Photobiol B (1994). 23(1): 49-56 
288 Izblcka E, Wheelhouse RT, Raymond E, Davidson KK, Lawrence 
RA, Sun D, Windle BE, Hurley LH, Von Hoff DD. 
Effects of catlonlc porphyrins as G-quadruplex interactive agents in 
human tumor cells. 
Cancer Res (1999). 59(3): 639-44 
289 Fedoroff OY, Salazar M, Han H, Chemeris VV, Kerwin SM, Hurley 
LH. 
NMR"Based model of a telomerase-inhibiting compound bound to 
G-quadruplex DNA. 
Biochemistry (1998). 37(36): 12367-74 
290 Gullaev AS, Leontis NB. 
Cationic 5,10,15,20"tetrakis(N-methylpyridinium-4-yl) porphyrin fully 
Intercalates at S'-CG-3' steps of duplex DNA in solution. 
Biochemistry (1999). 38(47): 15425-37 
171 
291 Ford K, Fox KR, Neldle S, Waring M7. 
DNA sequence preferences for an intercalating porphyrin compound 
revealed by footprinting. 
Nucleic Acids Res (1987). 15(5): 2221-34 
292 Dabrowlak 3C, Ward B, Goodisman 3. 
Quantitative footprinting analysis using a DNA-cleaving metalloporphyrin 
complex. 
Biochemistry (1989). 28(8): 3314-22 
293 Lipscomb LA, Zhou FX, Presnell SR, Woo R7, Peek ME, Plaskon RR, 
Williams I. D. 
Structure of DNA-porphyrin complex. 
Biochemistry (1996). 35(9): 2818-23 
294 Geacintov NE, Ibanez V, Rougee M, Bensasson RV. 
Orientation and linear dichroism characteristics of porphyrin-DNA 
complexes. 
Biochemistry (1987). 26(11): 3087-92 
295 Ford KG, Pearl LH, Neidle S. 
Molecular modelling of the interactions of tetra-(4-N-methylpyridyl) 
porphyrin with TA and CG sites on DNA. 
Nucleic Acids Res (1987). 15(16): 6553-62 
296 Pratviel G, Bernadou 3, Ricci M, Meunier B. 
Magnesium monoperoxophtalate: an efficient single oxygen atom donor 
in DNA cleavage catalyzed by metalloporphyrin. 
Blochern Blophys Res Commun (1989). 160(3): 1212-8 
297 Bernadou 3, Lauretta B, Pratviel G, Meunier B. 
1'-carbon hydroxylation of deoxyribose as the mechanism of cleavage of 
poly(dA) by manganese porphyrin combined with potassium 
monopersulfate. 
CR Acad Sci III (1989). 309(10): 409-14 
298 Bennett M, Krah A, Wien F, Garman E, McKenna R, Sanderson M, 
Neldle S. 
A DNA-porphyrin minor-groove complex at atomic resolution: the 
structural consequences of porphyrin ruffling. 
Proc Natl Acad Sci USA (2000). 97(17): 9476-81 
299 Lavery R, Sklenar H. 
The definition of generalized helicoidal parameters and of axis curvature 
for irregular nucleic acids. 
3 Blomol Struct Dyn (1988). 6(1): 63.91 
300 Ulyanov NO, Zhurkin VB. 
Sequence-dependent anisotropic flexibility of B-DNA. A conformational 
study. 
3 Biomol Struct Dyn (1984). 2(2): 361-85 
301 Laughton C. Luisl B. 
The mechanics of minor groove width variation in DNA, and its 
Implications for the accommodation of ligands. 
3 Mol ß1o1 (1999). 288(5): 953-63 
302 Bhattacharyya D, Bansal M. 
Groove width and depth of B"DNA structures depend on local variation in 
slide. 
3 Blomol Struct Dyn (1992). 10(1): 213.26 
172 
303 Shul X, Peek ME, Lipscomb LA, Wilkinson AP, Williams LD, Gao M, 
Ogata C, Roques BP, Garbay-3aureguiberry C, Wilkinson AP, 
Williams I. D. 
Effects of cationic charge on three-dimensional structures of 
Intercalative complexes: structure of a bis-intercalated DNA complex 
solved by MAD phasing. 
Curr Med Chem (2000). 7(1): 59-71 
304 Lipscomb LA, Zhou FX, Williams I. D. 
Clathrate hydrates are poor models of biomolecule hydration. 
Biopolymers (1996). 38(2): 177-81 
305 Belton PS. 
Nuclear magnetic resonance studies of the hydration of proteins and 
DNA. 
Cell Mol Life Sci (2000). 57(7): 993-8 
306 Calladine CR, Drew HR. 
A useful role for 'static' models in elucidating the behaviour of DNA in 
solution. 
3 Mol Blol (1996). 257(3): 479-85 
307 Peek ME, Williams I. D. 
X-ray crystallography of DNA-drug complexes. 
Methods Enzymol (2001). 340: 282-90 
Kochoyan M, Leroy 3L. 
308 Hydration and solution structure of nucleic acids. 
Curr Opin Struct Blol (1995). 5(3): 329-33 
309 Cheatham TE 3rd, Kollman PA. 
Molecular dynamics simulation of nucleic acids. 
Annu Rev Phys Chem (2000). 51: 435-71 
310 Halle B, Denisov VP. 
Water and monovalent Ions in the minor groove of B-DNA 
oligonucleotides as seen by NMR. 
Blopolymers (1998). 48(4): 210-33 
311 Lipscomb LA, Peek ME, Zhou FX, Bertrand JA, VanDerveer D, 
Williams I. D. 
Water ring structure at DNA interfaces: hydration and dynamics of DNA- 
anthracycllne complexes. 
Biochemistry (1994). 33(12): 3649-59 
312 Shul X, McFall-Isom L, Hu GG, Williams I. D. 
The B-DNA dodecamer at high resolution reveals a spine of water on 
sodium. 
Biochemistry (1998). 37(23): 8341-55 
313 Medforth C3, Senge MO, Smith KM, Sparks LD, Shelnutt 7A. 
3 Am Chem Soc (1992): 114: 9859-69 
314 Barkigla KM, Renner MW, Furenlid LR, Medford C3, Smith KM, 
Fajer 3. 
3 Am Chem Soc (1993). 115: 3627-35 
315 3entzen W, Simpson MC, Hobbs 3D, Song X, Ema T, Nelson NY, 
Medford C3, Smith KM, Veyrat M, Mazzanti M. 
3 Am Chem Soc (1995). 117: 11085-97 
316 Medforth C3, Muzzl CM, Shea KM, Smith KM, Abraham R3, )ia S, 
173 
Shelnutt 3A. 
J Chem Soc Perkin Trans (1997). 2: 833-7 
317 Wertsching AK, Koch AS, DiMagno SG. 
On the negligible impact of ruffling on the electronic spectra of 
porphine, tetramethyiporphyrin, and perfluoroalkylporphyrins. 
3 Am Chem Soc (2001). 123(17): 3932-9 
318 Ma 3G, Zhang 3, Franco R, 3ia SL, Moura I, Moura 33, Kroneck PM, 
Shelnutt 3A. 
The structural origin of nonplanar heme distortions in tetraheme 
ferricytochromes c3. 
Biochemistry (1998). 37(36): 12431-42 
319 Liaw YC, Gao YG, Robinson H, Sheldrick GM, Sliedregt LA, van der 
Marel GA, van Boom 3H, Wang AH. 
Cyclic diguanylic acid behaves as a host molecule for planar 
intercalators. 
FEBS Lett (1990). 264(2): 223-7. 
320 Chen YZ, Mohan V, Griffey RH. 
Spontaneous base flipping in DNA and its possible role In 
methyltransferase 
binding. 
Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (2000). 
62(1): 1133.7 
321 Woolfson M, Fan HF. 
Physical and non-physical methods of solving crystal structures. 
Cambridge University Press (1995) 
322 Glacovazzo C, Monaco HL, Viterbo F, Scordari F, Gilli G, Zanotti G, 
Cattl M. 
Fundamentals of crystallography 
Oxford University Press (1995) 
323 Blundell TL, Johnson I. N. 
Protein Crystallography. 
Academic Press (1976) 
324 Drenth 3. 
Principles of Protein X-ray Crystallography. 
Springer-Verlag (1994) 
325 Uson I, Sheldrick GM. 
Advances In direct methods for protein crystallography. 
Curr Opin Struct Blot. 1999 Oct; 9(5): 643-8 
326 Lamzin VS, Perrakis A, Bricogne G, Jiang 3, Swaminathan S, 
Sussman JL. 
Apotheosis, not apocalypse: methods in protein crystallography. 
Acta Crystallogr D Biol Crystallogr (2000). 56(11): 1510-1 
327 Hauptman HA. 
Shake-and-bake: an algorithm for automatic solution ab initio of crystal 
structures. 
Methods Enzymol (1997). 277: 3-13 
328 Mukherjee M, Haiti S, Ghosh S, Woolfson MM. 
A direct-method ab initio phasing of a protein, cupredoxin amicyanin, at 
1.31A resolution. 
174 
Acta Cryst D (2001). 57: 1276-80 
329 Guo DY, Blessing RH, Langs DA. 
Globbic approximation in low-resolution direct-methods phasing. 
Acta Cryst D. (2000). 56: 1148-55 
330 Mlao 3, Kirz 7, Sayre D. 
The oversampling phasing method. 
Acta CrystD (2000). 56: 1312-5 
331 Petrova TE, Lunin VY, Podjarny AD. 
Ab initio low-resolution phasing in crystallography of macromolecules by 
maximization of likelihood. 
Acta Cryst D (2000). 56: 1245-52 
332 Gilmore C, Dong W, Bricogne, G. (1999). 
A multisolution method of phase determination by combined 
maximization of entropy and likelihood. VI. The use of error-correcting 
codes as a source of phase permutation and their application to the 
phase problem in powder, electron and macromolecular crystallography. 
Acta Cryst A (1999). 55: 70-83 
333 Sayre D. 
The squaring method: a new method for phase determination. 
Acta Cryst (1952). 5: 60-5 
334 Debaerdemaeker T, Tate C. Woolfson MM. 
On the application of phase relationships to complex structures. XXVI. 
Developments of the Sayre-equation tangent formula. 
Acta Cryst A (1988). 44: 353-7 
33S Post B. 
A solution of the X-ray 'phase problem'. 
Acta Cryst A (1979). 35: 17-21 
336 Hummer K. Billy HW. 
Theoretical considerations on phase determination by three-beam 
Interference. 
Acta Cryst A (1982). 38: 841-8 
337 Han FS, Chang SL. 
Determination of a centrosymmetric crystal structure using 
experimentally determined phases with the direct method. 
Acta Cryst A (1983). 39: 98-101 
338 Hummer K, Billy H. 
Experimental determination of triplet phases and enantiomorphs of non- 
centrosymmetric structures. I. Theoretical considerations. 
Acta Cryst A (1986). 42: 127-33 
339 Templeton DH, Templeton LK. 
X-ray dichroism and polarized anomalous scattering of the uranyl ion. 
Acta Cryst (1982). A38: 62-7 
340 Templeton LK, Templeton DH. 
Biaxial tensors for anomalous scattering of X-rays in selenolanthionine. 
Acta Cryst A (1988). 44: 1045-51 
341 Hendrickson WA, Pahler A, Smith 3L, Satow Y, Merritt EA, 
Phizackerley RP. 
Crystal structure of core streptavidin determined from multiwavelength 
anomalous diffraction of synchrotron radiation. 
175 
Proc Natl Acad Sci USA (1989). 86(7): 2190-4 
342 Fanchon E, Hendrickson WA. 
Effect of the anisotropy of anomalous scattering on the MAD phasing 
method. 
Acta Cryst A (1990). 46(10): 809-20 
343 Sheldrick GM. 
Heavy atom location using SHELXS-90. 
In Wolf W, Evans PR, Leslie AGW. (eds). 
Isomorphous Replacement and Anomalous Scattering. 
CCP4 Daresbury Study Weekend (1991). 
344 Howell L, Smith D. 
Normal Probability Analysis: 
3 Appl Cryst (1992). 25: 81-86 
345 Rice LM, Earnest TN, Brunger AT. 
Single-wavelength anomalous diffraction phasing revisited. 
Acta Cryst D (2000). 56: 1413-20 
348 Abrahams JP, Leslie AGW. 
Methods used in the structure determination of bovine mitochondrial F1 
ATPase. 
Acta Cryst D. (1996). 52: 30-42 
346 Brodersen DE, de La Fortelle E, Vonrhein C, Bricogne G, Nyborg 3, 
Kjeldgaard M. 
Applications of single-wavelength anomalous dispersion at high and 
atomic resolution. 
Acta Cryst D (2000). 56(4): 431-41 
347 Wang BC. 
Resolution of phase ambiguity In macromolecular crystallography. 
Methods Enzym (1985). 115: 90-112 
348 Zhang KY31 Cowtan K, Main P. 
Combining constraints for electron-density modification. 
Methods Enzym (1997). 277: 53-64 
349 Abrahams JP, Leslie AGW. 
Methods used In the structure determination of bovine mitochondrial 171 
ATPase. 
Acta Cryst D. (1996). 52: 30-42 
350 Rossmann MG. 
The molecular replacement method. 
Acta Cryst A (1990). 46(2): 73-82 
351 Kissinger CR, Gehlhaar DK, Fogel DB. 
Rapid automated molecular replacement by evolutionary search. 
Acta Cryst D (1999). 55(2): 484-91 
352 Beurskens PT, Admiraal G, Beurskens G, Bosman WP, 
Garcia-Granda S, Gould RO, Smits 3MM, Smykalia C. 
DIRDIF: A Computer Program System for Crystal Structure Determination 
by Patterson Methods and Direct Methods Applied to Difference Structure 
Factors. 
353 Britton D. 
Two-dimensional packing and pseudosymmetry. 
Acta Cryst B (2000). 56(5): 828-32 
176 
354 White HE, Driessen HP, Slingsby C, Moss DS, Turnell WG, Lindley 
PF. 
The use of pseudosymmetry in the rotation function of gamma IVa- 
crystallin. 
Acta Cryst B (1988). 44(2): 172-8 
355 Carredano E, Kauppl-B, Choudhury D, Ramaswamy S. 
Pseudo-symmetry characterization and refinement of a trigonal crystal 
form of naphthalene 1,2-dioxygenase. 
Acta Cryst D (2000). 56 (3): 313-21 
356 Flack HD. 
On enantiomorph-polarity estimation. 
Acta Cryst A (1983). 39: 876-881 
357 Yeates TO, Farn BC. 
Protein crystals and their evil twins. 
Structure Fold Des (1999). 7(2): 125-9 
358 Dumas P, Ennifar E, Walter P. 
Detection and treatment of twinning: an Improvement and new results. 
Acta Cryst D (1999). 55(6): 1179-87 
359 Yeates TO. 
Detecting and overcoming crystal twinning. 
Methods Enzymol (1997). 276: 344-58 
360 Yang F, Dauter Z, Wlodawer A. 
Effects of crystal twinning on the ability to solve a macromolecular 
structure using multiwavelength anomalous diffraction. 
Acta Cryst D (2000). 56(8): 959-64 
361 Mueller U. Muller YA, Herbst-Irmer R, Sprinzl M, Heinemann U. 
Disorder and twin refinement of RNA heptamer double helices. 
Acta Cryst D (1999). 55 (8): 1405-13 
362 Rees DC. 
The Influence of twinning by merohedry on intensity statistics. 
Acta Cryst A (1980). 36: 578-581 
363 Jameson GB. 
On structure refinement using data from a twinned crystal. 
Acta Cryst A (1982). 38: 817-820 
364 Jameson GB. 
Personal communication. 
365 Arndt UW, Champness JN, Phizackerley RP, Wonacott A]. 
A single-crystal oscillation camera for large unit cells. 
3 Appl Cryst (1973). 6: 457-463 
366 Harrison SC, Winkler FK, Schutt CE, Durbin RM. 
Diffraction methods for biological macromolecules. Oscillation method 
with large unit cells. 
Methods Enzymoi (1985). 114: 211-37 
367 Patterson AL. 
A Fourier Series Method for the Determination of the Components of 
Interatomic Distances In Crystals 
Phys Rev (1934). 46: 372-6 
368 Harker D. 
177 
J Chem Phys (1936). 4: 381-390 
369 Patterson AL. 
An alternative interpretation for vector maps. 
Acta Cryst (1949). 2: 339-340 
370 Buerger, M. J. 
Vector sets. 
Acta Cryst (1950). 3: 87-97 
371 Sayre D. 
The double Patterson function. 
Acta Cryst (1953). 6: 430-1 
372 Rossmann MG, Blow DM. 
The detection of sub-units within the crystallographic asymmetric unit 
Acta Cryst (1962). 15: 24-31 
373 Buerger MJ. 
Vector space. 
Wiley (1967) 
374 Read R3. 
Pushing the boundaries of molecular replacement with maximum 
likelihood. 
Acta Cryst D (2001). 57: 1373-82 
375 Rossmann MG. 
Molecular replacement - historical background. 
Acta Cryst D (2001). 57(10): 1360-6 
376 Hauptman H, Karle 3. 
Solution of the phase problem. I The centrosymmetric crystal. 
ACA Monograph No: 3 (1953) 
377 Hauptman H, Karle J. 
Structure Invariants and seminvariants for noncentrosymmetric space 
groups 
Acta Cryst. (1956). 9: 45-55 
378 Cochran W. 
Relations between the phases of structure factors 
Acta Cryst (1955). 8: 473-8 
379 Germain G, Main P, Woolfson MM. 
On the application of phase relationships to complex structures. II. 
Getting a good start. 
Acta Cryst B (1970). 26: 274-85 
380 Narayan R, Nityanand R. 
The maximum determinant method and the maximum entropy method 
Acta Cryst A (1982). 38: 122-8 
381 Bricogne G. 
Maximum entropy and the foundations of direct methods 
Acta Cryst A (1984). 40: 410-45 
382 Bricogne G. 
A Bayesian statistical theory of the phase problem. I. A multichannel 
maximum-entropy formalism for constructing generalized joint probability 
distributions of structure factors. 
Acta Cryst A (1988). 44:: 517-45 
178 
383 Perutz MF. 
Isomorphous Replacement and Phase Determination in Non- 
centrosymmetric Space Groups. 
Acta Cryst (1956). 9: 867-73 
384 Blow DM, Rossmann MG. 
The Single Isomorphous Replacement Method. 
Acta Cryst (1961). 14: 1195-1202 
385 Yeates TO, Rees DC. 
An isomorphous replacement method for phasing twinned structures. 
Acta Cryst A (1987) 43: 30-36 
386 Bijovet 3M. 
Proc Koninki Ned Akad Wetenschap (1949) B52: 313-14 
387 Blundell TL, Pitts 3E, Tickle IL, Wood SP, Wu CW. 
Proc Nat Acad Sci USA (1981). 78: 4175-9 
388 Ralph AC, Woolfson MM. 
On the Application of One-Wavelength Anomalous Scattering. III The 
Wilson and MPS Method. 
Acta Cryst A (1991). 47: 533-537 
389 Woolfon MM, Yao 3X. 
On the Application of One-Wavelength Anomalous Scattering. 
IV The Absolute Configuration of the Anomalous Scatterers. 
Acta Cryst D (1994). 50: 7-10 
390 Mukherjee AK, Helliwell 3R, Main P. 
The use of MULTAN to Locate the Positions of Anomalous Scatterers. 
Acta Cryst A (1989). 45: 715-8 
391 Kartha G, Partharasarathy R. 
Combination of Multiple Isomorphous Replacement and Anomalous 
Dispersion Data for Protein Structure Determination. I. Determination of 
heavy-Atom Positions in Protein Derivatives. 
Acta Cryst (1965). 18: 745-52 
392 Ralph AC, Woolfson MM. 
On the Application of One-Wavelength Anomalous Scattering. III The 
Wilson and MPS Method. 
Acta Cryst A (1991). 47: 533-7 
393 Woolfon MM, Yao 3X. 
On the Application of One-Wavelength Anomalous Scattering. 
IV The Absolute Configuration of the Anomalous Scatterers. 
Acta Cryst D (1994). 50: 7-10 
394 Read R3. 
As MAD as can be. 
Structure (1996). 4(1): 11-4 
395 Hendrickson WA. 
Determination of macromolecular structures from anomalous diffraction 
of synchrotron radiation. 
Science (1991). 254(5028): 51-8 
396 Terwilliger TC, Berendzen J. 
Bayesian Correlated MAD Phasing. 
Acta Cryst D (1997). 53: 571-9 
179 
397 Blow DM, Crick FHC. 
The treatment of errors in the isomorphous replacement method 
Acta Cryst (1959). 12: 794-802 
398 Rossmann MG. 
The accurate determination of the position and shape of heavy-atom 
replacement groups in proteins. 
Acta Cryst (1960). 13: 221-6 
399 Hendrickson WA, Lattman EE. 
Representation of phase probability distributions for simplified 
combination of independent phase information 
Acta Cryst B (1970). 26: 136-43 
400 Cowtan K. 
Error Estimation and Bias Correction in Phase Improvement Calculations. 
Acta Cryst D (1999). 55: 1555-67 
401 Cowtan K. 
General quadratic functions in real and reciprocal space and their 
application to likelihood phasing. 
Acta Cryst D (2000). 56: 1612-21 
402 Terwilliger TC, Eisenberg, D. 
Unbiased Three-Dimensional Refinement of Heavy-Atom Parameters by 
Correlation of Origin-Removed Patterson Functions. 
Acta Cryst A (1983). 39: 813-7 
403 Abrahams 3P, De Graaff RA. 
New developments In phase refinement. 
Curr Opin Struct Biol (1998). 8(5): 601-5 
404 Read R7. 
Dealing with imperfect isomorphism in multiple Isomorphous 
replacement. 
in Wolf W, Evans PR, Leslie AGW. (eds). 
Isomorphous Replacement and Anomalous Scattering. 
CCP4 Daresbury Study Weekend (1991). 
405 Karle 3. 
Partial structural Information combined with the tangent formula for 
noncentrosymmetric crystals 
Acta Cryst B (1968). 24: 182-6 
406 Hull SE, Irwin MI. 
On the application of phase relationships to complex structures. XIV. The 
additional use of statistical Information in tangent-formula refinement 
Acta Cryst A (1978). 34: 863-70 
407 van den Hark EM, Prick P, Beurskens PT. 
The application of direct methods to non-centrosymmetric structures 
containing heavy atoms. 
Acta Cryst A (1976). 32: 816-21 
408 Read R]. 
Improved Fourier coefficients for maps using phases from partial 
structures with errors. 
Acta Cryst A (1986). 42: 140-9 
409 Srlnlvasan R. 
180 
Weighting functions for use in the early stage of structure analysis when 
a part of the structure is known. 
Acta Cryst (1966). 20: 143-4 
410 Fan HF, Gu YX. 
Combining direct methods with isomorphous replacement or anomalous 
scattering data. III. The incorporation of partial-structure information 
Acta Cryst (1985). A41,280-4 
411 Woolfson MM. 
An Improvement of the 'heavy-atom' method of solving crystal 
structures. 
Acta Cryst (1956). 9: 804-10 
412 Sim GA. 
The distribution of phase angles for structures containing heavy atoms. 
II. A modification of the normal heavy-atom method for non- 
centrosymmetrical structures. 
Acta Cryst (1959). 12: 813-27 
413 Sim GA. 
A note on the heavy-atom method 
Acta Cryst (1960). 13: 511-2 
414 Hendrickson WA. 
Some aids for breaking the phase ambiguity In the single isomorphous 
replacement method. 
Acta Cryst B (1971). 27: 1474-5 
415 Hauptman H. 
On Integrating the techniques of direct methods and isomorphous 
replacement. I. The theoretical basis 
Acta Cryst A (1982) 38: 289-94 
416 Fan HF, Han FS, Qian ]Z, Yao, ]X. 
Combining direct methods with isomorphous replacement or anomalous 
scattering data. I. 
Acta Cryst A (1984). 40: 489-95 
417 Liu YD, Gu YX, Zheng CD, Hao Q, Fan HF. 
Combining direct methods with isomorphous replacement or anomalous 
scattering data. VIII. Phasing experimental SIR data with the replacing 
atoms in a centrosymmetric arrangement. 
Acta Cryst D (1999). 55(4): 846-8 
418 Fan HF, Hao Q, Gu YX, Qian ]Z, Zheng CD, Ke HM. 
Combining direct methods with isomorphous replacement or anomalous 
scattering data. VII. Ab initio phasing of one-wavelength anomalous 
scattering data from a small protein 
Acta Cryst A (1990). 46: 935-9 
419 Gu YX, Liu YD, Hao Q, Ealick SE, Fan HF. 
Direct-method-aided phasing of MAD data. 
Acta Cryst D (2001). 57(2): 250-3 
420 Okaya Y. Salto Y, Pepinsky R. 
New Method In X-Ray Crystal Structure Determination Involving the Use 
of Anomalous Dispersion. 
Phys Rev (1955). 98: 1857-8 
421 Pepinsky R, Okaya Y. 
181 
Comparison of Two Procedures for Solution of Noncentric Crystal 
Structures Utilizing Anomalous Dispersion 
Phys Rev (1957). 108: 1231-2 
422 Hao Q, Woolfson MM. 
Application of the Ps-function method to macromolecular structure 
determination 
Acta Cryst. (1989). A45: 794-7 
423 Luzzati V. 
Resolution d'un structure cristalline lorsque les positions d'une partie 
des atoms sont connues: traltement statistique 
Acta Cryst (1953). 6: 142-152 
424 Engh RA, Huber R. 
Accurate bond and angle parameters for X-ray protein structure 
refinement. 
Acta Cryst A (1991). 47: 392-400 
425 Kuriyan 31 Osapay K, Burley SK, Brunger AT, Hendrickson WA, 
Karplus M. 
Exploration of disorder in protein structures by X-ray restrained 
molecular dynamics. 
Proteins (1991). 10(4): 340-58 
426 Dodson E, Moore M, Ralph A, Bailey S. 
Macromolecular Refinement. 
Proceedings of the CCP4 Study Weekend (1996). 
427 Jones TA, Zou JY, Cowan SW, Kjeldgaard M. 
Improved methods for building protein models in electron density maps 
and the location of errors In these models. 
Acta Cryst A (1991) 47: 110-9 
428 Longhi S, Czjzek M, Cambillau C. 
Messages from ultrahigh resolution crystal structures. 
Curr Opin Struct Biol (1998). 8(6): 730-7 
429 Jelsch, C. 
Sparsity of the normal matrix in the refinement of macromolecules at 
atomic and subatomic resolution. 
Acta Cryst A (2001). 57: 558-570 
430 Winn MD, Isupov MN,, Murshudov GN. 
Use of TLS parameters to model anisotropic displacements in 
macromolecular refinement. 
Acta Cryst D (2001). 57: 122-133 
t^. rn \ r. ar 
ýUM 
, 
ý: 
182 
